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ABSTRACT 
Polycyclic aromatic hydrocarbons (PAH) are ubiquitous pollutants released into 
the environment from the incomplete combustion of organic material and petrochemical 
sources. PAH are persistent molecules that partition into sediments and biota in the 
aquatic environment. PAH such as benzo[a]pyrene, are of concern because they are 
metabolised into potentially carcinogenic chemicals that can cause tumours in fish and 
mammals. 
The purpose of this research was three-fold, (1) to explore the use of the 
dungeness crab for monitoring PAH in the aquatic environment, (2) to adapt a 
physiologically based toxicokinetic (PBTK) model to describe the disposition of 
benzo[a]pyrene in the dungeness crab, and (3) to examine the lifetime cancer risk to 
humans associated with the consumption of PAH contaminated crabs. 
Kitimat Arm is an aquatic ecosystem in British Columbia, contaminated with 
PAH by industrial processes. Dungeness crabs were collected at several sites within this 
fjord, and concentrations of PAH were determined in the crabs by GCIMS. A 
synchronous fluorescence spectroscopy assay was adapted to screen crab haemolymph 
samples for pyrene and it's metabolites. PAH could be readily determined in the tissues 
of crabs and tissue concentrations decreased with distance from the source of the PAH 
contamination. Therefore, crabs were an effective tool for monitoring PAH 
contamination in the fjord. 
A PBTK model was adapted to describe the disposition of benzo[a]pyrene in the 
dungeness crab. The model was composed of seven compartments representing the major 
tissues of the crab. The flux of benzo[a]pyrene in each compartment was described by 
algebraic and mass-balance differential equations, coded into Visual Basic and solved 
numerically by an Excel spreadsheet. The model was implemented with parameters, 
calibrated, and validated using data obtained empirically. The model successfully 
predicted benzo[a]pyrene concentrations in the tissue compartments after simulated 
exposures to benzo[a]pyrene by intravascular, oral and water exposure routes. 
A human health risk assessment was conducted to evaluate the lifetime cancer 
risk associated with consumption of PAH contaminated crabs from Kitimat Arm. 
Deterministic and stochastic risk assessment models were implemented. There was an 
excess cancer risk associated with consumption of crabs from Hospital Beach, an area 
near the source of PAH contamination. 
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CHAPTER 1 
GENERAL INTRODUCTION 
1.1 Introduction 
PAH are a group of ubiquitous environmental pollutants. They are generated from 
the incomplete combustion of organic matter but are ultimately stored in the aquatic 
environment. PAH are generated as a complex mixture of heterocyclic ringed 
hydrocarbons, made up of hundreds of different molecules. Most PAH in the marine 
environment are associated with particulate materials such as black carbon (soot) and 
appear resistant to degradation and desorption (McGroddy and Farrington, 1995). PAH 
may also be associated with tars and oils in highly contaminated environments. 
1.1.1 Polycyclic Aromatic Hydrocarbons 
PAH have been studied as potential human carcinogens for many years. The 
initial discovery of the link between PAH and cancer is credited to Sir Percivall Pott who 
reported an increased incidence of scrota1 cancer among English chimney sweepers 
(Bjorseth and Becher, 1986). In the 1930s, PAH were identified as the cause of the 
carcinogenicity associated with soot and tar (OME, 1997). 
PAH may cause other types of toxic effects including skin and eye irritation, 
immunotoxicity, and developmental toxicity (OME, 1997). However, these effects have 
been demonstrated at high experimental doses, while the carcinogenic effects are 
assumed to occur at very low doses. 
Concern about PAH in the aquatic environment is largely related to their 
persistence in the environment and carcinogenic potential in fish and invertebrates. Some 
PAH are potent carcinogens for both aquatic and terrestrial animals. PAH are poorly 
water soluble, lipophilic molecules that partition readily into organic matter. PAH adsorb 
to particles of organic material in the air or water column, and ultimately settle into soil 
and sediments. Thus, an unusually high prevalence of oral, dermal and hepatic neoplasms 
have been observed in bottom-dwelling fish caught in PAH-contaminated waters and 
sediments (Couch and Harshbarger, 1985). However, the carcinogenicity of PAH appears 
to vary with the chemical composition of the mixture, the associated matrix, and the 
bioavailability of the PAH to animals (McGroddy and Farrington, 1995; Krahn et al., 
1986; Krahn et al., 1987). Despite the large number of studies on the environmental fate 
and effects of PAH, very few biomarkers of PAH exposure have been reported for 
invertebrates in the marine environment. Therefore, this research was conducted to 
examine the crab, (Cancer magister Dana), as an effective species for biomonitoring 
PAH on the Pacific Coast of North America. 
1.1.2 Crabs as Biomonitors 
The dungeness crab can be used as a tool for monitoring the presence of 
polycyclic aromatic hydrocarbons (PAH) in marine and estuarine environments. 
Generally, fish have been most commonly used to monitor PAH exposure in aquatic life. 
However, it is often difficult to determine PAH concentrations in fish tissues because 
these compounds are readily metabolised and eliminated by fish. Also, fish move around 
from place to place quickly, and are often only exposed to contaminants for short periods 
of time. 
Mussels have also been used extensively for biomonitoring a variety of 
contaminants including metals, PAH, and chlorinated organics such as pesticides and 
dioxins and furans. The Mussel Watch Project has been running since 1986 and involves 
numerous sites in the United States and around the world. In the year 2000, it was one of 
the largest, longest running monitoring programs ever conducted (National Status and 
Trends Program, 2000). 
The crab was seen as an alternative to the more commonly studied fish and 
bivalve species as a biomonitoring tool. While crabs are also important fisheries species, 
they have several differences that might be seen as attributes for biomonitoring. First, 
crabs are generally not as mobile as fish, and are intimately associated with sediments 
that may be contaminated with persistent chemicals such as PAH. Second, crabs and 
other invertebrates likely have a lower metabolic capacity than fish (Dunn and Fee, 
1979). Therefore, it may be expected that PAH may be more readily determined in the 
tissues of crabs than fish. Also, crabs are considered to have tissues that are richer in fat 
than fish. Environmental contaminants that are poorly water soluble such as PAH may be 
expected to accumulate more readily in the fatty tissues of the crab, rather than the leaner 
muscle of the fish. 
The dungeness crab has been used as a species for monitoring dioxins and furan 
contamination released from pulp mills and other sources on the Pacific Coast (PTI, 
1991 ; Bright et al., 1999; Yunker and Cretney, 1996; Yunker et al., 2002), and it has 
been shown that crabs can accumulate these persistent, fat soluble compounds in the 
hepatopancreas (Yunker and Cretney, 1996). Therefore, the dungeness crab was selected 
as a potentially ideal species for further study in biomonitoring PAH contamination in 
coastal environments. While mussels and other bivalves may also be well suited to 
biomonitoring PAH, I saw an opportunity to investigate the utility of the dungeness crab 
a species that has seen limited use as a biomonitor. 
1.1.3 Dungeness Crab 
The dungeness crab, (Cancer magister, Dana) is found along the Pacific coast of 
North America. It ranges from the northern shores of the Aleutian Islands in Alaska, to 
south of San Francisco in California. The dungeness crab preferentially inhabits eel-grass 
beds and muddy to sandy bottoms, from the low intertidal zone to depths in excess of 600 
ft. The dungeness crab is one of the most commercially important shellfish species 
harvested in many coastal communities. 
While crabs measuring approximately 25.5 cm (1 0 inches) across the back have 
been harvested off the coast of Washington, the crab seldom exceeds 20 cm (8 inches) 
and averages just under 18 cm (7 inches) of shell width. The legal harvestable size of 
male dungeness crabs in British Columbia is 16.4 cm. The dungeness crab has white- 
tipped claws and a brownish shell. 
The dungeness crab eats a wide variety of marine organisms. Stomachs of ocean 
crabs have been found to contain clams, fish, and crabs, as well as other items, including 
starfish, worms, squid, snails, and eggs from fish or crabs. The dungeness crab is also 
cannibalistic, a fact which has been observed in the laboratory and borne out by 
examination of stomach contents. 
The dungeness crab is also preyed upon by a number of organisms, including fish 
such as dogfish, hake, halibut, ling cod, sculpins, and wolf eel. The crab is consumed 
extensively by the octopus, cuttlefish, sea otters, and, of course, humans. 
1.1.4 Kitimat Arm 
Kitimat Arm was selected as an ideal location to examine the effectiveness of the 
crab as a biomonitoring tool. Kitimat Arm is part of a large group of fjords located on the 
northern coast of British Columbia, Canada (Figure 1.1). 
Figure 1.1 Map of British Columbia (adapted from Magellan Geographix, 1995) 
The head of Kitimat Arm is the site of considerable industrial activity including 
an aluminium smelter, a methanol plant and a pulp mill terminal (Figure 1.2). 
Figure 1.2 Kitimat Arm and Douglas Channel, BC, Canada. 
The aluminium smelter is alleged to be the primary source of PAH input into the 
marine environment through loss of green coke during transport to the smelter and 
release of PAH in airborne emissions, waterborne effluents, and surface runoff (Simpson 
et al., 1996; EVS, 1992). 
The town of Kitimat, BC, is situated about four miles from the head of Kitimat 
Arm. An aboriginal settlement, Kitamaat Village, is located on the eastern shore of 
Kitimat Arm (Figure 1.2). The largest tribe of aboriginal people settled there is known as 
the Haisla Nation. The Haisla people subsist on many indigenous aquatic organisms in 
Kitimat Arm including salmonids, halibut, seaweed, shrimp, seals, and crabs (Kitamaat 
Village Council, 1996). 
1.1.5 Risk Assessment 
Risk assessment is the characterisation of the potential adverse health effects of 
human exposures to environmental hazards (NAS, 1983). The risk assessment process 
can be divided into four main steps: hazard identification, dose-response assessment, 
exposure assessment, and risk characterisation. The hazard identification determines if 
human exposure to an agent could cause an increase in the incidence of an adverse health 
condition such as cancer or birth defects, etc. Dose-response assessment is the process of 
characterising the relationship between exposure of a population to an agent and the 
incidence of adverse health effects. Exposure assessment refers to the process of 
measuring or estimating the intensity, frequency, and duration of exposure to an agent in 
the environment (NAS, 1983). Risk characterisation involves the estimation of health 
effect incidences due to exposure to an agent described by the exposure assessment. 
I decided to conduct a human health risk assessment to determine if there was a 
potential for adverse health effects due to the consumption of PAH contaminated crabs 
collected from Kitimat Arm. This seemed to be a very logical use of the crab tissue data 
describing PAH contamination obtained from the biomonitoring studies. The risk 
assessment was designed to determine if the local aboriginal population located in 
Kitamaat Village were at a risk of increased cancer incidence. Presumably, the local 
peoples who subsist on crabs and other foods obtained from this environment would be at 
the greatest risk of adverse effects due to the consumption of contaminated crabs. 
1.1.6 PBTK Model 
Physiologically based pharmacokinetic (PBPK) models have been traditionally 
developed and used to describe the disposition of drugs in test animal models and 
humans. More recently, this modelling technique has been used to study the uptake, 
disposition, and elimination of drugs and antibiotics in fish. Physiologically based 
toxicokinetic models (PBTK) models have also been developed to predict the tissue 
concentrations of environmental contaminants in fish species, and to examine the uptake 
of these chemicals from the water. The PBTK model offers the risk assessor the ability to 
predict tissue concentrations in an organism based on the concentrations of a given 
chemical in the environment. Therefore, the PBTK model may used as a tool for 
predicting tissue concentration data for environmental and human health risk 
assessments. The PBTK model is a powerful tool because it is scalable and adaptable. A 
PBTK model developed for one species may be adapted by changing basic physiological 
parameters so that it can be used to predict tissue concentrations in another species. 
While this flexibility was initially designed for dealing with differences in scale between 
pharmaceutical test models such as rodents, and humans, it lends itself to adaptation for 
more environmentally relevant species such as fish. 
While PBTK models have been previously developed to describe the disposition 
of PAH such as pyrene in fish, this modelling approach has not been adapted to 
invertebrate species. Therefore, I chose to determine if a PBTK model designed to 
describe the disposition of PAH in fish, could be adapted to predict tissue concentrations 
of benzo[a]pyrene in the dungeness crab. 
1.1.7 Benzo[a]pyrene 
Benzo[a]pyrene was selected as the model PAH for the development of the PBTK 
model because it has been shown to be a carcinogenic in numerous animal studies, and is 
the best characterised PAH in terms of toxicity (U.S. EPA, 1991a). Figure 1.3 shows the 
structure of benzo[a]pyrene. 
Figure 1.3 Structure of benzolalpyrene 
In addition, benzo[a]pyrene is the reference to which all other carcinogenic PAH 
are compared for risk assessments (Nisbet and LaGoy, 1992; OME, 1997). Both the U.S. 
Environmental Protection Agency and the Ontario Ministry of Environment relate toxic 
equivalency or relative potency of carcinogenic PAH to benzo[a]pyrene (Nisbet and 
LaGoy, 1992; OME, 1997). The physical and chemical properties of benzo[a]pyrene are 
summarised in Table 1.1. 
Table 1.1 Physical and chemical properties of benzo[alpyrene' 
Property Value 
Molecular weight 252.3 
Melting point 
Boiling point 
Vapour pressure 
Density 
Log Kow 
Water solubility 
' ( ~ a t a  source: OME, 1997) 
Benzo[a]pyrene is a poorly water soluble PAH with a relatively high octanol 
water partition coefficient or log Kow. Thus it commonly adsorbs to organic material in 
the air or in water. Compounds with a high log Kow such as benzo[a]pyrene may be 
absorbed by aquatic organisms through the diet, or by gill uptake (Gobas and MacKay, 
1987; McElroy and Sisson, 1989; Gobas et al. 1993). Benzo[a]pyrene is a relatively 
stable and persistent molecule that can often be determined in soils, sediments, and biota 
that have been contaminated with PAH. 
1.2 Research Objectives 
The purpose of this research was three-fold, (1) to explore the use of the 
dungeness crab for monitoring PAH in the aquatic environment, (2) to adapt a 
physiologically based toxicokinetic (PBTK) model to describe the disposition of 
benzo[a]pyrene in the dungeness crab, and (3) to determine the lifetime cancer risk to 
humans associated with the consumption of PAH contaminated crabs. 
The remaining chapters of this thesis address these three objectives. Chapters 2 
and 3 examine the use of the dungeness crab as a biological tool for monitoring PAH in a 
coastal estuarine and marine environment. Chapters 4 and 5 describe laboratory 
experiments conducted to examine the toxicokinetics of benzo[a]pyrene in the dungeness 
crab for the development, calibration, and validation of the PBTK model for describing 
the disposition of benzo[a]pyrene in the crab. Finally, Chapters 6 and 7 address the 
potential for adverse human health effects associated with the consumption of PAH 
contaminated crabs collected from Kitimat Arm. 
CHAPTER 2 
DETERMINATION OF POLYCYCLIC AROMATIC 
HYDROCARBONS IN DUNGENESS CRABS 
OF KITIMAT ARM, BC. 
2.1 Introduction: 
Polycyclic aromatic hydrocarbon contaminants in the sediments and biota of 
Kitimat Arm have been the subject of a number of studies (Simpson et al., 1996; EVS, 
1992; Cretney et al., 1983; 6. EVS, 1995; 7. EVS, 1998; Paine et al., 1996). Although 
these studies have generally demonstrated elevated levels of PAH in the sediments, few 
studies have demonstrated significant levels of PAH contaminants in biota. Thus, 
although PAH have been found in the tissues of crabs (W. Cretney, personal 
communication, Institute of Ocean Studies, Sydney, BC, Canada, 1996), other 
researchers have concluded that there is limited bioavailability of PAH to the biota of 
Kitimat Arm (EVS, 1998; Paine et al., 1996). Since elevated levels of PAH in sediments 
may cause adverse effects to sediment-dwelling organisms, it is important to investigate 
the extent of PAH contamination in the dungeness crabs of Kitimat Arm. PAH- 
contaminated crabs are also a public health concern from the human consumers' 
perspective. 
Various species of crabs have been used to monitor PAH exposure around the 
world. Off the coast of North America, concentrations of PAH have been determined in 
the blue crab, Callinectes sapidus, collected from Chesapeake Bay, (Mothershead, 199 1 ; 
Hale, 1988; Anon., 1990); in the rock crab, Cancer irroratus, in New York Bight and 
Long Island Sound (Humason and Gadbois, 1982; Pancirov and Brown, 1977); in the 
snow crab, Chionoecetes opilio and the spider crab, Hyas coarctatus, on the coast of 
Newfoundland (Hellou et al., 1994). Other species have been used to biomonitor PAH 
elsewhere such as the swim crab, Polybius henslowi, on the Northern coast of France and 
Spain (Baumard et al., 1998); and the mud crab, Scylla serrata, obtained from the 
Brisbane River estuary in Australia (Kayal and Connell, 1995). 
Two hypotheses were formed at the outset of this study. First, the dungeness crab 
could be used to effectively biomonitor PAH in Kitimat Arm. To test this hypothesis, 
tissues would be collected from crabs caught in Kitimat Arm for analysis by GC-MS. The 
second hypothesis was that the concentrations of PAH determined in the crab tissues 
would decrease with increasing distance from the smelter, the alleged source of PAH 
input to the aquatic environment. 
This chapter describes the determination of 10 different PAH analytes in the 
hepatopancreas and muscle tissues of crabs collected from various sites within Kitimat 
Arm, BC, Canada. The levels and isomer distribution patterns of the PAH analytes in 
crabs from different sampling sites were examined to gain a better understanding of the 
bioavailability and fate of PAH in the crabs and to provide further evidence for the 
source(s) of PAH contamination in the area. 
2.2 Materials And Methods 
2.2.1 Study Area 
Crabs were collected from five different sites at or around Kitimat Arm, BC, 
Canada: Hospital Beach (53"59.60'N, 128"41.58'W), Kitamaat Village (53"59.22'N, 
128"39.25'W, 53"59.15'N, 128"39.30'W), Wathlsto Creek (53"57.09'N, 128"39.64'W), 
and one site each from Kildala Arm (53"50.52'N, 128'30.32'W) and Kitkiatka Inlet 
(53'38.1 'N, 129'15.5'W) (Figure 2.1). These sites were chosen based on their potential 
for collection of crabs and proximity to the smelter. The Hospital Beach site located on 
the western side of Kitimat Arm is the closest to the effluent outfall of the aluminium 
smelter. The Kitamaat Village and Wathlsto Creek sites located on the eastern side of 
Kitimat Arm are further away from the smelter. Kildala Arm, BC, Canada and Kitkiatka 
Inlet, BC, Canada, were selected as "clean" reference sites. 
2.2.2 Sample Collection 
Legal size, male dungeness crabs were caught at five different sites (Figure 2.1) 
using round, stainless steel, commercial crab traps (Ladner Crab Traps, Ladner, BC, 
Canada) at a depth of 15-50 m on four separate dates: March 1994, May 1995, May 1996 
and October 1996. Table 2.1 summarises the sampling locations, dates and catch results 
of these expeditions. Kitkiatka Inlet was only visited in March 1994. 
Table 2.1 Number of crabs collected at each sampling date and location in British Columbia, 
Canada. 
- - - 
Sample Date Hospital Kitamaat Wathlsto Kildala* Kitkiatka* 
Beach Village Creek Arm Inlet 
March 1994 - 2 0 - - 15 
May 1995 20 18 12 - 
May 1996 26 3 6 15 - 
October 1996 20 15 2 15 - 
Total 66 56 20 30 15 
* reference sites 
The crabs (n = 187) were weighed (744 10 g, mean + standard error) and the 
carapace width between the tips of the tenth antenna1 spines (1 7.6 0.1 cm, mean * 
standard error) was measured. Crabs were dissected on site to remove muscle and 
hepatopancreas tissues. Tissues were frozen immediately at -20•‹C for subsequent 
analysis in the laboratory at Simon Fraser University, Burnaby, BC, Canada. 
Figure 2.1 Map of Kitimat Arm showing crab collection sites. 
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2.2.3 Sample Preparation 
The tissue samples were homogenised individually using a model PT 10135 
Polytron homogeniser (Brinkman Company, Rexdale, ON, Canada). Excised muscle 
samples were solid, and required 0.9% saline (2: 1 wt tissuelwt saline) for 
homogenisation, while the hepatopancreas samples were soft and could be homogenised 
without added saline. An aliquot of the homogenate equivalent to 5 g hepatopancreas or 
15 g muscle was weighed separately in a 50 ml conical centrifuge tube with a Teflon- 
lined screw cap. Tissue samples were spiked separately with a solution containing the 
following deuterated internal PAH standards: acenaphthene-dlo, fluorene-dlo, anthracene- 
dl o, fluoranthene-dl 0, pyrene-dl 0, benz[a]anthracene-dl 2, benzo[b] fluoranthene-dl 2, 
benzo[k]fluoranthene-dl2, benzo[a]pyrene-d12 (CDN Isotopes, Pointe Claire, PQ, 
Canada), phenanthrene-dlo, and chrysene-d12, (Aldrich Chemical Company, Milwaukee, 
WI, USA). Acenaphthene-dlo, fluorene-dlo and benzofluoranthenes-d12 were not included 
in the spiking solution used to analyse the PAH analytes in muscle tissues. 
Each muscle homogenate was further split equally into two 50-ml conical 
centrifuge tubes before saponification. Both the hepatopancreas and muscle homogenates 
were saponified and extracted according to the procedure reported by the Axys Group 
(Axys Group, 1995) with recommendations from G. Brooks (personal communication 
Axys Group, Sydney, BC, Canada, 1997) and modifications. Briefly, about 1 ml of 50% 
wlv KOH and 7 ml of high performance liquid chromatography (HPLC) grade methanol 
were added to the homogenate. The mixture was refluxed at approximately 78•‹C for 1 
hour in a recirculating water bath. The samples were removed and vortexed after 20 and 
40 minutes of refluxing. After a 1 -hour saponification, distilled, deionised H20 (8 ml) 
was added to each sample. The procedure was repeated once. At the conclusion of a 2- 
hour saponification, the samples were allowed to cool to room temperature before being 
shaken with 22 ml of pentane for 15 min. Each saponified muscle homogenate was 
extracted in two separate tubes due to volume restrictions. However, each hepatopancreas 
tissue sample could be extracted in a single tube. The pentane layer was removed from 
each tube. The extraction procedure was repeated twice with freshly added pentane. The 
extracts were combined into one tube per sample and reduced to about 6 ml under a 
gentle stream of N2. One ml of iso-octane was added to minimise PAH loss through 
vaporization before volume reduction. The extracts were washed with 2 ml of 0.1 M HC1 
to remove the contaminants with basic pH. The organic extract was removed and reduced 
to 1 ml prior to silica gel column cleanup. 
Sample cleanup was performed by liquid chromatography using a 205 x 14 mm 
glass column packed with 1 cm sodium sulphate and 10 cm 230-400 mesh Silica Gel 60 
(Sigma-Aldrich Canada, Mississauga, ON, Canada). Column packing materials were 
mixed with pentane to form slurries and degassed before being added to the column. The 
packed column was rinsed with 1 bed volume of pentane before use. After adding the 
tissue extract, the column was rinsed with 12 ml of pentane and eluted with 15 ml of 
methylene chloride. The methylene chloride eluate was collected and evaporated down to 
near dryness with a gentle stream of N2. A solution of methylene chloride (50 pl) 
containing the deuterated recovery standards (naphthalene-d8, acenaphthylene-d8 and 
benzo[ghi]perylene-d12) was added, and the volume was adjusted to 100 pl prior to 
GUMS-selective ion monitoring (SIM) analysis. 
2.2.4 GCIMS-SIM Analysis 
Gas chromatography mass spectrometry was used to determine the concentrations 
of the following U.S. EPA priority PAH in the crab tissues: acenaphthene, fluorene, 
phenanthrene, anthracene, fluoranthene, pyrene, chrysene, benz[a]anthracene, 
benzo[b]fluoranthene and benzo[k]fluoranthene, and benzo[a]pyrene. An aliquot (1 p1) of 
the methylene chloride extract (see above) was injected directly into an Hewlett Packard 
5980 Series I1 gas chromatograph (Hewlett Packard Canada, Mississauga, ON, Canada). 
The GC was fitted with an HP 5971 mass selective detector (MSD) and a 30 m x 0.25 
mm (i.d.) HP-5 MS capillary column (cross-linked 5% phenyl methyl silicone; 0.25 pm 
film thickness). The GC oven was temperature-programmed for an initial temperature of 
70•‹C, held for 2 min, increased to 100•‹C in 1 min, held for 3 min and then raised to 
300•‹C in 20 min. The injector and MSD temperature were set to 250•‹C and 280•‹C, 
respectively. Helium was the carrier gas and flowed at a rate of 40-45 mllmin. A split- 
less injection mode was used in the analysis. 
The GCIMS system was operated in the electron impact (EI) mode and the 
electron energy was set at 70 eV. Initial mass calibration was performed according to the 
specification of Hewlett Packard Canada (Mississauga, ON, Canada). Two characteristic 
ions for each analyte were acquired using the SIM mode. Data from GCIMS analyses 
were processed with the HP G1034C MS ChemStation (Version C.03.00) on a 486 100 
MHz computer to integrate the ion pair peaks. 
A total of four ions were monitored for each PAH analyte in the sample extract; 
one ion pair from the deuterated standard and the other from the analyte. The ion pair of 
each PAH analyte consisted of  the molecular ion and a fragment ion at 112 of  the 
molecular weight. A summary of the ion pairs used in the SIM analysis is summarised in 
Table 2.2. While all ion pairs were integrated and used in calculating recoveries, only the 
molecular ions were used in concentration determination. 
Table 2.2 Ion pairs for selective ion monitoring in gas chromatography mass spectrometric analysis 
Analyte Compound Data Ion Pairs 
Acquisition Deuterated Standard Analyte Start Time 
Molecular (minutes) !h Molecular 94 Ion Molecular Ion Molecular 
Ion Ion 
Naphthalene* 9.00 136 68 128 64 
Acenaphthylene* 13.00 160 80 152 76 
Acenaphthene* 14.0 1 164 82 154 77 
Fluorene* 15.30 176 88 166 8 3 
Phenanthrene* 18.00 188 94 178 8 9 
Anthracene* 18.80 188 94 178 89 
~luoranthene~ 21.00 212 106 202 101 
~ e n z o ( ~ h i ) ~ e r y l e n e ~  34.50 288 144 276 138 
* Low molecular weight PAH, (LPAH); thigh molecular weight PAH, (HPAH). 
2.2.5 Analytical Quality Assurance and Quality Control 
A calibration curve for each PAH analyte was prepared using serial dilutions of 
the EPA 6 10 PAH standard mixture (Supelco Co., Division of Sigma-Aldnch Canada, 
Mississauga, ON, Canada). Six different standard concentrations were prepared, each 
containing the recovery and the surrogate standards for the relative response factor (RRF) 
calculation. The retention times and integrity of the surrogate standards were examined 
visually after each GCIMSD-SIM analysis. A test mixture was also prepared by adding 
known amounts of pyrene, benz[a]anthracene and benzo[a]pyrene to a blank 
hepatopancreas homogenate. This was used to check GC separation and MS sensitivity. 
The samples were prepared by other personnel in the laboratory and analysed blindly by 
the primary author. A test mixture sample, a method blank and a calibration standard 
were included with each set of 10-20 tissue extract samples. 
The PAH analytes in the tissue extracts were identified by comparison to the 
retention times and mass ratios of the standard mixture. PAH concentrations were 
calculated from the relative response factor, RRF, according to EPA 600 Series method 
1624 (Revision B) for isotope dilution GCIMS (US EPA, 1984). Background of the non- 
deuterated standards was subtracted from the calculated concentrations. Quantitation was 
performed using a technique that self-corrected concentrations by recoveries of the 
deuterated standards. Mean (* standard error) recoveries of spiked deuterated PAH 
surrogate standards were as follows: acenaphthene (63 * 1 %), phenanthrene (88 * 2%), 
anthracene (87 * 2%), fluoranthene (90 * 2%), pyrene (96 * 2%), benz[a]anthracene (92 
* 2%) chrysene (89 * I%), benzofluoranthenes (86 * 2%) and benzo[a]pyrene (76 * 1 %); 
while the recoveries of blind spiked unlabeled pyrene, benzralanthracene and 
benzo[a]pyrene in quality control samples were 81%, 67%, and 87%, respectively. No 
PAH analyte peaks were observed in the procedural blanks. Sample specific estimated 
detection limits (EDL) were also determined for each PAH analyte using the U.S. EPA 
8290 method (US EPA, 1994). The EDL of the PAH analytes were found to range from 
0.1 - 0.3 nglg for the hepatopancreas and 0.01-0.09 nglg for the muscle. These quality 
control results show that the GCIMSD-SIM system met all the acceptance criteria of the 
U.S. EPA method (US EPA, 1984) and that the PAH analysis was precise and sensitive. 
The benzo[b]fluoranthene and benzo[k]fluoranthene peaks co-eluted under the 
chromatographic conditions employed in this study. Therefore, they were integrated 
together and reported as a single value for benzofluoranthenes. Despite efforts to 
minimise photolytic degradation, relative recoveries of the photolytically-sensitive PAH 
such as acenaphthene-dlo and benzofluoranthene-d12 were low. Therefore, acenaphthene 
analyte concentration was determined reliably in about half of the hepatopancreas 
samples. Neither acenaphthene nor benzofluoranthenes were determined in the muscle 
because of rapid photolytic degradation of the deuterated surrogate standards. Also, 
fluorene was not determined in hepatopancreas and muscle tissues due to low recoveries. 
2.2.6 Statistical Analysis 
PAH tissue concentration data were analysed statistically using version 6.12 SAS 
for Windows (SAS Institute, Cary, NC, USA). Mixed model analysis of variance 
(ANOVA) was used to resolve the difference in sample size for the PAH concentrations 
in the hepatopancreas dataset. Hypotheses were tested at the alpha = 0.05 significance 
level. Each PAH analyte was analysed with respect to the date and location of sample 
collection. The data from Kitkiatka Inlet was excluded from the statistical analysis since 
they were obtained on only one occasion. In addition, acenaphthene was excluded since it 
could not be determined in all tissue samples due to degradation of the deuterated 
surrogate standard. Tissue PAH concentrations that were less than the EDL were 
included in the analysis to avoid left censoring of the data (Porter et al., 1988; Newman et 
al., 1989). The data were log transformed before analysis as they were found to be log 
normally distributed. PAH concentration correlation analysis between the hepatopancreas 
and muscle of crabs was performed on non-transformed data using Microsoft Excel 97 
SR2. 
2.3 Results 
A total ion chromatograph (TIC) obtained by GC-MS shows the PAH determined 
in the crab tissues collected from Kitimat Arm (Figure 2.2). 
Benzo(ghi)perylene (RS) ----= 
Benzo[a]pyrene ---------- 
Benzofluoranthenes 
Chrysene 
Bent[a]anthracene 
0 
0 
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All measured concentrations of PAH determined in crab tissues are presented in 
Appendix A. The mean concentration of each PAH analyte in the hepatopancreas tissue 
of crabs fkom different sites is shown in Figure 2.3. 
Figure 2.3 Mean PAH concentrations in the hepatopancreas of crabs at different sampling sites in 
Kitimat Arm Douglas Channel, BC, Canada (1994-1996). Error bars indicate standard 
error of the mean (SEM). Value at top of error bar indicates upper SEM value. 
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PAH concentrations in the hepatopancreas of crabs collected from May 1995 to 
October 1996 are displayed in Table 2.3. 
Ta
bl
e 2
.3
 
M
ea
n 
co
n
ce
n
tr
at
io
ns
 o
f P
A
H
 in
 h
ep
at
op
an
cr
ea
s o
f c
ra
bs
 co
lle
ct
ed
 in
 D
ou
gl
as
 C
ha
nn
el,
 B
C 
Ca
na
da
, a
ri
th
m
et
ic
 m
ea
n
s 
+
st
an
da
rd
 e
rr
o
r 
M
ea
n 
PA
H
 c
o
n
ce
n
tr
at
io
n 
(ng
lg 
w
et
 w
ei
gh
t) 
Si
te
 
AC
N 
PH
N
 
A
N
T 
FL
R 
PY
R 
BA
 
CR
Y
 
B
F 
B
A
P 
M
ar
ch
 1
99
4 
K
ita
m
aa
t V
ill
ag
e 
2.
29
 *
 0
.3
0 
0.
92
 *
 0
.6
7 
0.
74
 *
 0
.1
2 
0.
71
 *
 0.
08
 
0.
20
 *
 0
.0
2 
0.
53
 *
 0
.0
8 
0.
50
 *
 0
.0
3 
0.
33
 +
 0.
02
 
K
itk
ia
tk
a 
In
le
t 
2.
12
 *
 0
.1
9 
0.
12
 5
0.
02
 
0.
59
 5
0.
06
 
0.
51
 k
0.
04
 
0.
27
*0
.0
4 
0.
53
 *0
.0
8 
0.
40
 *
 0
.0
4 
0.
43
 +
 0.
06
 
M
ay
 1
99
5 
H
os
pi
ta
l B
ea
ch
 
0.
05
 *
 0.
01
 
2.
32
 &
 0
.4
2 
5.
06
 *
 0
.8
1 
1.
36
 *
 0.
20
 
3.
83
 *
 1
.2
5 
3.
67
 *
 1
.0
8 
2.
03
 *
 0
.2
9 
0.
98
 +
 0
.3
0 
K
ita
m
aa
t V
ill
ag
e 
0.
02
 *
0.
00
2 
0.
50
+ 
0.
12
 
0.
63
 *
0.
09
 
0.
52
 *
0.
05
 
0.
31
 *
0.
20
 
0.
80
*0
.2
3 
0.
40
* 
0.
04
 
0.
23
 +
 0.
05
 
W
at
hl
sto
 C
re
ek
 
0.
02
 *
 0.
00
3 
0.
17
 *
 0
.0
6 
0.
33
 *
 0.
06
 
0.
45
 *
 0
.1
0 
0.
09
 *
 0.
02
 
0.
33
 *
 0
.0
4 
0.
28
 *
 0
.0
4 
0.
25
 +
 0.
04
 
M
ay
 1
99
6 
H
os
pi
ta
l B
ea
ch
 
29
.1
 *
 22
.9
 
13
.7
 *
 2.
28
 
1.
48
 * 
0.
28
 
3.
79
 *
 1
.1
 1 
1.
38
 *
 0.
22
 
0.
58
 *
 0.
22
 
1.
38
 *
 0
.3
4 
1.
03
 * 
0.
1 1
 
0.
76
 *
 0
.2
6 
K
ita
m
aa
tV
ill
ag
e 
0.
28
*0
.0
6 
0.
97
*0
.1
3 
O
.ll
*0
.0
7 
0.
53
k0
.0
4 
0.
64
*0
.2
1 
0.
27
*0
.0
5 
0.
51
*0
.0
5 
0.
45
*0
.0
5 
0.
00
3+
0.
00
05
 
W
at
hl
sto
 C
re
ek
 
0.
34
 *
 0.
04
 
0.
22
 
0.
16
 
0.
23
 *
 0
.0
4 
0.
56
 *
 0.
10
 
0.
62
 *
 0
.0
9 
0.
24
 *
 0.
03
 
0.
43
 *
 0
.1
 1 
0.
44
 *
 0
.0
6 
0.
00
3 
+
 0.
00
1 
K
ild
al
a 
A
rm
 
0.
24
 *
 0
.0
3 
1.
16
 *
 0.
18
 
0.
20
 *
 0
.1
0 
0.
51
 *
 0
.0
9 
0.
64
 *
0.
06
 
0.
22
 *
 0
.0
5 
0.
41
 *
 0
.3
5 
0.
59
 *
0.
13
 
0.
29
 +
 0.
18
 
O
ct
ob
er
 1
99
6 
H
os
pi
ta
l B
ea
ch
 
0.
36
*0
.0
4 
24
.6
* 
12
.4 
7.
14
*2
.2
6 
29
.3
 *
21
.2
 
15
.7
* 
10
.5
 
3.
00
*2
.5
9 
20
.5
 *
 1
6.
9 
2.
58
k0
.6
3 
0.
82
+ 
0.
28
 
K
ita
m
aa
t V
ill
ag
e 
0.
42
 *
0.
04
 
5.
42
 *
 1
.2
6 
7.
77
 k
2.
67
 
1.
61
 *0
.3
0 
1.
00
*0
.1
9 
0.
11
 *
0.
02
 
0.
99
 *
0.
31
 
0.
55
 *
 0
.0
3 
0.
20
+ 
0.
03
 
W
at
hl
sto
 C
re
ek
 
0.
46
 
1.
80
 
0.
28
 
0.
36
 
0.
33
 
0.
15
 
0.
4 1
 
0.
47
 
0.
24
 
K
ild
al
a 
A
rm
 
0.
49
 *
 0
.0
2 
1.
44
 *
 0
.0
9 
0.
06
 *
 0
.0
1 
0.
21
 *
 0
.0
4 
0.
31
 *
 0.
04
 
0.
1 1
 * 
0.
01
 
0.
38
 *
 0
.0
5 
0.
35
 *
 0
.0
1 
0.
12
 +
 0.
02
 
Among the PAH analytes in the hepatopancreas, acenaphthene had the highest 
concentration. A high level of phenanthrene also was found in the hepatopancreas of 
crabs caught at different sites. A comparison of PAH analyte concentrations in different 
sampling sites by ANOVA showed that anthracene and pyrene tissue concentrations of 
Hospital Beach samples were significantly higher than those of Kildala Arm (t=3.34, 
p=0.023, t=2.7, p=0.038); and fluoranthene and benzo[a]pyrene tissue concentrations of 
crabs from Hospital Beach were significantly higher than those of Wathlsto creek 
(t=3.73, p=0.0047, t=2.21, p=0.0286) and Kildala arm (t=4.5, p=0.005, t=2.41, 
p=0.017 1). In contrast, benz[a]anthracene, benzofluoranthenes and chrysene 
concentrations of Hospital Beach samples were not found to be significantly different to 
those of the other sites. The site-specific tissue concentration data were analysed further 
by gradient analysis. Results of the ANOVA analysis showed that fluoranthene 
(p=0.0034) and benzo[a]pyrene (p=0.0152) concentrations significantly decreased in the 
hepatopancreas of crabs caught at an increasing distance down the Arm from Hospital 
Beach. PAH concentrations in the hepatopancreas of the two reference sites, Kildala Arm 
and Kitkiatka Inlet appeared similar. No significant differences in PAH concentrations 
were found at these sites using the ANOVA test (Figure 2.3, Figure 2.4) despite of the 
fact that these sites were far apart (Figure 2.1). At both sites, phenanthrene was found to 
be the predominant PAH in the hepatopancreas (Figure 2.3). 
Total PAH (TPAH) concentrations in hepatopancreas samples were calculated as 
the sum of all PAH analytes determined. Figure 2.4 shows that mean TPAH 
concentrations in the crabs of Hospital Beach were the highest among all sites. The 
TPAH concentration at Kitamaat Village was significantly different from those of 
Wathlsto Creek and Kildala Arm, but not Kitkiatka Inlet (F45.97, p<0.0001). 
Figure 2.4 Mean total PAH (TPAH) concentrations in the hepatopancreas of crabs at different 
sampling sites in Douglas Channel, BC, Canada (1994-1996). Error bars indicate 
standard error of the mean (SEM). 
Hospital Kitamaat Wathlsto Kildala Arm Kitkiatka 
Beach Village Creek Inlet 
A number of crabs, (1 9), were also analysed for PAH analytes in the muscle 
(Figure 2.5). These crabs were selected from crabs caught either at Hospital Beach or 
near Kitamaat Village which were suspected to have high concentrations of PAH in the 
tissue. As with the hepatopancreas data, PAH concentrations in the muscle of crabs from 
Hospital Beach were high and variable, but were not statistically different from the crabs 
from Kitamaat Village (Figure 2.5). A summary of all concentrations determined in 
muscle tissues is presented in Table A-6 in Appendix A. 
Figure 2.5 PAH concentrations in the muscle of selected crabs at different sampling sites in Kitimat 
Arm Douglas Channel, BC, Canada (1994-1996). Error bars indicate standard error of 
the mean (SEM). 
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2.4 Discussion 
In the present study, PAH-contaminated crabs were found throughout the Kitimat 
and Kildala Arms and down the Douglas Channel as far as Kitkiatka Inlet. These results 
show that the PAH contaminants in Kitimat Arm are detectable in crab tissues and 
therefore, bioavailable to the crabs. The highest tissue PAH concentrations are found in 
crabs caught near Hospital Beach, which is very close to the effluent discharge of the 
smelter's waste lagoons. Paine et al. (1996) suggested that there is limited PAH 
bioavailability to the dungeness crabs in Kitimat Arm since they found few PAH- 
contaminated crabs, and only in the Inner Harbour. A plausible explanation for the 
discrepancy in results between Paine et al. (1 996) and the present study may be related to 
the less sensitive analytical procedure employed by Paine et al. (1996). For example, the 
detection limits of PAH analytes in my study range from 0.1-0.3 pgikg whereas those of 
Paine et al. (1996) ranged from 5-20 ygkg.  Because most of the PAH concentrations in 
the crab tissues were below 10 pgikg (Figure 2.4, Figure 2.5), the analytical method used 
by Paine et al. (1996) was not sensitive enough to detect the PAH in the crab tissues. 
However, one might conclude that PAH bioavailability is low in crabs since only a low 
level of PAH is found in the tissues as compared to that in the sediments. However, the 
bioavailability of PAH cannot be fully appreciated based on the concentrations of parent 
compounds in the tissues alone because crabs are able to metabolise PAH (Eickhoff et 
al., 1995; Lee and Comer, 1982; Lee et al., 1976). For example, parent PAH are difficult 
to detect in groundfish such as the starry flounder (Namdari, 1998) because fish are 
capable of rapidly metabolising PAH such as pyrene, which is conjugated to form 
pyrene- 1 -glucuronide, and excreted in the bile. Therefore, it is often more effective to 
monitor the metabolites of PAH instead of the unchanged PAH in the bile of fish. 
Although invertebrates such as crabs do not metabolise PAH as quickly as fish, a 
significant level of metabolic activity also takes place in the invertebrates. The 
synchronous fluorescence spectrometry method (Ariese et al., 1993) described in Chapter 
3 was adapted to screen for pyrene- 1 -glucoside and 1 -hydroxypyrene in the haemolyrnph 
of crabs (Paine et al., 1996; Eickhoff et al., 1995; Eickhoff et al., 2003). 
These results show that tissue PAH concentrations were generally higher in crabs 
caught off Hospital Beach than those caught in other sites (Figure 2.4, Figure 2.5). This is 
consistent with the findings of previous studies that sediment PAH concentrations are the 
highest when they are sampled close to the smelter but decline sharply in concentrations 
at sites further down the Arm (Simpson et al., 1996; Paine et al., 1996). A similar 
observation was also reported in the marine sediments near a Norwegian aluminium 
smelter in the Sunndalsfjord (Naes et al., 1999). This Norwegian smelter is also set at the 
head of a long fjord remarkably similar in geography to Kitimat Arm. 
The hypothesis that a PAH concentrations in crab tissues should be highest in 
concentrations near the head of the Arm at Hospital Beach, with lower concentrations 
further down fitimat Arm, and the lowest levels at Kildala Arm and Kitkiatka Inlet was 
tested. However, Figure 2.3 - Figure 2.5 show that generally, PAH concentrations are 
highest at Hospital Beach, the site closest to the smelter, and at a much lower level at 
other sites throughout Douglas Channel (ANOVA, Tukey-Kramer, a=0.05, p<0.0001). 
We have been unable to demonstrate a significant concentration gradient of PAH 
concentrations in crab tissues although there is a significant tissue concentration 
difference between Hospital Beach and the reference sites. The total concentration of all 
PAH analytes (TPAH) determined in the tissues at all sites over time reflects the same 
trend (Figure 2.4), although there was a significant difference between the TPAH 
concentration in crab hepatopancreas from Kitamaat Village compared to Wathlsto Creek 
and Kildala Arm, (ANOVA, Tukey-Kramer, a=0.05, p<0.0001). My inability to 
demonstrate a spatial difference in concentration for these PAH analytes could be 
explained by the fact that the PAH emissions from the smelter are evenly distributed by 
the atmosphere over a very large area, and that cycling of PAH may occur throughout 
Douglas Channel. It is quite possible that the background level of PAH is comparable or 
perhaps greater than those attributed to the smelter's current emissions. 
Kildala Arm and Kitkiatka Inlet were chosen to represent "clean" reference sites. 
However, PAH levels in the hepatopancreas of crabs collected from these sites were 
similar to those collected from Wathlsto creek in Kitimat Arm (Figure 2.2). Aerial 
transport of PAH from the smelter, cycling of contaminants throughout Douglas Channel, 
as well as local logging operations and boat traffic may account for the PAH found in the 
crabs from these "clean" sites. 
The PAH concentrations in crab tissues were quite variable. This is especially 
evident in the crabs caught in Hospital Beach (Figure 2.3 - Figure 2.5). The variability in 
tissue PAH concentration appears to parallel that of the sediments and may have resulted 
from the randomness of soot, coal dust, and tar balls deposition or pitch spillage near the 
smelter (Simpson et al., 1996; EVS, 1992). 
My results show that low molecular weight PAH (LPAH), including naphthalene, 
acenaphthene, fluorene, phenanthrene, and anthracene (Simpson et al., 1996) were often 
found at a higher concentrations than high molecular weight PAH (HPAH) (fluoranthene, 
pyrene, chrysene, benzo[a]anthracene, benzofluoranthenes, and benzo[a]pyrene) in crab 
tissues. For example, LPAH, such as acenaphthene and phenanthrene, are found at high 
concentrations in the hepatopancreas of crabs (Figure 2.3 and Figure 2.4). This is 
consistent with the finding that a relatively high level of LPAH was found in the crab 
tissues in an earlier study conducted in Kitimat Arm (Paine et al., 1996). Acenaphthene 
or phenanthrene was often the predominant PAH determined in crab tissues from Kitimat 
Arm. Phenanthrene was also determined at high concentrations in crabs particularly at 
Hospital Beach, and was also the most prominent PAH determined in the tissues of two 
crab species, the snow crab, Chionoecetes opilio and the spider crab, Hyas coarctatus, 
collected from Conception Bay, Newfoundland (Hellou et al., 1994). Moreover, high 
concentrations of LPAH such as phenanthrene, and anthracene, and HPAH, fluoranthene 
and pyrene, were determined in the tissues of Polybius henslowi, an edible crab species 
caught on the coast of France and Spain in the North Atlantic (Baumard et al., 1998). 
This study also found that both LPAH and HPAH accumulated in the tissues of crabs, but 
HPAH such as benz[a]anthracene, benzofluoranthenes, and benzo[a]pyrene did not 
accumulate to the same degree as the LPAH and other HPAH such as fluoranthene, 
pyrene, and chrysene. 
In contrast, higher levels of HPAH than LPAH were reported in the sediments 
collected throughout Kitimat Arm (Simpson et al., 1996). Since LPAH are more water- 
soluble and therefore are less tightly bound to the organic materials of sediments than 
HPAH, crabs may be exposed to higher concentrations of LPAH than HPAH in water. 
This hypothesis is further supported by the finding that phenanthrene is found at a high 
concentration in the sediment and is the only LPAH detected in the pore waters (EVS, 
1998). Baumard et al. (1 998) reported a high ratio of phenanthrene to anthracene in crab 
tissues, and stated that phenanthrene is 20 times more water soluble than anthracene and 
therefore more available in the water column for uptake by crabs. Hellou et al. (1 994) 
stated that composition of diet, bioavailability of contaminants, differences in PAH 
distribution and location, and metabolism are factors which are involved in the 
differential accumulation of high and low molecular weight PAH by crabs. My results are 
consistent with the observations of these studies. Phenanthrene is also detectable in crab 
tissues at Kitkiatka Inlet. This suggests that phenanthrene may be more mobile due to it's 
solubility than some of the other PAH. 
Figure 2.6 shows the relationship between the water solubility of PAH analytes 
and their concentrations in the hepatopancreas of crabs collected near Hospital Beach. 
Generally, the higher the water solubility of the PAH, the higher the concentration in the 
hepatopancreas (Figure 2.6). 
Figure 2.6 Mean concentration of analyte PAH in the hepatopancreas of crabs collected from 
Hospital Beach (1994-1996) vs. water solubility. Regression Lines: Group 1 - solid line, r2 
= 0.845; Group 2 - short dash, r2 = 0.985; Group 3 - long dash, r2 = 0.999. Error bars 
indicate standard error of the mean (SEM). 
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PAH can be classified into two groups based on their structure and the log-linear 
relationship between water solubility and hepatopancreas concentrations (Figure 2.7). 
Group 1 is comprised of PAH which contain a two ringed naphthalene structural subunit, 
acenaphthene, phenanthrene chrysene, pyrene, fluoranthene, and benzofluoranthenes; 
while Group 2 compounds, anthracene, benzialanthracene and benzo[a]pyrene, are based 
on a three ringed anthracene structural subunit. Chrysene may be somewhat of an 
exception, as it appears to be concentrated in the hepatopancreas at a higher concentration 
relative to other PAH in group 1 with equal or greater water solubility. 
Figure 2.7 Chemical structures of PAH analytes, Group 1 includes PAH based on a 2 ring subunit 
(naphthalene) and Group 2 includes PAH based on a 3 ring structural subunit 
(anthracene). 
Group 1 
acenaphthene phenanthrene chrysene 
fluoranthene benzo[k] fluoranthene benzo[b] fluoranthene 
Group 2 
anthracene benz[a]anthracene benzo[a]p yrene 
Indeed, if regression lines are fit through the concentration vs. water solubility 
data, the correlation, r2, between the group 1 compounds, (r2 = 0.845) improves if 
chrysene is not included, r2 = 0.986 (Figure 2.6). There is a similarly strong correlation 
between the group 2 compounds (r2 = 0.999). These observations indicate that the water 
solubility of PAH appears to be an important factor in differential exposure and 
bioconcentration of PAHs by dungeness crabs. While the relationships between water 
solubility, chemical structure, and tissue concentration is interesting and may be u se l l  
for prediction of relative tissue concentrations, they are very simplistic. In fact, the 
concentration of PAH in the tissues of crabs is also influenced by the relative absorption, 
distribution, metabolism and excretion rates of each PAH in the crab. For example, 
pyrene and benzo[a]pyrene are metabolised and excreted at different rates by the 
dungeness crab. 
Since the hepatopancreas of male crabs contains a larger amount of lipid than the 
muscle, (6.6% and 0.9% wet weight respectively) (Allen, 1971), the hepatopancreas is 
expected to accumulate a higher level of PAH on a wet weight basis. As shown in Figure 
2.8, mean PAH analyte concentrations are greater in the hepatopancreas than in the 
muscle of selected crabs. 
Figure 2.8 Mean concentrations of PAH determined in hepatopancreas and muscle tissues of 
selected crabs. Error bars indicate standard error of the mean (SEM). Value at top of 
error bar indicates upper SEM value. 
Hepatopancreas 
Muscle 
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The muscle tissue analysis was performed on 19 crabs, which had particularly 
high concentrations of PAH in the hepatopancreas. The muscle tissue of these crabs was 
selected for analysis because crabs that had high levels of PAH in the hepatopancreas 
would be expected to have detectable levels of PAH in the muscle. 
The hepatopancreaslmuscle concentration ratios (Table 2.4) also reflect the higher 
concentration of PAH analytes in the hepatopancreas. 
Table 2.4 Concentration ratios and correlation coeftkients for concentrations of PAH determined 
in hepatopancreas and muscle samples from selected crabs collected at Hospital Beach. 
Parameter PHN ANT FLR PYR BA CRY BAP 
Mean ratio of 5 16 18 10 35 20 2 
hepatopancreasl 
muscle 
concentrations 
Hepatopancreas 0.09 0.63 0.3 1 0.34 0.07 -0.40 0.62 
:muscle 
correlation 
coefficient (r2) 
Site specific + + + + 0 0 + 
concentration 
differences 
Molecular 178 178 202 202 228 228 252 
weight 
Water solubility 1.18E-4 4.34E-6 2.65E-5 1.3E-6 1.4E-6 1.8E-7 3.8E-7 
(gl 100ml) 
log Kow* 4.5 4.45 5.2 5.2 5.6 5.9 6.3 
Hellou et al. (1 994) also reported higher mean concentrations of PAH in the 
hepatopancreas compared to the muscle of crabs. In another study conducted with blue 
crabs, Callinectes sapidus, from the Elizabeth River and Chesapeake Bay, PAH burdens 
in the hepatopancreas were found to be generally 2-4 fold greater than muscle burdens 
from the same crabs on a wet weight basis (Mothershead et al., 1991). 
While the PAH levels appear to be clearly higher in the hepatopancreas, only the 
mean concentration of anthracene in the muscle of crabs was found to be significantly 
different to that of the hepatopancreas using Student's t-test and one way analysis of 
variance (t=2.477, p=O.O 18 1). Probably, the statistical tests were unable to resolve the 
difference in PAH analyte concentrations between these tissues due to a large variability 
in the hepatopancreas dataset and a small sample size of 19 crabs which had PAH 
determined in both hepatopancreas and muscle tissues. Similarly, the 
hepatopancreas/muscle concentration ratios of PAH at Hospital Beach were likely 
distorted by one or two extreme outlying values of the dataset. 
Statistical analysis was performed to examine the correlation between the 
concentrations of individual PAH in the hepatopancreas and that of the muscle taken 
from the same crabs. In general, there was a poor correlation between PAH 
concentrations in the hepatopancreas and muscle tissues (Table 2.4). This may be due to 
the fact that the hepatopancreas data are confounded by the outlying values and a 
relatively small sample size of muscle values. If the extreme outlying values in the data 
set are excluded, reasonably good correlations between the hepatopancreas and muscle 
tissue concentrations can be found for the following PAH analytes (correlation 
coefficients, r2): anthracene (0.63) and benzo[a]pyrene (0.62), pyrene (0.34) and 
fluoranthene (0.3 1) (Table 2.4). However, phenanthrene (0.09) and benz[a]anthracene 
(0.07) display a low PAH concentration correlation between the hepatopancreas and 
muscle tissues and chrysene shows a negative correlation (-0.40). 
It is interesting that ANT, BAP, FLR, PYR, and PHN, which display a difference 
in concentration between the sample sites, also show a positive correlation of PAH 
concentrations between hepatopancreas and muscle tissues. In contrast, BA and CRY, 
which do not display a concentration differences in the sample sites, show a very low 
correlation of PAH concentrations between hepatopancreas and muscle tissues. These 
results indicate that the PAH analytes in Kitimat Arm vary markedly in their 
bioavailabilities, which cannot be determined solely by their molecular weights and log 
Kow values (Table 2.4). Thus, the accumulation of PAH analytes by crab tissues may be 
determined by a number of factors including PAH distribution in sediments, pore water 
and prey PAH concentrations, water solubility and binding of PAH analytes to organic 
sediment particles, and the toxicokinetics of individual PAH analytes in the crab. 
While tissue lipid concentrations may influence the relative concentrations of 
PAH in the muscle and hepatopancreas, lipid analysis was not performed on the tissues in 
this study. In retrospect, lipid analysis may have greatly enhanced this study by allowing 
for the normalisation of contaminant concentrations based on lipid content, because 
dungeness crabs may exhibit significant seasonal and annual variations in lipid levels. 
Unfortunately, the influence of lipid tissue content on the apparent temporal trends in 
PAH concentrations cannot be examined for this dataset. 
The concentrations of PAHs determined in the hepatopancreas and muscle of 
dungeness crabs collected in Kitimat Arm are much lower that those of blue crabs 
collected from the Elizabeth River, an industrial area with one of the highest recorded 
PAH loads recorded in the world (Mothershead et al., 1991). Concentrations of total 
resolvable PAHs in the hepatopancreas of the blue crabs were between 2,900-1 1,000 
pgkg, while concentrations of total PAH determined in dungeness crabs collected from 
sites in Kitimat Arm ranged from 0.7-308 pgkg. Similar total PAH concentrations levels, 
<5- 1,100 pgkg were previously determined in blue crabs collected in South Chesapeake 
Bay (Hale, 1988). Concentrations of total PAH between 55.5-123.1 pgkg have been 
determined in tissues of mud crabs collected in the Brisbane River estuary on the coast of 
Australia (Kayal and Connell, 1995). It should be noted that the TPAH concentrations 
reported in the present study are based solely on the 10 PAH analytes determined. 
Since crabs are in close contact with sediments, it is reasonable to hypothesize 
that concentrations of PAH in crabs generally reflect the sediments in Kitimat Arm. 
Indeed, Chris Simpson found that "levels (of PAH) are highest in the head of Kitimat 
Arm - especially in the vicinity of the aluminium smelter, and decline rapidly with 
increasing distance from the smelter" (Simpson, 1996). Concentrations of total PAH in 
Inner Harbour sediments ranged from 12 - 528 pglg dry weight, while sediment 
concentrations near Kitamaat Village ranged in concentration between 9.3 - 20 pglg dry 
weight (Simpson, 1996). The concentration of TPAH at one site in Kildala Arm was 1.0 
pglg dry weight while the concentration of a sediment sample obtained from Kitkiatka 
Inlet was 1.4 pglg dry weight (Simpson, 1996). One of the sources of PAH input into 
Kitimat Arm from the smelter, B Lagoon had TPAH concentrations of 10,000 pglg dry 
weight in the sediments (Simpson, 1996). Previous work by Cretney et al. (1983), also 
demonstrated the same spacial pattern of PAH in Kitimat Arm that is reflected by the 
levels of PAH contamination in the crab tissues. While concentrations of PAH in crab 
tissues are 2-3 orders of magnitude lower than those found in sediments, the PAH 
concentrations in the crab tissues reflect the concentrations observed in the sediments. 
Concentrations in crab tissues are lower than those found in the sediments most likely 
due to factors involving uptake, metabolism, and elimination of the PAH in crabs. 
The dungeness crab seems to be an effective indicator species for monitoring 
PAH exposure to biota in Kitimat Arm for the following reasons. Firstly, crabs can be 
readily caught at many sites in the Arm. Secondly, detectable levels of PAH are present 
in the muscle and the hepatopancreas. Crabs are an important benthic species of Kitimat 
Arm, and do not move about from one area to another as quickly as many fish species. 
Finally, crabs do not metabolise and excrete PAH from their tissues as rapidly as fish 
(Dunn and Fee, 1979). Therefore, PAH levels in crabs may reflect differences in the 
relative amount and bioavailability of PAH at different sites, particularly between 
Hospital Beach, and other sites downstream in Douglas Channel. 
The study area focused mainly on sites along the eastern side of Kitimat Arm such 
as Kitamaat Village and Wathlsto Creek (Figure 2.1). These sites have been chosen based 
on the potential of catching crabs, distance from the smelter, and proximity to human 
settlement. Future studies should determine the concentrations of PAH in crabs on the 
western side of Kitimat Arm. As suggested by Simpson et al. (1 996), waterborne PAH- 
laden particles and atmospheric emissions tend to be deposited along the western side by 
prevailing currents and winds. This was reflected in studies by Cretney et al., (1983) and 
Simpson et al., (1996) that showed higher PAH concentrations in the sediments on the 
western side of Kitimat Arm. 
2.5 Conclusions 
In summary, this study has demonstrated that PAH in Kitimat Arm and Douglas 
Channel are bioavailable to dungeness crabs. Concentrations of PAH in the tissues were 
the highest and the most variable in crabs collected from the site close to the smelter and 
dropped off sharply to a lower level along the eastern side of the arm and reference sites. 
Levels of PAH at reference sites were not significantly different from sites in Kitimat 
Arm that were closer to the smelter. Water solubility and chemical structure appear to be 
important factors that affect PAH exposure and bioconcentration by crabs. 
Hepatopancreas PAH concentrations were higher and more variable than those in the 
muscle tissues. Overall, this study has shown that dungeness crabs can be used to monitor 
tissue concentrations of parent PAH in biota in estuarine and marine environments such 
as Kitimat Arm. 
CHAPTER 3 
SCREENING PYRENE METABOLITES IN THE 
HAEMOLYMPH OF DUNGENESS CRABS USING 
SYNCHRONOUS FLUORESCENCE SPECTROMETRY 
(SFS): METHOD DEVELOPMENT AND APPLICATION 
3.1 Introduction: 
Despite the large number of studies on the environmental fate and effects of PAH, 
very few biomarkers of PAH exposure have been reported for invertebrates in the marine 
environment. Typically, PAH are determined in tissues of aquatic organisms using 
analytical tools such as GCIMS or HPLC-Fluorescence. 
Ariese et al., (1 993) first used SFS as a biomonitoring tool to screen for pyrene- 1 - 
glucuronide in fish bile. In recent years, SFS also has been used increasingly to screen for 
PAH in various sample matrices including seawater (Santana Rodriguez et al., 1993), fish 
bile (Ariese et al., 1993; Eickhoff et al., 1995; Fragoso et al., 1999), terrestrial isopods 
(Stroomberg et al., 1999), and crab haemolyrnph (Eickhoff et al., 1995; Paine et al., 
1996). A spectrofluorometric assay may be conducted either by scanning both the 
excitation and emission monochromator of a spectrofluorometer simultaneously with a 
constant wavelength difference (the SFS approach) or by scanning the emission 
monochromator and keeping the excitation wavelength fixed (the fixed wavelength 
approach) (Ariese et al., 1993; Lin et al., 1994). The SFS method usually results in a 
much simpler fluorescence spectrum than the fixed wavelength method because SFS has 
the ability to reduce the spectral interferences from other chemicals with similar 
excitation and emission wavelengths and provides a single peak for quantification. In this 
case, a constant wavelength difference of h = 37 nm is selective for pyrene and its 
metabolites because other potentially interfering compounds or PAH do not produce 
spectral bands in the resulting spectra. Therefore, the SFS method has been successfully 
adapted to obtain separate fluorescent peaks to determine pyrene and pyrene metabolites 
in the haemolymph of crabs without relying on chromatographic separation. 
While GUMS is a highly sensitive and selective instrument for PAH separation, 
detection and analysis, a laborious and expensive extraction step is often required to clean 
up tissue samples prior to analysis. SFS has several advantages over the more traditional 
GC/MS method in analysing PAH-related chemicals in the tissues of aquatic organisms. 
For example, my SFS assay uses the haemolymph of crabs to selectively screen for both 
pyrene and pyrene metabolites. The volume of haemolymph in crabs is large and can be 
easily obtained with a syringe from the arthroidal membrane of a leg joint. Sample 
preparation is fast, requiring only a short centrifugation treatment rather than a long 
extraction and clean-up process. Therefore, a large number of haemolymph samples can 
be processed quickly. Scanning of haemolymph samples by SFS is also rapid. It takes 
only 2-3 minutes to analyse a haemolymph sample. Finally, the SFS method can be used 
together with a non-destructive haemolymph collection method, which allows the release 
of crabs back into the environment if they are not required for hrther study. 
The SFS method also has several advantages over the high performance liquid 
chromatography-fluorescence (HPLC-F) method developed by Krahn et a1.(1986) for 
monitoring PAH in fish bile (Krahn et al., 1986). The HPLC-F method requires an 
enzyme hydrolysis and extraction step to prepare the samples (Ariese et al., 1993, Krahn 
et al., 1986) whereas enzyme hydrolysis is not used in this SFS method. Moreover, the 
HPLC-F method involves the summation of chromatographic peaks at different 
wavelength pairs for individual PAH. It should be noted that the majority of the HPLC-F 
peaks are unidentified as they are assumed to represent a particular parent PAH or PAH 
metabolite based on retention time (RT) of the chromatogram. Since chemicals other than 
the target PAH may fluoresce at the monitoring wavelengths in the HPLC-F (Krahn et 
al., 1986), total fluorescence is just an arbitrary number if it is not calibrated or validated 
with an independent standard. This can make inter-laboratory comparison of HPLC-F 
results difficult due to dependence on sample treatment and instrument parameters. In 
contrast, the SFS method is selective for pyrene and its metabolites and is calibrated with 
1 -hydroxypyrene as an independent standard. 
The objectives of this study were: 1) to develop a new rapid screening method by 
adapting the SFS method to screen crab haemolymph for PAH-exposure; 2) to apply the 
SFS method for detecting pyrene and its metabolites in the haemolymph of crabs caught 
in Kitimat Arm; and 3) to compare the results of this technique to tissue concentrations 
determined by GCIMS. 
The SFS method (Ariese et al., 1993) was adapted to monitor pyrene and its 
metabolites in the haemolymph of PAH-exposed crabs. To validate the method, we 
exposed crabs to pyrene in the laboratory. Enzymatic hydrolysis experiments were 
conducted and HPLC-F analysis was used to identify the pyrene metabolites in the 
haemolymph. The haemolymph samples were also analysed by the SFS method and 
HPLC-F to quantitate the concentration of pyrene metabolites and parent pyrene 
respectively, in the haemolymph. Once validated by the laboratory generated samples, the 
SFS assay was applied to the analysis of field samples obtained fiom Kitimat Arm. 
3.2 Materials And Methods 
3.2.1 Chemicals 
Pyrene and 1 -hydroxypyrene were purchased fiom Aldrich Chemical Company, 
Milwaukee, WI, USA. Sulfatase (arylsulfatase, aryl-sulfate sulfohydrolase, 
phenolsulfatase; EC 3.1.6.1 ) from Aerobacter aerogenes, P-glucosidase (EC 3.2.1.2 I), P- 
glucuronidase (type B-I O from bovine liver), ~ r izma@ buffer (Sigma Chemical Company, 
St. Louis, MI, USA),p-nitrophenyl sulfate potassium salt, salicin, trichloroacetic acid, 
sodium acetate trihydrate, potassium biphthalate sodium hydroxide buffer and sodium 
citrate buffer were obtained from Sigma Chemical Company, St. Louis, MI, USA. All 
chemicals were used without prior purification. HPLC grade ethanol and water were 
obtained from Fisher Scientific, Vancouver, BC, Canada. These solvents were used to 
prepare 66% and 50% ethanol solutions for spectrofluorometric measurements. 
3.2.2 Laboratory Studies 
3.2.2.1 Treatment of Crabs in the Laboratory 
Three adult male dungeness crabs (mean weight 0.886 kg) were obtained locally 
at the Dollarton Crab Shack, North Vancouver, BC, Canada. The crabs were kept in a 
large refrigerated tank at 1 O•‹C in 27%0 seawater at Simon Fraser University, Burnaby, 
BC, Canada and fed chopped fish for a week before experimentation. After each crab was 
administered a single dose of pyrene (2 mgkg) intravascularly via the arthroidal 
membrane of a leg joint, they were held in separate aquaria in a temperature-controlled 
room at 10*l•‹C in 27%0 seawater. Seawater was changed daily. Haemolymph samples 
(1 ml) were taken via the arthroidal membrane of a different leg joint from that used for 
dosing, using 1 -ml disposable syringes at time intervals up to 100 hours post-dosing. The 
experiment was terminated at 100 hours at which time the crabs were bled by sectioning 
a walking leg and 15 ml of haemolymph was collected before the crabs were euthanised. 
3.2.2.2 Determination of Glucuronic Acid and Sulfate Conjugated Metabolites 
Aliquots of the haemolymph (2 ml) were extracted with 8 ml of hexane to remove 
unchanged pyrene and unconjugated pyrene metabolites. Trichloroacetic acid was added 
(5 pl) to breakdown gel formation at the solvent interface. The hexane layer was 
removed. A further 4 ml of hexane was added to the remaining aqueous phase and 
extracted as above. The hexane layer was again removed. Two extraction steps were 
found to be sufficient to remove all unchanged pyrene and unconjugated pyrene 
metabolites. The remaining aqueous layer was blown gently with N2 to remove any 
hexane that might still be remaining. Water-soluble, conjugated pyrene metabolites in the 
aqueous layer were hydrolysed with each specific enzyme in 5 ml of sodium citrate 
buffer (pH 6.8) as follows: To hydrolyse the glucuronic acid conjugated metabolites, a 1 
ml aliquot of P-glucuronidase enzyme resuspended in HPLC grade water was added to 
the sodium citrate buffered solution (Sigma, 1994). This mixture was incubated at 37OC 
for 2 1 hours. Sulfate conjugated pyrene metabolites were hydrolysed by mixing an 
aliquot of the sodium citrate buffered solution (5 ml) with 27.5 units of sulfatase in 1.5 ml 
of potassium biphthalate sodium hydroxide buffer (0.05 M, pH 5.0). The mixture was 
incubated for 23 hours at 37OC according to methods supplied with the enzyme. These 
enzyme mediated reactions have been previously shown to hydrolyse pyrene or 
benzo[a]pyrene conjugates (Kennedy et al., 1989; Namdari, 1998; Seubert and Kennedy, 
1997). 
3.2.2.3 Examination of Unknown Metabolite 
An aliquot of haemolymph (5 ml) was deproteinised with 66% ethanol (1 5 ml) in 
a 50-ml polypropylene centrifuge tube. The mixture was refrigerated for 20 minutes at 
4•‹C and centrifuged at 9000 rpm at 4OC for 20 min using a Sorvall RC-5B refrigerated 
superspeed centrifuge Sorvall Instruments, Wilmington, DE, USA. The supernatant was 
decanted and dried under a Jouan RC 10 centrifugal evaporator, Canberra Packard 
Canada, Mississauga, ON, Canada. The residues were resuspended in 3 ml of 100 mM 
sodium acetate buffer (pH 5.0). To hydrolyse the glucose conjugated metabolite(s), an 
aliquot of the sodium citrate buffered solution (3 ml) was mixed with 10 units of P- 
glucosidase in 1 ml of buffer. The mixture was incubated at 37OC for 24 hours. 
3.2.2.4 Extraction of Incubated Mixture 
At the conclusion of the incubation, the enzymatic reactions were stopped with an 
equal volume of hexane containing benz[a]anthracene, the internal standard. The reaction 
mixture was mixed on a mechanical shaker and the hexane layer was removed. The 
extraction was repeated once because two extraction steps were found to be sufficient to 
remove all unchanged pyrene and unconjugated pyrene metabolites. The hexane extracts 
were combined and evaporated with N2. The residues were redissolved in acetonitrile (2 
ml) and analysed by HPLC. 
3.2.2.5 High Performance Liquid Chromatography 
Both conjugated and unconjugated metabolites of pyrene were qualitatively 
identified initially by comparing their retention time with those of the authentic 
chemicals, pyrene, 1 -hydroxypyrene, and 1 -pyrene glucoside, in a Hewlett-Packard 1050 
high performance liquid chromatograph (HPLC) Hewlett-Packard Canada, Mississauga, 
ON, Canada. The HPLC was equipped with a Hypersil5 ODs 100 rnrn x 4.6 mm 
column, a Hypersil5 C 18 30 mm x 4.6 mm guard column Phenomenex, Terrence, CA, 
USA, and an Hewlett-Packard 1046A fluorescence detector. The excitation and emission 
wavelengths of the detector were set at 230 nm and 400 nm, respectively. A gradient 
mobile phase was used to resolve pyrene from its metabolites: solvent A was composed 
of HPLC grade water containing 0.005% acetic acid and solvent B was 100% methanol. 
The initial solvent ratio was 95% A and 5% B. The proportion of Solvent B was 
increased at a linear rate over 15 minutes to loo%, held for 10 min, and returned to initial 
solvent proportions over 5 minutes. 
3.2.3 Field Studies 
3.2.3.1 Sampling Location and Date 
Legal size, male dungeness crabs were caught at a depth of 15-40 m from Kitimat 
Arm and Douglas Channel with round, stainless steel, commercial crab traps (Ladner 
Crab Traps, Ladner, BC, Canada). The following are specific sites of sampling: Hospital 
Beach (53"59.60'N, 128"41.58'W), Kitamaat Village (53"59.22'N, 128O39.25'W - 
53"59.15'N, 128"39.30'W), Wathlsto Creek (53"57.09'N, 12g039.64'W) (Figure 2.1). 
The two reference sites were Kildala Arm (53"50.52'N, 128O30.32'W) and Kitkiatka 
Inlet (53O38.l 'N, 129" 15.5'W). The crabs were collected on four separate occasions; 
March 1994, May 1995, May 1996 and October 1996. Because of sampling and time 
constraints, and inequalities in catch success, all sites were not sampled equally. Table 
2.1 lists the locations, dates and catch results. Whenever possible, at least 15 crabs were 
collected from each site for statistical analysis. The crabs were weighed (mean, standard 
error 744 i 10 g) and the carapace width (between the tips of the tenth antenna1 spines) 
was measured (mean, standard error 17.6 h 0.1 cm), prior to the removal of haemolymph 
for subsequent analysis. 
3.2.3.2 Collection of Haemolymph Samples 
The crabs were bled individually by sectioning a walking leg at the segment 
above the dactyl tip. Haemolymph samples were collected from each crab separately in 
22 ml glass scintillation vials. The crabs were dissected and hepatopancreas tissues were 
removed and stored individually in glass vials. All tissues were stored at -20•‹C for 
subsequent SFS or GCMS analysis (Eickhoff et al., 2003a). The study by Ariese et al. 
(1 993), stated that the pyrene metabolite conjugates are quite stable at -20•‹C. My own 
studies showed that prepared samples were stable for up to 4 weeks when stored at 4OC, 
but decomposition of the conjugates took place after approximately one month of storage. 
3.2.4 Synchronous Fluorescence Spectrometry 
An aliquot of haemolymph sample (1 ml) fiom pyrene-exposed crabs in the 
laboratory or fiom crabs caught in &timat Arm was deproteinated with 3 ml of pre- 
chilled ethanol (66%) in a 10-ml polypropylene centrifuge tube. The mixture was kept at 
4•‹C for 20 minutes before being centrifuged at 9000 rpm at 4OC for 20 min in a Sorvall 
RC-5B Refngerated Superspeed Centrifuge Sorvall Instruments, Wilmington, DE, USA. 
The supernatant was decanted into a 7-ml glass vial and refrigerated at 4OC prior to 
analysis. 
The sample extracts were warmed to room temperature before analysis. Each 
extract was vortexed thoroughly before being decanted into a 1-cm quartz cuvette and 
scanned on a Perkin Elmer LS 50 Luminescence Spectrometer Perkin Elmer, Norwalk, 
CT, UK. Both monochromators were scanned synchronously at a fixed wavelength 
difference (Ah) of 37 nrn from 300-400 nm. Excitation and emission slit widths were 
both set at 5 nm. Net Peak Area (NPA) was integrated from 330-35 1 nm using 
background subtraction to quantify unchanged pyrene and pyrene metabolites in the 
haemolyrnph extract. Peak integration was performed using the FL Data Manager 
software Perkin Elmer, Beaconsfield, Buckinghamshire, UK, on an IBM PS2 computer, 
model 50Z IBM Corp., h o n k ,  NY, USA. Authentic pyrene and 1-hydroxypyrene were 
used as fluorescence standards. A standard curve was prepared for the spectrofluorometer 
using 1 -hydroxypyrene standard concentrations ranging from 1.2 E-9 - 4.9 E-8 M. 
Fluorescence units were expressed as nanograms of 1 -hydroxypyrene equivalents per ml 
of haemolymph. The detection limit was 0.02 ng of 1 -hydroxypyrene equivalents/ml 
haemolymph. The detection limit was determined as 3 times the baseline NPA or 
"baseline noise" of a blank sample. 
3.2.5 Statistical Analysis 
Spectrometric results from different sites or dates were compared. Differences in 
1 -hydroxypyrene equivalents were analysed using SAS version 6.12 for Windows SAS 
Institute Inc., Cary, NC, USA. Both the mixed model analysis of variance (Proc Mixed) 
and the multiple comparison tests (Tukey-Kramer least squares means) were used to 
examine the differences in haemolymph 1 -hydroxypyrene equivalents between sites or 
dates. Mixed model analysis of variance (ANOVA) was used to resolve the differences in 
sample size and collection date of the sites. The contrast test was used to determine if a 
gradient in concentrations between sites was present. Correlation analysis was preformed 
using Proc Corr and Microsoft Excel 97 SR-2. Data was log transformed prior to analysis 
because both 1 -hydroxypyrene equivalent values and hepatopancreas PAH concentrations 
were found to be log normally distributed. 
3.3 Results 
3.3.1 SFS Assay Adaptation 
SFS analysis of the haemolymph of crabs exposed to pyrene in the laboratory 
revealed a number of peaks in the spectrum representing unchanged pyrene, 1 - 
hydroxypyrene and an unknown pyrene metabolite(s). As expected, the pyrene metabolite 
profiles in the haemolymph were found to vary with the post-dosing time. For example, 
within one hour after dosing, only one spectrographic peak represented by pyrene was 
found by SFS in the spectrum at 355 nm. At 100 hours post-dosing, however, an 
unknown metabolite peak which had a maximum fluorescence by SFS at 344 nm together 
with pyrene (335 nm) was observed in the spectrum. Figure 3.1 shows a spectrograph 
with two peaks obtained from the haemolymph of a crab 100 hours after dosing. 
Figure 3.1 Synchronous fluorescence spectrograph of crab haemolymph extract from a laboratory 
dosed crab showing pyrene (P) and an unknown metabolite (M) 100 hours post dose. 
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One peak corresponds to pyrene, while the identity of the molecule which 
produced the second peak is unknown. An overlay of the unknown metabolite peak in 
relation to the pyrene and I -hydroxypyrene peaks in 50% ethanol is shown (Figure 3.2). 
Figure 3.2 Overlay of synchronous fluorescence spectrographs of crab haemolymph extracts 
showing pyrene, 1-OH pyrene, and the unknown conjugated metabolite. 
Pyrene, the unknown metabolite and 1 -hydroxypyrene had maximum 
fluorescence in the SFS spectrum at 335 nm,  344 nrn, and 349 nm,  respectively. Bile was 
obtained from the gall bladder of a starry flounder, (Platichthys stellatus) exposed to 
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pyrene in the laboratory by R. Namdari. I analysed the bile using the SFS technique. The 
bile contained mainly pyrene-1 -glucuronide (Ariese et al., 1993; Namdari, 1998) which 
had maximum fluorescence at 342.5 nm in the SFS assay (Figure 3.3). 
Figure 3.3 SFS scan of bile obtained from starry flounder exposed to pyrene. 
Based on the results of these studies, the unknown pyrene metabolite in the 
haemolymph of crabs was determined to be neither 1 -hydroxypyrene nor pyrene- 1 - 
glucuronide. 
3.3.1.1 Identity of Unknown Pyrene Metabolite Peak 
The identity of the unknown metabolite in the haemolymph was characterized 
further using reverse phase HPLC equipped with a fluorescence detector. A typical 
HPLC chromatogram of the haemolymph extracts shows 4 peaks: a large polar peak 
representing the unknown metabolite(s), the benz[a]anthracene internal standard peak, 
and two smaller peaks co-eluting with the 1 -hydroxypyrene and pyrene standards (Figure 
3.4a). 
Figure 3.4 Chromatograph of pyrene metabolites extracted from haemolymph a) before and, b) 
after glucosidase treatment. 
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Pre-treatment of haemolymph with P-glucosidase reduced or eliminated the 
unknown metabolite peak (RT 1 - 1.9 min) with a concomitant increase in the size of the 
1 -hydroxypyrene peak (RT 3.2 min) (Figure 3.4b). Pre-treatment of the haemolymph 
with sulfatase produced a much smaller yield of 1 -hydroxypyrene, and P-glucuronidase 
pre-treatment had no effect on the unknown pyrene metabolite at all (data not shown). 
These results show that the dungeness crabs preferentially conjugate 1 -hydroxypyrene 
with glucose to form the glucoside conjugate(s) and that the SFS assay is able to 
distinguish the carbohydrate moiety in the conjugated metabolite. 
3.3.2 Use of SFS Assay to Monitor Pyrene Metabolites in Laboratory Dosed Crabs 
The SFS assay was used to monitor pyrene metabolites in the haemolymph of 
crabs exposed to pyrene in the laboratory. The uptake and elimination of pyrene was 
measured by HPLC, and the increase in pyrene metabolite was measured by SFS. Thus 
the concentrations of pyrene and metabolites in the haemolyrnph were monitored in three 
crabs dosed intravascularly with 2 mgkg pyrene (Figure 3.5). 
Figure 3.5 Concentration of pyrene determined by high performance liquid chromatography 
(ng pyrenelml) and pyrene metabolites determined by synchronised fluorescence 
spectroscopy (ng 1-OH pyrene equivalentslml) in haemolymph over time. 
The pyrene haemolymph concentration vs. time curve appears to show a two 
compartment elimination phase following an intravascular dose. As the concentration of 
pyrene decreases in the haemolymph, the concentration of pyrene metabolites increases 
to a maximum of 670 ngtml after 100 hours. 
3.3.3 Use of SFS for Screening Field Samples 
The SFS assay was also used to screen for pyrene metabolites in the haemolymph 
of PAH-exposed crabs in Kitimat Arm. A typical scan of the haemolymph (Figure 3.6) 
shows the pyrene-1 -glucoside peak. 
Figure 3.6 Synchronous fluorescence spectrograph of crab haemolymph field sample extract 
showing pyrene-1-glucoside peak. 
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The concentration of pyrene metabolite in the haemolyrnph of these crabs was 
generally the highest at Hospital Beach, the site closest to the aluminium smelter, 
although the level of pyrene-related fluorescence was quite variable and appeared to 
change with time particularly at the Kitamaat Village site. (Figure 3.7). 
Figure 3.7 Mean 1-OH pyrene equivalents in samples from Kitimat Arm with respect to sampling 
time. Error bars indicate standard error the mean (SEM). 
Hospital Beach Kitamaat Village Wathlsto Creek Kildala Arm Kitkiatka Inlet 
Indeed, there were significant differences in the 1 -hydroxypyrene equivalent 
concentrations over time (ANOVA, p<0.05). The mean concentration of 1 - 
hydroxypyrene equivalents in the haemolymph of crabs at each site (Figure 3.8) showed a 
marked difference in concentration (ANOVA, pc0.05) from a high level near the source 
of pollution to a lower level at various distances from the source. Multiple comparison 
tests using the Tukey-Kramer least squares means analysis confirmed that there were 
three significantly different ($0.05) levels of 1-hydroxypyrene equivalent 
concentrations, denoted as A, B and C in Figure 3.8. The error bars in Figure 3.7 and 
Figure 3.8 represent the standard error of the mean, and show the variability in SFS 
measurements. Therefore, variability in 1 -hydroxypyrene equivalents is the highest in 
Hospital Beach samples and decreases with distance from the smelter (Figure 3.8). 
Figure 3.8 Mean fluorescence values of haemolymph extracts from sampling sites in Kitimat Arm 
. - 
including all sampling times for each site. Error bars indicate standard error the mean 
(SEM). 
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3.3.4 Comparison of PAH Concentrations Obtained by SFS and GCIMS 
When the log concentration of 1-OH pyrene equivalents in the haemolymph was 
plotted against the log concentration of individual PAH in the hepatopancreas of each 
crab (Eickhoff et al., 2003a), the fluorescence responses in individual crabs were found to 
weakly correlate with the GUMS determined pyrene level in the hepatopancreas ( ~ 0 . 3 0 ,  
pC0.05) (Figure 3.9). This data was plotted on a log scale because both data sets were 
found to be log normally distributed. 
Figure 3.9 Correlation of log concentration of 1-hydroxypyrene equivalents in haemolymph and log 
pyrene concentrations in the hepatopancreas. 
log Pyrene (nglg hepatopancreas) 
There was a somewhat stronger positive correlation between the concentration of 
1 -OH pyrene equivalents in the haemolymph in individual crabs and the TPAH 
concentration in the hepatopancreas (~0.39,p<0.05) (Figure 3.10). It should be noted 
that TPAH is a sum of the phenanthrene, anthracene, fluoranthene, pyrene, chrysene, 
benz[a]anthracene, benzo[b]fluoranthene, benzo[k]fluoranthene, and benzo[a]pyrene 
concentrations determined by GUMS in the hepatopancreas of each crab. 
Figure 3.10 Correlation of log concentration of 1-hydroxypyrene equivalents in haemolyrnph and log 
total PAH (TPAH) concentrations in the hepatopancreas. 
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3.4 Discussion 
3.4.1 Glycosylation of Pyrene by Dungeness Crab 
Results of this study indicate that dungeness crabs are capable of metabolising 
pyrene to 1 -hydroxypyrene and pyrene- 1 -glucoside, which can be detected semi- 
quantitatively in the haemolymph using SFS. These results are consistent with a previous 
report that the American lobster (Homarus americanus) converts benzo[a]pyrene to 
benzo[a]pyrene- 1 -glucoside (Li and James, 1993,2000). Pyrene and other PAH such as 
fluoranthene are often found at relatively high concentrations in PAH-contaminated water 
or sediments (Giger and Blumer, 1974). Pyrene therefore serves as a good indicator for 
the presence of other PAH in the aquatic environment and is easier to monitor than other 
PAH indicators such as fluoranthene because pyrene has high fluorescence and is more 
readily detectable by fluorescence analytical techniques. 
3.4.2 Adaptations of SFS Method for Screening Crab Haemolymph Samples 
3.4.2.1 Rationale 
The SFS method of Ariese et al. (1993) has been used to screen for pyrene 
metabolites in the bile of fish. However, this SFS assay could not be adapted directly 
without modification to analyse the haemolyrnph of crabs since fish and crabs are 
different physiologically (Bone et al., 1995; Bliss, 1982) and in the pathways of pyrene 
biotransfomation (Ariese et al., 1993; James, 1989; Kennedy et al., 1989; Li and James, 
1993,2000; Namdari, 1998). To compensate for these differences, the following three 
modifications were made to the SFS fish bile assay: 
(i) Changes in Monitoring Wavelengths 
First, the monitoring wavelengths were modified. The wavelengths used to 
quantify the fluorescence peak were modified to reflect the difference in the type and 
number of pyrene metabolite peaks produced in crabs and fish. Previous studies have 
shown that different carbohydrate substrates are used to conjugate 1 -hydroxypyrene 
metabolite in fish and invertebrates. For example, English sole (Parophlys vetulus), 
flounder (Platichthysflesus), and starry flounder (Platichthys stellatus) conjugate 1 - 
hydroxypyrene primarily with uridine diphospho glucuronic acid (UDPGA) (Ariese et 
al., 1993; Namdari, 1998; Krahn et al., 1984). In contrast, invertebrates such as the 
lobster, Homarus americanus (Li and James, 1993) and other crustaceans (James, 1987) 
use uridine diphospho glucose (UDPG) co-substrates to form glucoside metabolites. The 
current study suggests strongly that dungeness crabs also use UDP-glucose to form 
pyrene- 1 -glucoside from 1 -hydroxypyrene. Since pyrene- 1 -glucoside and pyrene- 1 - 
glucuronide had maximum fluorescence at different wavelengths; 344 nm and 342.5 nm 
respectively, the SFS assay for the haemolymph was modified accordingly. In addition, 
although there is typically only one SFS peak representing pyrene-1-glucuronide in the 
bile of flounder (Ariese et al., 1993), several SFS peak representing pyrene and pyrene 
metabolites may be present in the haemolymph of crabs (Figure 3.1). Because unchanged 
pyrene fluoresces maximally at 335 nm in the SFS assay, crab haemolymph is scanned 
from 330-35 1 nm instead of the reported 335-356 nm for fish bile flounder (Ariese et al., 
1993). 
(ii) Change in Calibration Units 
Secondly, the calibration unit also has been modified. As mentioned before, little 
or no unchanged pyrene is typically found in the bile of pyrene-exposed fish flounder 
(Ariese et al., 1993; Namdari, 1998). Therefore, the fluorescent response of fish bile is 
calibrated against 1 -hydroxypyrene standard and the results are expressed as pyrene-l- 
glucuronide units after correcting for the difference in molecular weight and fluorescence 
yield of 1 -hydroxypyrene and pyrene- 1 -glucuronide. In contrast, both unchanged pyrene 
and pyrene metabolites are found in the haemolymph of crabs and the fluorescent peaks 
of pyrene and pyrene metabolites often cannot be resolved completely (Figure 3.1). 
Therefore, the SFS assay for the haemolymph of crabs is calibrated against the 1- 
hydroxypyrene standard and the results are reported as 1 -hydroxypyrene equivalent units. 
(iii) Changes in Sample Preparation 
Finally, a modification has been made to sample dilution and preparation. The 
flounder converts pyrene rapidly to pyrene-1 -glucuronide and excretes the metabolites 
into the bile (Namdari, 1998). We have observed that crabs metabolise pyrene relatively 
slowly, therefore, both unchanged pyrene and pyrene metabolites can be found in the 
haemolymph. The volume of bile is usually less than 1 ml in fish, and therefore, pyrene 
metabolites can be detected readily after diluting the bile by as much as 11500. In 
contrast, the volume of the haemolymph in crabs is very large; it is estimated to comprise 
35.7% of the dungeness crab's body weight (Allen, 1971). Since pyrene metabolite 
concentrations in the haemolymph are likely to be very low, a much smaller dilution 
factor is used in the SFS assay (114 as compared to 11500 in fish bile). Furthermore, in 
order to prepare an optically transparent solution for fluorescence spectrometry, 
haemolymph proteins and macromolecules were precipitated with chilled ethanol 
(Autrup, 1979). A 66% ethanol solution (chilled to 4OC) was used to deproteinise the 
haemolymph so that the final ethanol concentration was 50%, the same percentage used 
in the fish bile assay (Ariese et al., 1993). 
3.4.3 Effectiveness of SF'S Assay 
3.4.3.1 Comparison of Results with Other Studies 
Results of my field study show that SFS is an effective tool for monitoring 
exposure of dungeness crabs to PAH. Pyrene-associated fluorescent response in the 
haemolymph of crabs is found to decrease to a lower level with distance from the 
aluminium smelter, the alleged source of PAH pollution in Kitimat Arm and Douglas 
Channel. My results are in agreement with those of a previous SFS study on juvenile 
salmon in Kitimat Arm, which showed the highest pyrene-related fluorescent response in 
bile from fish collected close to the aluminium smelter (EVS, 1995). Similarly, the 
concentrations of individual PAH analytes in the sediments were high near the smelter 
but are at lower, but similar concentrations at sites further down the Arm (Paine et al., 
1996; Simpson et al., 1996) as seen in the haemolymph samples. A recent study near an 
aluminium smelter in Norway also has reported a similar pattern of PAH concentrations 
in sediments and indicator organisms (Nas et al., 1999) Similar concentration profiles of 
individual PAH analytes have also been found in the hepatopancreas of crabs at Kitimat 
Arm (Eickhoff et al., 2003a). It appears that the concentration of PAH in the crabs are 
representative of the concentration of PAH in the sediments, and that movement of crabs 
between sampling areas is unlikely due to separation of muddy, sandy areas favoured by 
crabs by rocky areas that are uninhabited by dungeness crabs. Therefore the crab 
represents an effective biomonitor for PAH in contaminated sediments. 
3.4.3.2 Variability in 1-OH Pyrene Equivalents in the Haemolymph 
A large variability in fluorescence measurements was observed among crabs 
collected from Hospital Beach, the site closest to the aluminium smelter (Figure 3.7 and 
Figure 3.8). The variability in 1-OH pyrene equivalent concentrations is consistent with 
the hypothesis that Kitimat Arm is contaminated by random deposition of PAH in soot, 
coal dust, and tar balls or the accidental spillage of pitch (EVS, 1991). This observation is 
also consistent with the variability in PAH concentrations determined in the 
hepatopancreas and muscle by GUMS. Therefore, the SFS method is also capable of 
demonstrating that crabs experience varying levels of exposure to PAH contaminated 
materials. 
3.4.3.3 Comparison of Results Obtained by GCIMS and SFS 
A high concentration of PAH analytes have been observed in the hepatopancreas 
tissue of crabs collected near the aluminium smelter (Eickhoff et al., 2003a). The 
variability in the hepatopancreas PAH concentrations in the hepatopancreas and muscle 
appear to parallel that of the pyrene-associated fluorescent responses in the haemolymph. 
Correlation analysis was performed, comparing either the concentrations of pyrene or 
TPAH in the hepatopancreas with the concentration of 1 -OH pyrene equivalents in the 
haemolymph for individual crabs collected from all sites. A positive but low correlation 
was found between pyrene-associated fluorescence in the haemolymph and the 
concentration of pyrene in the hepatopancreas whereas the correlation between pyrene- 
associated fluorescence in the haemolyrnph and TPAH in the hepatopancreas was 
stronger (Figure 3.9 and Figure 3.1 0). An explanation for the low correlation between the 
SFS and GCIMS results is not readily available but may be related to a comparison of 
different PAH within the tissues of individual crabs, rather than a comparison of the 
tissue concentrations related to site specific exposure levels for each group of crabs. 
Further, the correlation between SFS and GCJMS results may be low because of the 
differences in the toxicokinetics of individual PAH in crabs and the target analytes of the 
analytical method. The toxicokinetics of PAH in crabs or other animals is rather 
complicated and involves the interplay of PAHs with the biochemistry and physiology of 
crabs. Because of the high Kow of PAHs and the relatively high lipid content of the 
hepatopancreas, PAHs are readily absorbed by crabs and accumulate in the 
hepatopancreas. However, since the mixed-function oxidases activities in the 
hepatopancreas of crabs are relatively low, pyrene is metabolised slowly to 1 - 
hydroxypyrene and pyrene- 1 -glucoside. As a result, a relatively high concentration of 
unchanged pyrene is found in the hepatopancreas, since pyrene concentration is 
determined mainly by uptake, and absorption horn water and food, metabolism, and 
elimination rates of pyrene, and may also be affected by feeding and respiration rates. On 
the other hand, only low levels of pyrene metabolites are present in the haemolymph, and 
these levels are determined by the rate of pyrene metabolism in the hepatopancreas, any 
uptake or metabolism by other tissues, and the rate of metabolite elimination in the 
antenna1 gland including the urinary bladder. Since the rates of absorption, metabolism 
and elimination could vary with the individual PAH and with the post-exposure time, it is 
not surprising that a relatively low correlation exists between pyrene-related fluorescence 
in the haemolymph and the concentration of pyrene or TPAH in the hepatopancreas. 
Correlation with TPAH levels may be stronger because pyrene may be eliminated faster 
than other PAH in the hepatopancreas, while other PAH may remain longer. Therefore, 
the SFS analysis of pyrene and metabolites may be a better indicator of short-term 
exposure, while analysis of more persistent parent compounds by GCIMS may be a better 
monitor for long term exposure. Finally, there are differences in target analytes and 
tissues used for analysis between the two analytical methods. The SFS analysis measures 
the combined fluorescent responses of pyrene and pyrene metabolites in the 
haemolyrnph, while the GCIMS method was used to determine the concentration of 
individual parent PAH compounds in the hepatopancreas. 
However, despite the apparent weak statistical correlation between the levels of 
pyrene metabolites measured by SFS and pyrene and TPAH determined by GCIMS in 
individual crabs, the SFS method is an effective method to monitor crabs exposed to 
PAHs in the marine environment. The SFS assay is equally capable of differentiating 
between different levels of PAH exposure within Kitimat Arm when compared with the 
GUMS method but at a lower cost in time and effort. 
3.4.3.4 SFS as a Biomonitoring Tool 
The SFS assay provides a simple, rapid, and effective method for monitoring both 
pyrene and pyrene metabolites in the haemolymph of crabs exposed to pyrene. This assay 
is capable of resolving the difference between pyrene, 1 -hydroxypyrene and conjugated 
pyrene metabolites such as pyrene-1-glucuronide and pyrene-1 -glucoside. We have 
demonstrated that concentrations of pyrene metabolites can be monitored in the 
haemolymph of crabs exposed to pyrene. Thus, this assay can be a powerful tool to study 
the toxicokinetics of pyrene in the crab, or other aquatic invertebrates. 
The dungeness crab seems to be an excellent indicator species for monitoring 
PAH pollutants in Kitimat Arm or other geographical locations on the Pacific coast for 
the following reasons. Firstly, crabs can be readily caught at many sites in the Arm. 
Secondly, detectable levels of pyrene and pyrene metabolites are present in the 
haemolymph. Finally, the crab, which has economic importance, is a benthic invertebrate 
which does not move about from one area to another as quickly as most fish species. 
Therefore, pyrene-related fluorescent response in the haemolymph of crabs may reflect 
the bioavailability of PAHs at a particular site. 
3.4.4 Other Potential Applications of SFS Method 
The SFS method may be used to monitor the exposure of crab species other than 
the dungeness crabs in other geographic locations. These crab species may include the 
snow crab, Chionoecetes opilio, and spider crab, Hyas coarctatus, which are important 
species in both the northern Atlantic and Pacific oceans to support fisheries in Alaska, the 
Bering Sea, and the Gulf of St. Lawrence (Hellou et al., 1994). Similarly, the edible crab, 
Cancerpagurus, is an important fisheries species on the Atlantic coast of Europe; while 
the blue crab, Callinectes sapidus Rathbun has been frequently used as a biomonitor on 
the Atlantic and Gulf coasts (Mothershead et al., 1991 ; Hale, 1988; Anon, 1990). 
3.4.5 Future Studies 
The field study has focused mainly on sites along the eastern side of Kitimat Arm 
such as Kitamaat Village and Wathlsto Creek (Figure 2.1). These sites have been chosen 
based on limited knowledge of the sub-populations of crabs in this area, the habitat of 
crabs, distance from the smelter, and proximity to human settlement. Further studies 
should be conducted with crabs on the western side of Kitimat Arm. Waterborne PAH- 
laden particles and atmospheric emissions tend to be deposited along the western side by 
prevailing currents and winds (Simpson et al., 1996). Unfortunately, my past attempts to 
catch crabs in this area have been hampered by rocky terrain, which is unsuitable habitat 
for the dungeness crab. We have subsequently identified some potential sites on the 
western side of Kitimat Arm for crab sampling. 
Future studies could involve conducting a tag and release study to examine the 
motility of crabs in Kitimat Arm. Sub-populations of crabs may be localised in small 
areas with favourable sandy or muddy bottoms surrounded by rocky areas throughout this 
fjord. Therefore, tagging and recapturing crabs may determine if the tagged crabs have 
moved from one site to another. PAH exposure may also be assessed on the western side 
of the Arm. SFS may be used to monitor the exposure of crabs to PAHs for this purpose. 
Haemolymph samples can be removed without endangering the health of animals, which 
are released and can be re-sampled upon recapture. This would provide a unique 
opportunity to assess the temporal levels of PAH exposure in individual animals. 
3.5 Summary 
In summary, a rapid screening method has been adapted for monitoring exposure 
of dungeness crabs to PAHs using SFS. This rapid screening assay is capable of resolving 
different exposure levels between geographically distinct sites in a PAH-contaminated 
environment. Also, the pyrene-associated fluorescent response in the haemolymph of 
crabs generally parallels the concentration profile of PAH in crab tissues determined by 
GUMS. Therefore, SFS is an effective semi-quantitative method for biomonitoring PAH 
exposure in the crab. 
CHAPTER 4 
EMPIRICAL STUDIES 
FOR THE DEVELOPMENT OF THE PBTK MODEL 
4.1 Introduction 
Physiologically based toxicokinetic (PBTK) models involve the embodiment of 
anatomical, physiological, and biochemical parameters that can be used to describe the 
disposition of toxic chemicals in a biological organism. These parameters are obtained 
from the literature or from laboratory experiments. This chapter describes the 
experiments that were conducted to parameterise, calibrate, and validate the PBTK model 
adapted to describe the disposition of benzo[a]pyrene in the dungeness crab. 
The objectives of this study were to provide empirical data to parameterise, 
calibrate, and validate the PBTK model. Experiments were conducted to examine the 
toxicokinetics, bioavailability, and tissue distribution of benzo[a]pyrene in the crab 
following three routes of exposure: intra-vascular, oral bolus dose, and water borne 
exposure. Partition coefficients for the PBTK model were estimated using an in vitro 
method. A body composition analysis was performed to estimate tissue volumes for the 
PBTK model. The results of these experiments are presented and discussed. 
In addition to the experiments for the PBTK model, the elimination of 
benzo[a]pyrene and metabolites in the urine was examined, and the major solvent 
extractable metabolites were identified. 
4.2 Materials and Methods 
4.2.1 Crabs 
Dungeness crabs (Cancer magister) were obtained commercially from a local 
seafood retailer (Dollarton Crab Shack). Crabs were maintained in a recirculating, 
temperature controlled 490 L seawater tank located in an indoor aquatic facility at Simon 
Fraser University. The crabs were acclimated to aerated 100% seawater at a temperature 
of 9 "C and a salinity of 29 + 1 ppt for one or two weeks before experiments. Crabs were 
fed biweekly with a mixed diet of chopped fish and previously frozen clam meat but were 
fasted for three days prior to an experiment. The seawater in the tank was changed after 
feeding to remove uneaten food and animal waste. Seawater used in the holding tank and 
for experiments was filtered using a paper and charcoal filter apparatus to remove 
impurities. 
4.2.2 Chemicals 
Unlabeled benzo[a]pyrene, (3,4-benzpyrene), and polyoxyethylene sorbitan 
monooleate (Tween 80) were obtained from Sigma Chemical Co. (St. Louis, MO). 1,2- 
Benzanthracene was purchased from Aldrich Chemical Co. (Milwaukee, WI). (7,lO- 
14~)~enzo[a]pyrene (specific activity 63 mCi/mmol) was purchased from Amersham 
Canada Ltd. (Oakville, ON). I4c-labelled benzo[a]pyrene was purified by thin layer 
chromatography (TLC) on silica-gel plates using 9: 1 pentane:benzene as the developing 
solvent. The radiochemical purity of the I4c-labeled benzo[a]pyrene exceeded 99% as 
determined by TLC. Unlabeled benzo[a]pyrene purity was found to exceed 99% by high 
pressure liquid chromatography (HPLC) and was used without further purification. 
HPLC grade organic solvents were obtained from Caledon Laboratories Ltd. 
Radioactivity was determined using Biodegradable Counting Scintillant, BCS supplied 
by Amersham Canada Ltd., Oakville, ON, or Carbon 14 Cocktail from the R.J. Harvey 
Instrument Corporation, Hillsdale, NJ. All other chemicals were of analytical grade or 
better. Benzo[a]pyrene metabolite standards, benzo[a]pyrene-trans-7,8-dihydrodiol, and 
benzo[a]pyrene-trans-9,lO-dihydrodiol were obtained from Midwest Research Institute, 
Kansas City, MO. 
4.2.3 Toxicokinetic Studies with Crabs 
4.2.3.1 Toxicokinetics of Benzo[a]pyrene in Crabs Following Intravascular Injection 
To facilitate intravascular dosing and haemolymph sampling, a septum was 
formed on the dorsal carapace of crabs. A 1-2 mm hole was carefully bored into the 
carapace above the pericardial cavity using a ~ r e m e l ~  drill fitted with a small burr bit to 
ensure the integrity of the hypodermis (skin) below the shell. This hole was covered with 
14 dental dam affixed with cyanoacrylate glue to form a septum. C-labeled benzo[a]pyrene 
was dissolved in mulgofen with "cold" benzo[a]pyrene (specific activity 0.924 mg/pCi) 
and diluted with 0.9% saline. An aliquot of the solution, (2 mgkg or 1 mlkg) was 
injected as a single bolus into the pericardial chamber of each crab. At l , 2 , 4 ,  8, 18,24, 
29,48, 75,96, 144, 192, 240 and 480 hours following dosing, 1 ml haemolymph samples 
were withdrawn from crabs through the septum. Each 1 ml haemolymph sample was 
mixed with 1 ml of 50 mg/ml N-ethyl maleimide to prevent clotting and all samples were 
frozen until analysis. Crabs were maintained at 9OC in a 490 L rehgerated seawater tank. 
Seawater (29 + l%o) was continuously recirculated (approx. 22 Llmin) and filtered with 
an Omnifilter charcoal cartridge to remove any excreted parent chemical, metabolites and 
waste products. Sets of three crabs were sacrificed on each of days 1,2, and 4 post 
dosing. Sets of two crabs were sacrificed on each of days 8 and 20. Crabs were 
euthanised by freezing on dry ice and were kept frozen at -28OC until tissues were 
dissected for analysis. 
4.2.3.2 Toxicokinetics of Benzo[a]pyrene in Crabs Following Single Oral Bolus Dose 
In order to study oral bioavailability and tissue disposition, crabs were 
administered with a single oral bolus dose of benzo[a]pyrene. Crabs were administered a 
dose of 2 mgkg (lmglml) I4c-labelled benzo[a]pyrene (specific activity 0.964 mg1pCi) 
in the first of two experiments. In the second experiment, crabs were administered a more 
environmentally relevant 100 fold lower dose of non-radiolabelled benzo[a]pyrene 20 
pgkg (1 0 pglml). Benzo[a]pyrene was dissolved in mulgofen (0.1% wlv), suspended in 
0.9% saline, and thoroughly mixed with a clam homogenate before dosing. A red food 
colouring dye was incorporated into the dose for detection of regurgitation. Crabs were 
gavaged directly into the stomach using a gavage needle fitted to a 2 ml glass Hamilton 
syringe. No regurgitation was observed following dose administration. Haemolymph 
samples were taken from the membrane at the base of a walking leg at certain time points 
post-dosing. Crabs were maintained in recirculated seawater as described above. Sets of 
three crabs were euthanised by quick freezing in a plastic bag on dry ice at predetermined 
time points after dosing and were kept frozen at -28 OC until dissected for tissue analysis. 
4.2.3.3 Toxicokinetics of Benzo[a]pyrene in Crabs Following Water-borne Exposure 
Crabs were exposed to benzo[a]pyrene in seawater to examine the uptake, 
elimination and tissue disposition of this chemical from the water medium. Water-borne 
exposures were conducted in glass aquaria tanks equipped with an aerator, two large stir 
bars (7.2 x 1.2 cm) and a stainless steel grid to prevent the animals from interfering with 
the stirring motion as depicted in Figure 4.1. 
Figure 4.1 Exposure system for water-borne benzolalpyrene experiments with crab in situ. 
Experiments were conducted at 9 OC in a temperature controlled room. Separate 
experiments were conducted with two different nominal concentrations of 
benzo[a]pyrene in seawater, 20 pg/L and 2 pg/L. Prior to experiments, a stock solution of 
benzo[a]pyrene was prepared with the universal solvent, dimethyl-formamide (DMF). In 
addition, 0.5 ml of Tween 80 was added to 16 L of 29 ppt seawater in the exposure tanks. 
The 3.1 E-3 % v/v Tween 80lseawater solution was stirred for a period of 12 hours prior 
to the addition of a 100 pl aliquot of the stock solution. The seawater solution was then 
stirred for a 24 hour period prior to exposure. A 3 ml water sample was taken at either 
end of each tank using clean glass volumetric pipettes 1 hour and 24 hours after addition 
of chemical to determine the concentration of chemical in the water prior to exposure. 
Water samples were also taken during the exposure phase at certain times concurrent 
with haemolymph samples. Haemolymph samples were taken from the arthroidal 
membrane at the base of the legs. Crabs were individually exposed to benzo[a]pyrene for 
a period of 72 hours and were then transferred to 16 L of clean seawater in fresh tanks to 
monitor elimination. Seawater was changed daily during the depuration phase of the 
experiment. Sets of three crabs were euthanised on dry ice at certain time points after 
dosing and were kept frozen at -28 "C until dissected for tissue analysis. 
4.2.4 Urinary Excretion and In Vivo Metabolism 
The in vivo metabolism and excretion of benzo[a]pyrene in the urine was 
examined using a published urine collection method (Eickhoff and Law, 1995) adapted 
from two previous methods for measuring urinary flow rates, Holliday (1 977) and 
Wheatley (1 985). Sets of three crabs were administered 2 mgkg doses of 14c-labelled 
benzo[a]pyrene by two different routes; intravascular and oral (specific activities 0.925, 
0.964 mg/pCi) as described previously. Crabs were maintained in separate glass aquaria 
containing approximately 12 L of 29 f 1 ppt seawater which completely covered the 
crab's carapace to a level of about 1 cm from the bottom of the collection vessel (Figure 
4.2). 
Figure 4.2 Crab fitted with urine collection vessel in experiment tank 
The static seawater was changed daily. Haemolymph was sampled via the 
pericardial chamber to minimise handling and disruption of crabs. Urine was collected 
daily at regular time intervals using a disposable 10 ml syringe and a 2 1 gauge needle 
fitted with a 10 - 1 2 cm length of PE 100 polyethylene tubing. Urine volumes were 
measured in graduated cylinders tubes and were subsequently transferred to disposable 
50 ml glass centrifuge tubes. Collection vessels were rinsed with 10 ml of ethanol 
following each sample. The ethanol rinse was added to urine samples which were frozen 
at -28 "C prior to analysis. Urine flow rates were calculated by dividing the volume of 
urine excreted by the appropriate time interval. Parent BaP and metabolites were 
determined and characterised in pooled urine samples using the analytical methods 
described below. 
4.2.4.1 Urine Collection System 
Urine collection vessels were rectangular shaped, hand blown glass globes, 
approximately 50 - 60 ml in volume. The reusable glass vessels conformed to the 
contours of the dorsal carapace Figure 4.3. 
Figure 4.3 Exploded view of urine collection system 
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Two entry tubes (ID 3/16"), at the front of the vessel were connected with heat 
moulded 7 - 8 cm long XPLE collection tubes (ID 1/8", OD 114") using tight fitting 
PharmedB (Norton) (ID 3/16") tubing collars. Collection tubes were secured to the crab 
with short (2 cm) Pharmed attachment collars as detailed below. At the top of each 
collection vessel was a sampling port fitted with a modified 10.25 mrn VacutainerB 
septum (Becton Dickinson, Rutherford, New Jersey). The septum was shortened and 
bored to accommodate an attenuated 2-200 yl polypropylene pipette tip used to guide a 
sampling syringe. 
4.2.4.2 Attachment of Urine Collectors 
Crabs were kept on crushed ice for 15 to 20 minutes before being fitted with 
catheters. External catheters were mounted around both nephropores (external urinary 
ducts) on the epistome (also called the third antennal segment which refers to the 
antennal sternal plate forming the anterior part of the buccal frame). The epistome was 
cleared of epibiota (small hair-like processes), cleansed with acetone and primed with a 
glue accelerant. Sutures on the epistome around both nephropores were filled with 
cyanoacrylate glue (Hot Stuff@, Satellite City, Simi, California) to prevent catheter 
leakage at the base. A rim of glue was built up around both nephropores to obtain a good 
seal with the tubing. Short attachment collars, ( ~ 1 . 5  cm), of flexible PharmedB tubing, 
were fixed with cyanoacrylate glue around each nephropore, taking care not to occlude 
the operculae. A previously heat moulded collection tube was then pressed into each 
collar so that it curved upward between the eye stalks of the crab and connected with the 
glass vessel. Collection tubes were connected to the glass collection vessel with a 
PharmedB tubing collar. The collection vessel was placed on the surface of the dorsal 
carapace, marginally posterior to the cephalic ridge. To stabilise the vessel, rubber bands 
were fixed to the attachment points (Figure 4.3) and were glued to the carapace of the 
crab. Chelae were banded so that the crab could not remove or interfere with the 
collection device. A dungeness crab fitted with a urine collector is shown in Figure 4.4. 
Figure 4.4 Urine collection system fitted to a dungeness crab. 
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The catheters displaced the third maxillipeds slightly, but did not produce obvious 
signs of stress in the crabs. Catheterised crabs were able to evacuate freely, as the tubing 
did not impair the flow of urine, or create a capillary force to draw urine out of the 
bladder. Crabs could remain catheterised for a period of 2 weeks or more, over which 
time samples could be taken without any obvious signs of degeneration in the 
experimental animal. 
When the urine collection system was fitted to crabs, the glue seal surrounding 
each nephropore was tested with a food colour preparation to ensure the patency of the 
attachment collars. This test was administered by pressing a length of XPLE tubing into 
the attachment collar glued around each nephropore. A low pressure was applied to a 
food colouring solution in a 30 ml syringe fitted to the tubing in order to detect the 
presence of any leaks. 
4.2.4.3 Patency Tests of Assembled Collection Systems 
Two different patency tests were performed on the collection system which was 
assembled but not attached to crabs. The collars normally glued around crab nephropores 
were plugged with ground glass stoppers. The tests are described as follows: a) The first 
test used a dye to test for leakage from the collection system under ambient conditions. A 
urine collecting system containing 22 ml of 41.5 pg/ml Fast Green FCF dye was 
immersed in 340 ml of distilled water at room temperature (25"). After 96 hours, the 
surrounding water was tested for the presence of dye with a spectrophotometeric assay 
(Eickhoff and Law, 1995). b) A second test was conducted to test the resistance of the 
collection system to osmotic pressure. A collection system containing 25 ml of 3 1 ppt 
saline solution was placed in 400 ml of distilled water. After 96 hours, the volume and 
salinity of the saline solution in the urine collector and the immersion water outside the 
collector were measured (Eickhoff and Law, 1995). 
4.2.5 Crab Dissection and Body Composition Analysis 
Following toxicokinetic experiments, crabs were reweighed and the weights were 
recorded. A total of 67 crabs ranging from 571 - 922 g were dissected for the estimation 
of tissue volumes. Tissues including the muscle, hypodermis, gills, hepatopancreas, 
testes, bladder, stomach, intestine, and heart were excised, rinsed with deionised, distilled 
water, patted dry on a paper towel, and weighed to the nearest thousandth of a gram. The 
mass of each tissue was recorded. The chitinous parts of the cardiac stomach were 
excised from the membrane prior to mass determination. Tissue volumes for the PBTK 
model were calculated for each tissue as a percentage of the total body mass of each crab. 
The volume of haemolymph was calculated as 35.7% of the total body mass. The total 
amount of muscle tissue was calculated as 23.2% of the total body mass based on the 
body composition of a subset of crabs. For this subset of six crabs, the entire muscle 
tissue was excised from the carapace and the mass was determined. Crab tissues were 
subsequently analysed to determine the concentration of benzo[a]pyrene. Tissues that 
were not extracted immediately were frozen at -28OC. 
4.2.6 Determination of in vitro Partition Coefficients 
The tissue:tris buffered saline (TBS) partition coefficient was determined for each 
of nine tissues: bladder, gill, muscle, hepatopancreas, heart, haemolymph, gastrointestinal 
tract (gut), hypodermis (skin), and testes for each concentration. Additionally, 
haemo1ymph:seawater partitioning was examined using autoclaved 29 ppt seawater rather 
than TBS. In vitro partition coefficients were determined using a dialysis membrane 
method adapted from the in vitro methods of Jepson et al. (1 994) and Sato and Nakajima 
(1 979) described in Andersen et al. (1 984). Tissues from four freshly euthanised crabs 
were excised and pooled. Tissues were homogenised in TBS pH 7.4 at a ratio of 4: 1 
tissue:buffer. 
Dialysis tubing (spectra/por@, #3 MWCO 3500 Molecular porous membrane 
tubing, 18.5 mm, spectruma, Laguna Hills, CA) was pre-cut to 6.5 cm lengths, soaked in 
distilled water for 15 minutes, and heated to 80 OC while stirring for 30 minutes in a 10 
mM sodium bicarbonate solution. Dialysis tubing was then transferred to a 10 mM 
sodium EDTA solution and soaked for 30 minutes, stirred in distilled water for 30 min @ 
80 "C, allowed to cool and conditioned in TBS for prior to use. 
Homogenised tissues were added to dialysis tubing as follows; one end of each 
dialysis tube was tightly tied with 2-0 non-sterile, non-absorbable, surgical suture 
(Ethicon Inc.). Two glass beads were placed in the bottom of the bag and a 2.000 g 
aliquot of freshly homogenised tissue was weighed into each bag using a bench top 
balance. Dialysis bags were sealed by carefully tying the open end with 2-0 silk to 
prevent the inclusion of air bubbles. Excess suture was cut off, but one length was kept 
long to suspend the dialysis bags in TBS buffer solution. Bags were dialysed in TBS for 
48 hours prior to experiments to clear molecules below the 3500 molecular weight cut off 
(MWCO). 
Mixtures of 14~-benzo[a]pyrene and non-radiolabelled benzo[a]pyrene were 
prepared in methylene chloride in 2 ml volumetric flasks, blown down with a gentle 
stream of nitrogen, redissolved in 100 p1 of Tween 80, and resuspended in TBS to a final 
volume of 2 ml. Two stock solutions were formulated so that amounts of 100 ng or 1000 
ng of '4~-benzo[a]pyrene (specific activity 224, 23.0 pCi1mg respectively) could be 
added in a 48 pL aliquot to each test vial for test concentrations of 50 and 500 nglml. 
Aliquots were added to vials using a 50 p1 Hamilton syringe and were analysed by LSC 
and HPLC to determine the concentration and specific activity of 14c-benzo[alpyrene. 
Into each 22 ml test vial (Supelco), 20 ml of TBS was pipetted. A micro stirring 
bar (Fisher) and a dialysis bag containing 2g of homogenised tissue were then added. A 
48 pL aliquot of chemical was added to the TBS in each vial which was sealed with a 
Teflon lined cap. Dialysis bags were suspended in test vials with 2-0 silk suture so that 
the bag was submerged in buffer but was not disturbed by the stir bar at the bottom of the 
vial as depicted in Figure 4.5a. Vials were placed randomly in groups of nine onto stir 
plates as shown in Figure 4.5b. 
Figure 4.5 Dialysis vial set-up for in v i m  partition coefficient determination a)detailed diagram of 
vial containing tissue dialysis bag, b) vials set-up on stir plate 
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Reference vials consisting of dialysis bags filled with 2 g of TBS were tested at 
both concentrations and with both TBS and seawater. Control vials were also prepared 
which contained all components except dialysis bags. Four replicates were run for each 
tissue, reference and control at each test concentration. The experiment was conducted at 
9 "C in a temperature controlled room. Vials were stirred continuously for a period of 14 
days. At the end of the test, 2 ml aliquots were taken from each vial using 2 ml glass 
volumetric pipettes. Aliquots were added to scintillation vials with 15 ml of liquid 
scintillation cocktail. Vials were counted for 10 minutes using a Beckman LS 8000 liquid 
scintillation counter. 
The concentration of benzo[a]pyrene was calculated based on the DPM measured 
in each medium by scintillation counting. The concentration of benzo[a]pyrene in the 
tissues was calculated as the difference in the concentration of benzo[a]pyrene in the TBS 
of the control vial without dialysis bag minus the concentration of benzo[a]pyrene in the 
TBS of each vial with dialysis bag. The tissue:TBS partition coefficient was calculated as 
the benzo[a]pyrene concentration in each tissue over the concentration of benzo[a]pyrene 
in the TBS. Tissue:haemolymph partition coefficients were calculated as the tissue:TBS 
partition coefficient over the haemo1ymph:TBS partition coefficient. 
4.2.7 Determination of Benzo[a]pyrene in Crab Tissues and Seawater 
4.2.7.1 Extraction of Haemolymph Samples 
Haemolymph samples (lml) were added to lml of 50 mglml N-ethyl maleimide 
to prevent clotting. Each sample was spiked with a 10 ml aliquot of a stock 
benzanthracene internal standard solution. Haemolymph was deproteinised and extracted 
with 6 ml of HPLC grade acetonitrile. Samples were shaken in 15 ml disposable conical 
glass tubes closed with PFTE lined screw caps for 30 minutes and were then centrifuged 
for 10 minutes at 3500 rpm to pellet the denatured protein and macromolecules. 
Supernatant aliquots were pipetted directly into 2 ml autosampler vials for HPLC 
analysis. Low analyte concentration supernatants were concentrated using a Jouan 
RC10.22 Centrivap (Jouan Inc. Winchester, VA), resuspended with 1 ml acetonitrile, and 
pipetted into 2 ml autosampler vials. 
4.2.7.2 Extraction of Benzo[a]pyrene from Tissue Samples 
Excised crab tissues including muscle, bladder, hypodermis, gastrointestinal tract, 
testes and carcass were weighed and homogenised 1 : 1 with 0.9% saline using a Polytron 
homogeniser (Brinkman Co., Rexdale, Ont.). Hepatopancreas samples were homogenised 
either 4: 1 tissue:saline with 0.9% saline, or with no saline added. Homogenised tissue 
aliquots (2,4, or 5g) were weighed into 50 ml disposable glass centrifuge tubes sealed 
with PFTE lined screw caps. Homogenate aliquots were spiked with 20 pL of a 2 ng/pL 
benzanthracene internal standard stock solution. Samples were allowed to sit for 30 
minutes and were then saponified. 
Saponification was performed by adding 0.6 ml of 50% w/v KOH and 5 ml of 
HPLC grade methanol. Samples were refluxed in a recirculating heated water bath at 78 
"C for 1 hour and were vortexed at 20 minute intervals. Samples were removed from heat 
and 5 ml of distilled water was added prior to a further hour of reflux at 78 "C and 
periodic vortexing at 20 and 40 minutes. 
Saponified samples were allowed to cool to room temperature and were then 
extracted with 22 ml of pentane. Samples were shaken for 30 minutes on a mechanical 
shaker and centrifuged at 3500 rpm for 10 minutes to separate the aqueous and organic 
layers. The extraction was repeated twice and extracts were pooled separately in 50 ml 
centrifuge tube and were concentrated with a gentle stream of N2 in 1 ml of octanol prior 
to liquid chromatography column cleanup. 
Sample cleanups were performed by liquid chromatography using 205 X 14 mm 
glass columns. Sodium sulphate was added to a height of 1 cm in a followed by 230-400 
mesh Silica Gel 60 to a total height of 10 cm. Both column packing materials were added 
in degassed pentane slurries and the packed columns were rinsed with 1 bed volume of 
pentane. Samples were added to columns, rinsed with 12 ml of pentane and then eluted 
with 15 ml of methylene chloride. Column eluates were concentrated with N2, 
resuspended with 2 ml of acetonitrile and placed in autosampler vials for HPLC analysis. 
Recoveries of benzo[a]pyrene from each tissue type were determined by spiking clean 
tissues with known amounts of analyte and intemal standard. 
4.2.7.3 Extraction of Benzo[a]pyrene from Seawater 
Seawater samples were placed in 15 ml disposable glass centrifuge tubes. 
Samples were spiked with 10 yL of a 2 nglyL benzanthracene intemal standard stock 
solution. Samples were extracted with 9 ml of pentane, shaken for 15 minutes on a 
mechanical shaker, and centrifuged at 3000 rpm for 5 minutes. This extraction was 
repeated twice and extracts were combined and evaporated under a gentle stream of N2. 
Extracts were resuspended with 1 ml of acetonitrile and placed in 2 ml autosampler vials 
for HPLC analysis. 
4.2.7.4 Analytical Method for the Determination of Benzo[a]pyrene 
An aliquot of sample extract was injected into a Hewlett-Packard High Pressure 
Liquid Chromatograph (HPLC) Model 1050 equipped with a Vydac PAH column (5 ym, 
250 x 4.5 mm), C18 cartridge guard column and pre-column filter assembly. The column 
assembly was eluted with an isocratic acetonitri1e:water (90%: 10%) mobile phase at a 
flow rate of 1 mllminute. An Hewlett Packard 1046A programmable fluorescence 
detector was linked with an Hewlett Packard 3396 Series I1 integrator to record and 
analyse chromatograms. The excitation and emission wavelengths of the detector were 
set at 280 and 430 nrn, respectively. The detector was calibrated using at least five 
benzo[a]pyrene concentration standards prepared with the benzanthracene internal 
standard stock solution. Calibration curves were prepared by plotting the ratios of analyte 
over internal standard peak areas versus analyte concentration. Calibration curves were 
analysed by linear regression using Microsoft ~xce l@ spreadsheet software on a PC 
computer. An example of a typical calibration curve is presented in Figure 4.6. 
Figure 4.6 Typical calibration curve for the determination of benzo[a]pyrene by HPLC 
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4.2.8 Analytical Methods for Determination of Benzo[a]pyrene Metabolites in 
Urine 
4.2.8.1 High Performance Liquid Chromatography 
Urine samples were thawed and a 1 ml aliquot of each urine sample was analysed 
by LSC for total radioactivity. Urine samples were individually treated to evaporate 
added ethanol and reduce sample volume to approximately 10 ml using a Jouan RC 10.22 
Centrivap (Jouan Inc. Winchester, VA). The 10 ml urine aliquots were extracted 3 times 
with 25 ml of ethyl acetate in 50 ml glass centrifuge tubes. The extracts were collected 
and blown down under a gentle stream of nitrogen. The extracts were resuspended with 2 
ml of reagent grade alcohol. A 0.5 ml aliquot of each extract was counted for 
radioactivity. The remaining 1.5 ml was placed in an HPLC autosampler vial for 
metabolite analysis. The aqueous phase of each urine sample was resuspended to 10 ml 
following extraction. A 0.5 ml aliquot was counted for determination of radioactivity. 
The remaining aqueous fractions were hydrolysed by acidification with HC1 and 
heating in a boiling water bath for 1 hr. The hydrolysed fractions were then extracted 
three times with a three fold volume of ethyl acetate. Aliquots of the ethyl acetate extracts 
and aqueous layers were analysed by LSC. Ethyl acetate extracts of hydrolysed and non- 
hydrolysed aqueous fractions were pooled separately, concentrated using a gentle flow of 
N2 and resuspended in acetonitrile. Extracts were analysed using an Hewlett Packard 
HP1090 liquid chromatograph equipped with a reverse phase Zorbax ODs column, 
Diode Array Detector (DAD) and a Gilson fraction collector (model FC204). Injected 
samples were eluted at a flow of 1 mllmin with a non-linear gradient solvent system 
(Varanasi et al. 1986) as shown in Table 4.1. Solvent A consisted of 0.005% v/v glacial 
acetic acid in deionised, distilled water while Solvent B was HPLC grade acetonitrile. 
Table 4.1 Timetable for non-linear gradient mobile phase 
Time (minutes) % Solvent A % Solvent B 
Fractions were collected at 0.5 minute intervals in 7 ml vials analysed by liquid 
scintillation counting (LSC). Peaks were identified by comparison with retention times of 
the following metabolite standards run under identical conditions: 3- 
hyclroxybenzo[a] pyrene, 9-hydroxybenzo [a] pyrene, benzo[a] pyrene-4,5 -dione, 
benzo[a]pyrene-trans-7,8-dihydrodiol, benzo[a]pyrene-trans-9,lO-dihydrodiol (Midwest 
Research Institute, Kansas City, MO). UV absorbance of eluted metabolites and 
metabolite standards was monitored at a wavelength of 280 nm. 
4.2.8.2 Gas Chromatography Mass Spectrometry 
Fractions corresponding to the retention times of radiolabelled metabolite peaks 
were isolated using the HPLC method described above. The fractions obtained from 
several HPLC runs were pooled and reacted with trimethyl sulfoxide (TMS) to form 
derivatives in ethyl acetate. Aliquots were injected into an Hewlett Packard 5980 Series I1 
GC fitted with an HP-5 M.S. cross-linked 5% Ph Me silicone 30 m x 0.25 mm GC 
column with a 0.25 pm film thickness (Hewlett Packard). The column was connected to 
the ion source of an Hewlett Packard 597 1 Mass Selective Detector (MSD). The GC oven 
was programmed as follows: the initial temperature was 200 "C and increased at a rate of 
8"CIminute to 280 "C and held for 10 minutes. The injector temperature was set to 250•‹C 
and the MSD to 280•‹C. A splitless injection sequence was used and the carrier gas was 
He with a flow rate of 40-45 mllmin. The mass spectrometer was operated in the Electron 
Impact mode (EI) and the electron energy was set at 70 eV. Chromatographic data was 
acquired and Selective Ion Monitoring (SIM) was performed using Hewlett Packard 
G1034C Version C.03.00 MS ChemStation and Standalone Data Analysis software on a 
PC computer to analyse total ion chromatograms. Metabolites were identified using a 
library composed of benzo[a]pyrene metabolite standards including 3-hydroxy- 
benzo[a]pyrene, 6-hydroxy-benzo[a]pyrene, 9-hydroxy-benzo[a]pyrene, benzo[a]pyrene- 
trans-4,5-dihydrodiol, benzo[a]pyrene-cis-7,8-dihydrodiol, benzo[a]pyrene-r-7,t-8,~-9,t- 
10-tetrahydrotetrol, benzo[a]pyrene-trans-7,8-dihydrodiol, benzo[a]pyrene-trans-9,lO- 
dihydrodiol, benzo[a]pyrene-3,6-dione, benzo[a]pyrene-l,6-dione, (Midwest Research 
Institute, Kansas City, MO) and cis-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene (Chemsyn 
Science Laboratories, Lenexa, KS) that were derivatised using TMS and run under the 
same conditions as unknown metabolite analytes. 
4.2.9 Determination of Radioactivity 
Radioactivity in liquid samples such as urine, haemolymph, tissue extracts, 
seawater, buffer samples, and dose aliquots was determined by liquid scintillation 
counting (LSC). Sample aliquots were pipetted separately into 20 ml scintillation vials. 
After addition of 10 ml of BCS scintillation cocktail, samples were vortexed. 
Radioactivity in each vial was counted for either 5 or 10 minutes using a Beckrnan LS- 
8000 liquid scintillation counter. HPLC fractions collected in 7 ml vials were similarly 
analysed by LSC following addition of 5 ml of BCS cocktail. 
Radioactivity in non-liquid samples such as homogenised tissues, gut contents 
and tissue pellets was determined using a Model OX 300 Biological Material Oxidiser 
(BMO) (R.J. Harvey Instrument Co., Hillsdale, NJ) followed by LSC. The "CO~ evolved 
from each sample oxidation was trapped in Carbon 14 Cocktail (R.J. Harvey Instrument 
Co., Hillsdale, NJ) and counted for 5 minutes using the Beclunan LS-8000 LSC. The 
recovery of radioactivity from sample oxidation was assessed using methyl methacrylate 
14 C standards (Du Pont Co., Wilmington, DE) and was found to exceed 99%. Tissue 
homogenates and pellets from untreated crabs were oxidised and counted for use as 
sample blanks. 
4.2.10 Toxicokinetic Analysis 
The concentrations of benzo[a]pyrene in the haemolymph obtained following 
exposure of crabs to benzo[a]pyrene were plotted using Microsoft ~ x c e l @  or Sigma plot@ 
Scientific Graph Program Version 1 .OO (Jandel Corporation). Curves were fit using PC 
Nonlin (Statistical Consultants Inc., Lexington, KY). The half-life was calculated by 
regression of the semi-logarithmic concentration versus time data. The formula used to 
calculate half-life is presented in Equation 4.1 : 
where, 
t1,2 = half-life 
p = elimination rate constant 
The elimination rate constant was calculated as the negative slope of the non- 
weighted least squares curve fit for the logarithmically transformed concentration data 
versus time data using Equation 4.2. 
where, 
Ct = Concentration at time t 
b = Constant 
p = elimination rate constant 
Apparent bioavailability was calculated using kinetic parameters obtained from PC 
Nonlin. (Statistical Consultants Inc., Lexington, KY) using the following equations: 
where, 
A% = Apparent Bioavailability 
AUCoral = Area under the curve for oral dose 
AUCiv = Area under the curve for i.v. dose 
Doseoral = Amount of the oral dose 
Doseiv = Amount of the iv dose. 
The corrected apparent bioavailability was calculated according to equation 4.5. 
Where, 
tl12iv = half-life of the i.v. dose 
t1/2x = half-life of the oral dose. 
The area under the concentration vs. time curves, AUC, was calculated using the 
following formula: 
AUCo-+a, = AUCo-I+ (ti * C1 /P) + (CI/ P2) 
Where, 
AUCo,m = Area under the curve for time 0 to infinity, 
AUCo+ = Area under the curve for time 0 to t 
C1 = the last measurable concentration at time tl 
tl = the time of the last measurable concentration. 
The AUC from 0 to tl is calculated by means of the linear trapezoid rule, and the AUC 
from tl to infinity was estimated using the statistical moment theory. Calculations were 
performed using the pharmacokinetic functions above (Gibaldi and Perrier, 1982) in 
Microsoft ~xcel@. 
4.3 Results 
4.3.1 Chromatographic Analysis of Benzo[a]pyrene 
Table 4.2 shows the extraction recoveries obtained from crab tissues spiked with a 
known amount of benzo[a]pyrene. The extraction recoveries were generally good for all 
tissues. The percent recovery was highest for the gill, and the lowest recovery was 
obtained from bladder tissue. 
Table 4.2 Extraction recoveries of benzolalpyrene from dungeness crab tissues 
Tissue Recovery (%) 
Haemol ymph 
Gill 
Muscle 
Testes 
Gut 
Heart 
Bladder 
Skin 
Hepatopancreas 
Water 
Figure 4.6 shows a typical HPLC chromatogram describing the elution profile of 
benzanthracene and benzo[a]pyrene. The retention times of benzanthracene and 
benzo[a]pyrene were approximately 5.8 minutes and 10.3 minutes respectively. 
Figure 4.7 A typical HPLC chromatogram of benzo[a]pyrene and benzanthracene (internal 
standard). Peaks I and 11 represent benzanthracene and benzo[a]pyrene respectively. 
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The method detection limit of benzo[a]pyrene ranged from 0.1 - 0.5 nglml 
depending on the HPLC injection volume and the calibration curve. 
4.3.2 Toxicokinetics of Benzo[a]pyrene in the Crab Following Intravascular Dose 
Figure 4.8 shows the concentration of benzo[a]pyrene determined in the 
haemolymph of crabs administered with a 2 mg benzo[a]pyrene/kg intravascular dose. 
Error bars on all graphs represent one standard deviation from the mean of three 
measurements per time point. 
Figure 4.8 Concentrations of benzolalpyrene in the haemolymph over time following a 2 mglkg 
intravascular dose 
The kinetics of benzo[a]pyrene in the haemolymph suggest that a one 
compartment classical toxicokinetic model would describe the disposition of 
benzo[a]pyrene in the crab following an intravascular dose. The half-life of 
benzo[a]pyrene in the haemolymph following the intravascular dose was 134 hours. 
The mean concentration of benzo[a]pyrene determined in the tissues of crabs is 
shown in Figure 4.9. 
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The greatest concentrations of benzo[a]pyrene were determined in the 
hepatopancreas, bladder, hypodermis, and heart tissues following the intravascular dose. 
The lowest concentrations were determined in the muscle, haemolymph and gut tissues. 
4.3.3 Toxicokinetics of benzo[a]pyrene in the Crab Following Single Oral Bolus 
Dose 
4.3.3.1 Single Oral Bolus Dose 2 mg Benzo[a]pyrene/kg 
The concentrations of benzo[a]pyrene determined in the haemolymph of crabs 
following administration of a 2 mg benzo[a]pyrene/kg single bolus over time is shown in 
Figure 4.10. 
Figure 4.10 Concentration of benzolalpyrene in the haemolymph following a 2 mglkg oral dose 
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Figure 4.10 shows that there is a fairly rapid uptake of benzo[a]pyrene into the 
haemolymph from the gastro intestinal tract that peaks at 1 1.5 ng benzo[a]pyrene/ml, 
approximately 24 hours after the dose. At this point, there is a fairly rapid linear 
elimination of benzo[a]pyrene from the haemolymph as this compound is distributed to 
the tissues and is excreted from the crab. The half-life of benzo[a]pyrene in the crab 
following the 2 mgkg single oral bolus dose was 194 hours. 
The mean concentrations of benzo[a]pyrene determined in the tissues of crabs 
administered with a 2 mg benzo[a]pyrene/kg single bolus oral dose is shown in Figure 
4.1 1. The error bars represent the standard deviation of three measurements per time 
point. 
Figure 4.11 Concentration of benzolalpyrene in crab tissues following a 2 mgkg oral bolus dose 
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The distribution of benzo[a]pyrene in the various tissues is remarkably similar 
following a 2 mgkg oral bolus dose. The highest concentrations were initially associated 
with the hepatopancreas and gut tissues. After 20 days, the concentrations of 
benzo[a]pyrene in most of the tissues were still between 5 - 10 nglg wet weight 
indicating that the elimination of benzo[a]pyrene is very slow. 
4.3.3.2 Single Oral Bolus Dose 20pg Benzo[a]pyrene/kg 
The mean concentrations of benzo[a]pyrene determined in the haemolymph of 
crabs following administration of a 20 pg benzo[a]pyrene/kg single oral dose is shown in 
Figure 4.12. 
Figure 4.12 Concentration of benzolalpyrene in the haemolymph following a 20 pg/kg oral dose 
The concentration of benzo[a]pyrene in the haemolymph peaks at 0.94 nglml, 
approximately 8 hours following an oral bolus dose of 20 pg benzo[a]pyrene/kg. The 
concentration of benzo[a]pyrene declines slowly at a linear rate following the uptake 
phase. The half-life of benzo[a]pyrene in the haemolymph following the dose was 354 
hours. 
The concentrations of benzo[a]pyrene determined in the tissues of crabs following 
a 20pg benzo[a]pyrene/kg dose is presented in Figure 4.13. 
Figure 4.13 Concentration of benzolalpyrene in crab tissues following a 20pglkg oral dose 
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The concentration of benzo[a]pyrene was greatest in the gill, hepatopancreas, 
gastro-intestinal tract and bladder following the oral dose. The concentration of 
benzo[a]pyrene was lowest in the haemolymph and muscle tissues. The concentration of 
benzo[a]pyrene peaked in most tissues at 24 hours following the oral dose, except for in 
the testes and heart, where the peak concentrations were reached at 96 hours. 
4.3.4 Toxicokinetics of Benzo[a]pyrene in the Crab Following Water-borne 
Exposure 
4.3.4.1 Exposure to 20 pg Benzo[a]pyrenelL in Seawater 
Crabs were exposed to benzo[a]pyrene in the seawater for a period of 72 hours. 
Crabs were then placed in fresh seawater to examine chemical elimination. The 
concentration of benzo[a]pyrene in the water was monitored over time before and during 
the exposure phase. At the beginning of the exposure phase, the concentration of 
benzo[a]pyrene in the seawater was 20.5 * 0.7 ng/L (Figure 4.14). By the end of the 
exposure phase, the concentration declined to 5 * 1.7 ng benzo[a]pyrene /L. 
Figure 4.14 Mean concentrations of benzolalpyrene in seawater over time. 
The mean concentrations of benzo[a]pyrene determined in the haemolymph of 
crabs following exposure to a nominal concentration of 20 pg benzo[a]pyrene/L in 29 ppt 
seawater is shown in Figure 4.15. The error bars represent one standard deviation from 
the mean of three samples. 
Figure 4.15 Concentration of benzo[a]pyrene in the haemolymph after 72 h exposure to a nominal 
concentration of 20 pg benzo[a]pyrene/L in seawater 
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The concentration of benzo[a]pyrene in the haemolymph peaked at 16.9 ng 
benzo[a]pyrene/ml at 72 hours. The half-life of benzo[a]pyrene in the haemolymph 
during the depuration phase was 98 hours. 
Figure 4.16 shows the concentrations of benzo[a]pyrene determined in the tissues 
of crabs following 72 hours of exposure to a nominal concentration of 20 pg 
benzo[a]pyrene/L in seawater. 
Figure 4.16 Mean concentrations of benzo[a]pyrene in the tissues of crabs following exposure to a 
nominal concentration of 20 pg benzolalpyrenell in seawater. 
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The concentration of benzo[a]pyrene was greatest in the gill following exposure 
to benzo[a]pyrene in the water. The concentrations of benzo[a]pyrene at time 216 hours 
in the remaining tissues decreased in the order of hypodermis (skin), bladder, testes, 
heart, haemolymph, hepatopancreas, gut, and muscle. 
4.3.4.2 Exposure to 2 pg Benzo[a]pyrene/L in Seawater 
The concentration of benzo[a]pyrene in the seawater was monitored over time 
before and during the exposure phase. At the beginning of the exposure phase, the mean 
measured concentration of benzo[a]pyrene in the seawater was 2.5 * 1.5 ng/L (Figure 
4.1 7). By the end of the 72 hour exposure phase, the mean concentration declined to 0.8 * 
0.6 ng benzo[a]pyrene /L. 
Figure 4.17 Mean concentrations of benzo[a]pyrene in the seawater over time 
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Figure 4.18 shows the mean concentrations of benzo[a]pyrene determined in the 
haemolymph of crabs following exposure to a nominal concentration of 2 pg 
benzo[a]pyrene/L in 29 ppt seawater. Crabs were transferred to clean seawater following 
72 hours of exposure. The error bars represent one standard deviation from the mean of 
three samples. 
Figure 4.18 Mean concentration of benzolalpyrene in the haemolymph of crabs exposed to 2 pg 
benzo[a]pyrene/L in seawater 
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During the exposure phase, the concentration of benzo[a]pyrene in the 
haemolymph peaked at 5.3 ng benzo[a]pyrene/ml after 24 hours. The half-life of 
benzo[a]pyrene during the elimination phase was 74 hours. 
Figure 4.19 shows the mean concentrations of benzo[a]pyrene determined in the 
tissues of crabs following water-borne exposure. 
Figure 4.19 Mean concentrations of benzolalpyrene in the tissues of crabs following exposure to a 
nominal concentration of 2 pg benzo[a]pyrene/L in seawater. 
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The concentration of benzo[a]pyrene was greatest in the gill following the 
exposure phase. The concentrations of benzo[a]pyrene in the remaining tissues decreased 
in the order of hypodemis, bladder, heart, testes, gut, hepatopancreas, muscle and 
haemolymph. 
4.3.5 Apparent Bioavailability of Benzo[a]pyrene 
The estimated apparent bioavailability of benzo[a]pyrene was calculated for each 
route of exposure. A summary of the bioavailability of benzo[a]pyrene in the dungeness 
crab for each exposure route is presented in Table 4.3. 
Table 4.3 Apparent Bioavailability (A%) of benzolalpyrene in the crab 
Route iv oral oral branchial branchial 
- 
Dose 2 2 20 320000* 32000* 
Dose (ng) 1620000 1696667 13367 209157~ 19200~ 
AUC 47352.6 2546.6 126.88 3672.74 561.93 
TI12 134 194 354 98 74 
A% con - 3.5 12 82 180 
*nominal concentration * volume for branchial route 
?average measured concentration * volume for branchial route 
These bioavailability values were used as parameters in the PBTK model 
described in Chapter 5. 
4.3.6 Estimation of in vitro Partition Coefficients 
4.3.6.1 Preliminary Experiment to Determine Tissue Homogenate Volume 
Prior to determination of the in vitro partition coefficients, a preliminary 
experiment was conducted to determine the best volume of tissue homogenate to place in 
the dialysis bags so that tissue concentrations would reach equilibrium over a period of 
14 days. The experiment was conducted with two tissues, muscle and hepatopancreas 
with either 1 or 2 ml of tissue homogenate per bag. A total of 100 ng of benzo[a]pyrene 
was added to each vial. Two replicates were conducted for each treatment. Figure 4.20 
shows that the mean amounts of benzo[a]pyrene in the tissues reached a flatter plateau in 
the bags containing 2 ml of tissue homogenate for both the muscle and hepatopancreas. 
Therefore, 2 ml of tissue homogenate per dialysis bag were used for the definitive 
experiments for determining partition coefficients. 
Figure 4.20 Amount of benzo[a)pyrene partitioned into tissues over time 
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4.3.6.2 Partition Coefficient Determination 
Tissue partition coefficient experiments were conducted in the dark at g•‹C. The 
concentration of benzo[a]pyrene was determined in the TBS solutions of each vial by 
HPLC-fluorescence and scintillation counting techniques. Analysis of reverse phase 
chromatographs showed that there was one peak present representing benzo[a]pyrene 
indicating that metabolism of the benzo[a]pyrene did not occur to any measurable extent. 
Partition coefficients were estimated using either 100 ng or 1000 ng in 20 ml of TBS for 
each tissue. Partition coefficients for haemolymph were also determined with a seawater 
medium. The mean calculated percentage of benzo[a]pyrene for each tissue is shown in 
Figure 4.2 1. 
Figure 4.21 Percentage of total benzo[a]pyrene in 2 ml of homogenised tissues (dialysis bags). Haem 
SW = haemolymph in seawater, Ref SW = reference seawater. 
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The in vitro partition coefficients estimated for each treatment of benzo[a]pyrene, 
100 and 1000 ng, are summarised in Table 4.4. Mean and standard deviations are based 
on four measurements per treatment. 
Table 4.4 Crab tissue:haemolymph partition coefficients for benzo[a]pyrene determined in vitro 
Tissue 
100 1000 Overall 
Mean SD Mean SD Mean 
Gill 
Muscle 
Testes 
Gut 
Heart 
Skin (hypodermis) 
Bladder 
Hepatopancreas 
Generally, the partition coefficient obtained using 1000 ng of benzo[a]pyrene in 
the vials was greater than that obtained when 100 ng was used. The haemo1ymph:tissue 
partition coefficients declined in the order of hepatopancreas, heart, bladder, hypodermis, 
gut, testes, muscle and gill. 
4.3.7 Body Composition Analysis 
Table 4.5 shows the body composition of the dungeness crab. Mean values and 
standard deviation for each tissue are presented in terms of tissue mass in grams and 
percent of total body mass. Nerve tissues and other small organs are represented as 
"other". 
Table 4.5 Body composition of the dungeness crab (n = 57) 
Tissue Mean mass (g) SD 
Mean Percent of 
Body Weight SD 
Stomach & gut 
Hepatopancreas 
Bladder 
Muscle 
Gill 
Heart 
Testes 
Hypodemis 
Haemol ymph 
Carapace 
Other 
Total 696 - 100.00 - 
The haemolymph, carapace, and muscle tissues have the largest tissue volumes, 
35.7%, 33.2% and 23.2% respectively, which together comprise 92.1% of the total body 
mass of the crab. 
4.3.8 Examination of in vivo Metabolism and Urinary Excretion 
Individual urine samples were collected from three crabs administered with a 2 
mg benzo[a]pyrene/kg intravascular dose, and three crabs with a 2 mg benzo[a]pyrene/kg 
single bolus oral dose. Urine samples were collected daily over a period of ten days. 
Urine flow rates were calculated based on cumulative urine volumes over time (Figure 
4.22). The mean urine flow rate of crabs dosedper os, 2.25 ml/kg/hr was greater than that 
for crabs dosed i. v., 1.5 1 ml/kg/hr. 
Figure 4.22 Mean volume of urine excreted and urinary flow rates measured in crabs following either 
a 2 mg benzolalpyrenelkg intravascular or oral dose 
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The amount of benzo[a]pyrene equivalents was measured in each urine sample. 
Figure 4.23 shows the cumulative amount of parent benzo[a]pyrene and metabolites 
determined in urine samples over time for both sets of crabs. 
Figure 4.23 Cumulative amount of benzolalpyrene equivalents in urine over time following either a 
2 mg benzolalpyrenelkg intravascular or oral dose 
+Oral Dose 
+ IV Dose 
1 E-2 ! I I I 
0 24 48 72 96 120 144 168 192 216 240 
Time (hours) 
The total amount of benzo[a]pyrene excreted and metabolites in the urine of crabs 
dosedper os represented 1.2% of the total dose, whereas, 2.3% of the total dose was 
excreted in the urine by crabs administered with an i.v. dose. 
Urine samples were extracted with ethyl acetate to determine the amount of 
extractable benzo[a]pyrene and metabolites. Figure 4.24 shows the percentage of 
radiolabelled benzo[a]pyrene that was associated with either the aqueous fraction (non- 
extractable) or the solvent extractable fraction. 
Figure 4.24 Percentage of benzolalpyrene and metabolites excreted in urine associated with aqueous 
and ethyl acetate extractable fractions from crabs dosed with either a 2 mg 
benzo[a]pyrene/kg intravascular or oral dose 
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Generally, 45% of the parent benzo[a]pyrene and metabolites were extractable 
and 55% remained in the aqueous fraction following an oral dose. However, a smaller 
proportion of benzo[a]pyrene and metabolites was extractable in the urine from crabs 
administered with an intravascular dose, 3 I%, while 69% remained in the aqueous 
fraction. 
4.3.9 Identification of Benzo[a]pyrene Metabolites in the Urine 
Two benzo[a]pyrene metabolites were identified in the extractable fractions of 
urine samples. Figure 4.25 shows an overlay of an HPLC-fluorescence chromatogram of 
benzo[a]pyrene metabolite standards compared with a histogram showing the 
radioactivity in fractions collected following injection of an ethyl acetate urine extract. 
Figure 4.25 Overlay of HPLC-fluorescence chromatogram and radioactivity of collected fractions for 
identification of solvent extractable benzolalpyrene metabolites in crab urine 
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Two of the most prominent peaks matched the metabolite standards for 9,lO- 
dihydroxybenzo[a]pyrene and 7,8-dihydroxybenzo[a]pyrene at retention times of 19 and 
28 minutes respectively. Figure 4.26a shows a comparison of the ions determined by 
GUMS in the fraction collected at 19 minutes compared with a trans-9,lO- 
dihydroxybenzo[a]pyrene metabolite standard (Figure 4.26b). 
Figure 4.26 Comparison of GCIMS ion chromatogram a) benzo[a]pyrene metabolite extracted from 
crab urine, b) Trans-9,lO-dihydroxybenzo[a]pyrene standard. 
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The major ions of the urinary metabolite ion chromatogram match those of the 
metabolite standard indicating that the metabolite is trans-9,lO-dihydroxybenzo[a]pyrene. 
Figure 4.27 shows a comparison between the prominent ions in the 28 minute HPLC 
fraction, putatively identified as 7,8-dihydroxybenzo[a]pyrene and the metabolite 
standard. 
Figure 4.27 Comparison of GCIMS chromatograms a) benzolalpyrene metabolite extracted from 
crab urine, b) Trans-7,8-dihydroxybenzoIa1pyrene standard. 
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A comparison of the two ion chromatograms indicated that the second metabolite 
was trans-7,8-dihydroxybenzo[a]pyrene. 
4.4 Discussion 
4.4.1 Kinetics of Benzo[a]pyrene in the Crab 
The uptake of benzo[a]pyrene in the crab following exposure to benzo[a]pyrene 
in the water or an oral dose was fairly rapid. James et al., (1995) found similar kinetics of 
benzo[a]pyrene in the haemolymph of the American lobster, Homarus americanus 
following a single oral bolus dose. The uptake and elimination phases following an oral 
dose were remarkably similar to those observed in the crab. A rapid uptake in the 
haemolymph was followed by a slow linear decline (James et al., 1995). 
The elimination of benzo[a]pyrene from crabs following exposure was relatively 
slow. Half-lives of benzo[a]pyrene in the haemolymph ranged from 60 to 354 hours. 
Analysis of tissues 20 days after administration of a single 2 mg benzo[a]pyrenekg oral 
dose showed that tissue concentrations were still relatively high, indicating a very slow 
rate of elimination from the crabs. However, the half-life of benzo[a]pyrene in lobsters 
dosed orally with 50 pg benzo[a]pyrenekg (James et al., 1995) was significantly longer, 
>672 h, than that observed for the dungeness crab. 
The elimination of benzo[a]pyrene in fish is much more rapid in comparison. For 
example, the whole body half-life of benzo[a]pyrene in fish, such as the bluegill sunfish, 
is only 2 to 3 days (Dunn and Fee, 1979; Spacie et al., 1983, Shugart et al., 1990). 
Lamaire et al. (1 992) estimated that the half-life of benzo[a]pyrene in the liver of the sea 
bass, (Dicentrarchus labrax) following a 20 mgkg oral dose was 8.18 days. In contrast, 
the half-life of benzo[a]pyrene in the hepatopancreas of crabs administered with a 10 fold 
lower oral dose, 2 mgkg, was 10 days (240 hours). 
4.4.2 Tissue Distribution 
The distribution of benzo[a]pyrene in the tissues varied depending on the route of 
administration. For each exposure route, the tissue concentrations of benzo[a]pyrene 
decreased in the following orders: 
Intravascular dose 2mgkg 
Oral 2 mglkg dose: 
Oral 20 pgkg dose: 
Gill>gut>testes>heart>bladder>hepatopancreas>haemolymph>hypodemis>muscle 
Water Exposure 20 pg/L: 
Water Exposure 2 pg/L: 
The disposition of benzo[a]pyrene in the spiny lobster was studied by James and Little 
(1 984) following an 1 mglkg intrapericardal dose of 14c labelled benzo[a]pyrene. The 
concentration of benzo[a]pyrene equivalents in each tissue decreased according to the 
following order: 
This pattern of tissue disposition is somewhat similar to the pattern obtained following 
the intravascular dose in the crab. 
4.4.3 Partition Coefficients 
The haemo1ymph:tissue partition coefficients declined in the order of 
hepatopancreas, heart, bladder, hypodermis, gut, testes, muscle and gill. The partition 
coefficients seem to correlate with the lipid content of each tissue. Analysis of C. 
magister tissues by Allen (1 97 1 ; 1972) showed that the of the seven tissues analysed, the 
hepatopancreas has the highest concentrations of lipid, followed by the testes, viscera, 
skeletal muscle, gill, exoskeleton, and haemolymph. This result may be expected because 
benzo[a]pyrene is a very lipid soluble compound with a relatively high Kow of 
approximately 6.1 (OME, 1 997). 
4.4.4 Elimination of Benzo[a]pyrene and Metabolites in the Urine 
Analysis of the urine collected from crabs dosed with benzo[a]pyrene showed that 
crabs are capable of metabolising benzo[a]pyrene. However, the rate of metabolite 
excretion in the urine appears to be very slow. Crabs were only capable of eliminating 
1.2% to 2.3% of the total benzo[a]pyrene dose in the urine over a period of 10 days. It is 
likely that the urine is not the primary route of benzo[a]pyrene excretion in the crab. For 
example, the majority of benzo[a]pyrene and metabolites were excreted in the feces of 
dosed rats, rather than the urine following intraperitoneal or oral administration (van de 
Wiel et al., 1993). van de Wiel et al., (1993) also found that the amount of 
benzo[a]pyrene in the urine was greater following an intrapericardial dose compared with 
an oral dose. This is expected because the whole dose is theoretically bioavailable 
following intravascular or intrapericardial administration, whereas, only a percentage of 
an orally administered dose is absorbed. 
In fish, the majority of PAH metabolites are eliminated in the bile. Steward et al., 
(1 99 1) found that 25% of an intraperitoneally administered dose of radio-labelled 
benzo[a]pyrene was excreted into the bile. Crabs do not possess a gall bladder like 
structure that is present in fish and other vertebrates. However, the hepatopancreas 
probably excretes metabolites of PAH such as benzo[a]pyrene directly into the intestine. 
The total amount of benzo[a]pyrene and metabolites excreted in the feces by crabs was 
not determined in this study due to difficulties in collecting feces from crabs released into 
the surrounding medium. 
4.4.5 Benzo[a]pyrene Metabolites 
Figure 4.25 shows that there were at least two main phase I benzo[a]pyrene 
metabolites that could be identified in the urine of crabs, trans-9,lO- 
dihydroxybenzo[a]pyrene and trans 7,8-dihydroxybenzo[a]pyrene. These two phase I 
benzo[a]pyrene metabolites have also been determined in the urine of rats, (van de Weil 
et al., 1993), in the bile of carp, (Steward et al., 1991), English sole, and starry flounder, 
(Varanasi et al., 1986), and in the digestive gland and gills of the mussel, Mytilus 
galloprovincialis (Michel et al., 1995). Microsomes isolated from the English sole, 
Parophrys vetulus, (Nishimoto, et al., 1992), and the sea anemone, (Bunodosoma 
cavernata), (Winston et al., 1 998), have also produced trans-9,lO- 
dihydroxybenzo[a]pyrene and trans 7,8-dihydroxybenzo[a]pyrene, metabolites among 
others. 
The presence of trans-7,8-dihydroxybenzo[a]pyrene and trans 9,lO- 
dihydroxybenzo[a]pyrene is significant because these metabolites are the products of 
epoxide intermediates catalysed by mixed function oxidases (Gelboin, 1980), and these 
diol metabolites themselves have also been shown to bind directly to DNA (Borgen et al., 
1973). Therefore, the dungeness crab is capable of metabolising benzo[a]pyrene into well 
characterised carcinogenic compounds. While tumours related to benzo[a]pyrene 
exposure has been demonstrated in numerous studies of other aquatic species, such as 
fish, (Varanasi, et al., 1982; Black et al., 1988; Couch and Harshbarger, 1985; Fong et 
al., 1988; Hawkins et al., 1988; Collier, et al., 1992), to date there are no published 
studies demonstrating tumours in crabs related to PAH exposure. In addition, it has been 
shown that American lobsters exposed to PAH do not develop tumours or neoplastic 
changes, although finfish exposed under the identical conditions do develop cancer 
(James et al., 1995). There are two factors which may account for a reduced carcinogenic 
potential of PAH in crabs and other decapod crustaceans, (1) fish metabolise PAH much 
more rapidly than crabs and therefore, are likely to produce more carcinogenic 
metabolites that may bind to DNA and cause tumours, (2) crabs may conjugate a large 
amount of the potentially carcinogenic benzo[a]pyrene metabolites with glutathione. 
High levels of glutathione S-transferase activity has been found in the 
hepatopancreas of the blue crab, Callinectes sapidus (Keeran and Lee, 1987). My studies 
showed that there was a relatively large amount of radiolabelled benzo[a]pyrene 
metabolites associated with the aqueous fraction of the urine that could not be made 
soluble in ethyl acetate after hydrolysis treatment with HC1, or treatment with sulfatase 
or glucosidase enzyme assays (59-69%). It was assumed that most of the metabolites 
associated with the aqueous fraction were therefore glutathione conjugates. Since 
glutathione S-transferase has been proposed to protect rats from hepatocarcinogenesis 
(Jernstrom, et al., 1985), this phase I1 reaction, coupled with a slow rate of phase I 
metabolism may be the reason that tumours observed in benthic species such as the 
English sole, have not been similarly observed or reported in crabs. To date there is no 
literature evidence that PAH cause tumours in crabs. 
While protecting the crab from cancer, the relatively slow metabolism and 
elimination of PAH such as benzo[a]pyrene also makes the crab a better biomonitoring 
species than the fish. Fish metabolise and eliminate PAH very quickly following 
exposure, therefore, it is very difficult to determine concentrations of PAH in the tissues 
of fish caught in the field. Usually PAH exposure in fish is best evaluated by the analysis 
of metabolites excreted into the bile. However, tissue concentrations of PAH can be 
determined in the hepatopancreas, muscle, and haemolymph of crabs exposed to PAH as 
demonstrated in Chapters 2 and 3. Therefore, these slow metabolic and elimination rates 
make the crab a better sentinel species for monitoring environmental contamination. 
4.5 Conclusion 
Benzo[a]pyrene is readily absorbed into the haemolymph by dungeness crabs 
following exposure to contaminated food or water. Once absorbed, this chemical is 
readily distributed throughout the tissues of the crab. Elimination of benzo[a]pyrene from 
the crab is very slow compared with fish or mammals. While crabs are capable of 
metabolising benzo[a]pyrene using very similar enzymatic reactions as vertebrates 
(James, 1989) the rate of metabolism is relatively slow. However, this slow metabolism 
may protect the crab from the carcinogenic potential of benzo[a]pyrene and other PAH. 
In addition, the slow removal of PAH from the tissues of the crab facilitates the use of the 
crab as a good biomonitor of PAH in the marine environment. 
CHAPTER 5 
PBTK MODEL DEVELOPMENT AND VALIDATION 
5.1 Introduction 
Physiologically based toxicokinetic (PBTK) models have been used extensively 
to describe the disposition of chemicals in living organisms. One of the strengths of the 
PBTK modelling approach is the ability to scale a model to different body sizes and 
species. Most often these models are used to extrapolate the toxicokinetics of a toxicant 
from rodents to humans (Gerlowski and Jain, 1983). However, many PBTK models have 
been developed in the aquatic species in recent years. Zaharko, et al. (1 972) was the first 
to report a PBTK model for an aquatic species, the sting ray. Zaharko originally 
developed a model in the mouse to simulate the disposition of methotrexate in the tissues 
and then adapted this model to the sting ray. Following this, Bungay et al. (1 976) 
developed a PBTK model to predict the disposition of phenol red in the dogfish shark. 
Realising the potential of PBTK models to predict the disposition of organic pollutants in 
fish, Nichols et al., developed a PBTK model to describe the kinetics of chlorinated 
ethanes in rainbow trout (1 991) and then extrapolated this model to the channel catfish 
(1993). More recently, a PBTK model which predicted pyrene disposition in the rainbow 
trout (Law et al., 1991) was successfully adapted to marine flatfish species including the 
starry flounder and flathead sole (Namdari, 1998). This model has also been adapted to 
predict the elimination of oxytetracycline from the tissues of farmed Atlantic salmon 
(Law, 1999). The current study represents the first attempt to extrapolate a PBTK model 
developed in the vertebrate to an invertebrate, the dungeness crab (Cancer magister). 
The purpose of this study was to determine if a PBTK model could be developed 
to describe the disposition of benzo[a]pyrene in the dungeness crab. The PBTK model of 
pyrene for rainbow trout (Law et al., 1991) was modified to meet this objective. The 
model design was altered to suit the anatomy and physiology of the crab. Additionally, 
the anatomical, biochemical and physiological parameters in the rainbow trout model 
were replaced by those of the crab and the model was then used to predict the time course 
of benzo[a]pyrene concentrations in the crab tissues. Despite the many differences in the 
physiology and biochemistry between the trout and the crab, and the physico-chemical 
differences between pyrene and benzo[a]pyrene, the PBTK model of pyrene for rainbow 
trout was successfully adapted to predict benzo[a]pyrene distribution in the tissues of the 
crab. 
Many PBTK models have been developed in one animal species using the 
intravascular route of chemical administration and then used to predict tissue disposition 
in another animal species after exposure by an environmentally relevant route such as the 
inhalation, dermal or oral route. For example, Ramsey and Andersen (1 984) developed a 
PBTK model to describe the disposition of styrene in the rat following exposure by 
inhalation. This model was subsequently adapted to describe the disposition of styrene in 
humans via inhalation (Ramsey and Andersen, 1984). 
The current model was designed to simulate benzo[a]pyrene disposition in the 
crab following intravascular injection, bolus oral administration with food or exposure 
via the water. These exposure routes were chosen in order to develop a model which 
could be used to predict benzo[a]pyrene concentrations in the tissues of crabs exposed to 
PAH in the environment. It was my intention to apply the model for this purpose when 
information on benzo[a]pyrene concentrations in the biota which crabs prey upon, and 
water of a specific site became available. In addition, we intended to link this model 
describing the internal toxicokinetics of benzo[a]pyrene in the crab, to a food web model 
developed by Glenn Harris and Frank Gobas, (Harris, 1999) to describe the fate of PAH 
such as benzo[a]pyrene in the Kitimat water system. This chapter describes the 
development and validation of the PBTK model for the crab while Chapter 4 describes 
the empirical studies used for the development, calibration and validation of the model. 
5.2 PBTK Model 
5.2.1 Model Conceptualisation 
The PBTK model has been conceptualised to simulate the uptake, distribution, 
metabolism and elimination of benzo[a]pyrene in the dungeness crab following chemical 
exposure via water or food. The model was adapted from a previously reported PBTK 
model of pyrene for the rainbow trout (Law et al., 1991). The compartmental design of 
the model was modified to suit the anatomy and physiology of the crab. For example, the 
membrane-limited muscle compartment in the trout model was replaced with a more 
suitable flow-limited muscle compartment for the crab. A schematic diagram of the 
PBTK model of crab is depicted in Figure 5.1. The model is composed of seven 
compartments which represent the major organs or tissues of the crab; they include the 
haemolymph, gill, hepatopancreas, gut, urinary bladder, muscle and carcass. 
All compartments in the model are connected together via the circulatory system 
represented by the arterial and venous haemolyrnph. The flux of chemical between the 
compartments is regulated by flow rates of the haemolymph and haemo1ymph:tissue 
partition coefficients of benzo(a)pyrene. The chemical concentration in a compartment is 
assumed to be homogenous and in equilibrium with the chemical concentration in the 
haemolymph exiting the compartment. 
Figure 5.1 Schematic diagram of the PBTK model for predicting the disposition of benzo[a]pyrene 
in the dungeness crab. 
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The model is designed to accept benzo(a)pyrene input through the intravascular, 
oral or branchial route. Thus, the amount of benzo[a]pyrene administered by the i.v. or 
oral dose is used for inputting the chemical into the crab via these exposure routes 
whereas the concentration of benzo(a)pyrene in water is used for inputting waterborne 
benzo(a)pyrene into the crab via the branchial route. In addition, intravascular injection is 
modelled by direct addition of the chemical into the mixed venous haemolyrnph. The 
absorption of benzo[a]pyrene by the gut is represented by a first-order absorption rate 
constant k, with bioavailability, A,. Uptake of chemical from water into the gill 
compartment and the circulating haemolymph was also modelled by a first-order uptake 
rate expression which includes gill ventilation (Qw), first-order uptake rate (kb) and a 
branchial bioavailability constant (Ab). Elimination of benzo[a]pyrene by metabolism and 
other processes is assumed to occur in the hepatopancreas and is represented by both 
linear and Michaelis-Menten saturable clearances. 
5.2.2 Mass Balance Differential Equations 
The PBTK model is composed of a set of mass-balance differential and algebraic 
equations which describe the change of benzo[a]pyrene concentration in each tissue 
compartment over time. The differential equations were simultaneously solved by 
numerical integration to determine the concentration of chemical in each compartment 
for any time point. These equations were programmed in Visual ~ a s i c @  and solved by a 
spreadsheet program, Microsofi ~ x c e l @  which stores the input data and model 
parameters. Model output is stored in Excel and plotted graphically. The basic differential 
equation which describes the change of concentration of benzo[a]pyrene per unit of time 
in a simple compartment is defined by Equation 5.1 : 
where Qi represents the haemolymph flow rate constant for the compartment, Vi 
represents the volume of compartment i, Ri represents the partition coefficient and CA 
and Ci represent the concentration of chemical in the arterial haemolymph and the tissue 
compartment respectively. This equation forms the basic unit upon which the entire 
PBTK model is based. A simple explanation of it's derivation from Fick's First Law can 
be obtained from O'Flaherty (1 987). 
Compartment volumes were expressed in units of ml where solid tissues were 
assumed to have the density of 1.0 g/ml. The concentration of benzo[a]pyrene in each 
compartment is expressed in units of nglml haemolymph or ng/g tissue. The 
hepatopancreas compartment incorporates elimination through saturable metabolism and 
linear clearance; the basic compartment equation was modified to accommodate these 
processes as described by Equation 5.2: 
dCL/dt = (CBA(QL - QGT) + QGT(CGT/RGT) - QL(CL/RL) - 
((V,ax(VL) (CL/RL))/(Km + CLIRL)) - KL (CL/RL))/VL 
where the concentrations of benzo[a]pyrene in the hepatopancreas and arterial 
haemolyrnph are represented by CL and CBA, the hepatic partition coefficient is RL and 
the volume of the compartment is VL. Hepatic clearance is denoted by KL and the 
Michaelis-Menten rate constants are V,, and Km. 
The basic equation was also modified to include direct uptake of benzo[a]pyrene 
from the gut compartment as shown in Figure 5.1. Thus haemolymph flow and partition 
coefficient for the gut are represented by QGT and RGT respectively. A complete listing 
of the mass balance equations that describe the PBTK model are summarised in 
Appendix C. 
5.2.3 Model Parameterisation 
Many types of parameters are required to implement the PBTK model. These 
parameters represent compartment volumes, blood flow, partition coefficients and uptake 
and clearance rates. The parameters used to simulate the disposition of benzo[a]pyrene in 
the dungeness crab are displayed in Table 5.1 - Table 5.5. These parameters were 
determined either empirically in the laboratory or were obtained from the literature. For 
example, values for some parameters such as tissue blood flow constants were estimated 
based on information from other researchers. Compartment volumes and partition 
coefficients were estimated using experimental methods. Other parameters such as uptake 
and clearance rates were optimised by comparing model simulation results with empirical 
data. 
5.2.3.1 Anatomical Parameters 
The PBTK model requires volumes for the tissues represented by the various 
model compartments. The compartment volumes used for the PBTK model are presented 
in Table 5.1. 
Table 5.1 Compartment volume (% body weight) parameters for the PBTK model of 
benzolalpyrene in the dungeness crab. 
Compartment Abbreviation Volume (% BW) 
Muscle VM 23.20 
Hepatopancreas VH 3.46 
Gut VGT 0.19 
Bladder 
Gill 
VK 
VGL 
Haemol ymph VB 35.70 
Carcass VC 36.28 
- -- 
Compartment volumes were determined empirically by dissecting the dungeness 
crabs and weighing the excised organs. It was assumed that all tissues had a density of 
1.0 glml. The hepatopancreas, gut, bladder, muscle, gill and haemolymph compartments 
were assigned volumes equal to 3.46, 0.19,0.36,23.20,0.81, and 35.7% of body weight, 
respectively. The sum of these compartments amounted to 63.72% of the total body 
volume while the remaining 36.28% was assigned to the carcass. 
5.2.3.2 Physiological Parameters 
Cardiac output is an important parameter which drives the disposition of chemical 
throughout the tissue compartments. The circulatory system and cardiac output of the 
dungeness crab have been extensively studied by researchers at the University of Calgary 
(Burnett et al., 198 1 ; McMahon and Burnett 1989; McGaw and McMahon 1996; De 
Wachter and McMahon, 1996; De Wachter and Wilkens, 1996). The parameters that 
describe haemolymph flow in the PBTK model are presented in Table 5.2. These 
parameters were calculated for a dungeness crab with a body weight of 750g based on 
data obtained from the studies of McMahon, et al., 1979; McDonald et al., 1980; Airiess 
and McMahon, 1994; McGaw et al., 1994; DeWachter and McMahon, 1996; and McGaw 
and McMahon 1996. 
Table 5.2 Physical parameters and haemolymph flow rates for the PBTK model of benzolalpyrene 
in the dungeness crab based on a 750 g body weight. 
Physiological Parameters Abbreviation Value 
Cardiac output ( m l h )  QT 5729 
Ventilation rate ( m l h )  Q w 9189 
Water temperature ("C) wtemp 9 
Haemolymph flow rates (%QT) Abbreviation Value 
Muscle 
Hepatopancreas 
Gut 
Bladder 
Gill 
Carcass 
A function for the cardiac output of dungeness crabs, based on water temperature, 
was obtained from a study by B. McMahon et al., (1978). Figure 5.2 shows the regression 
of cardiac output and temperature data from this study which produced the following 
linear function described by Equation 5.3: 
where QT and T represent cardiac output (ml g-' h-') and water temperature ("C). The 
cardiac output was calculated by multiplying the resulting value of this function by 
bodyweight, thus the cardiac output of a 750 g crab at 9 "C equals 5729 r n l h .  The line 
fit had an r2 = 0.997. 
Figure 5.2 Plot of Cardiac output (QT) vs Temperature (McMahon et al., 1978) 
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Haemolymph flow rates to the various compartments were initially estimated 
based on the studies of Airriess and McMahon of the University of Calgary (Airriess and 
McMahon, 1994 and 1996; McGaw, Airriess and McMahon, 1994) and were defined by 
model optimisation. Haemolymph flow rates were assigned values of 35, 10,20, 30 and 
15% of QT for hepatopancreas, gut, bladder, muscle and carcass compartments, 
respectively. 
The respiratory volume describes the volume of water which is ventilated across 
the gills over a period of time. This is an important parameter for calculating the uptake 
of benzo[a]pyrene through the gills. Gill ventilation rates in Cancer magister have also 
been extensively studied by the aforementioned research group at the University of 
Calgary (McMahon, McDonald and Wood, 1979; McDonald, Wood and McMahon, 
1980). A function for the gill ventilation rate based on water temperature was obtained 
from the study by B. McMahon et al. (1978). Figure 5.3 shows a regression of gill 
ventilation rate and temperature data from this study which produced the following linear 
function described by Equation 5.4: 
where Qw and T represent ventilation rate (ml g-' hr-') and water temperature ("C). Qw 
was calculated by multiplying the resulting value of this function by the bodyweight, thus 
the Qw of a 750 g crab at 9 "C equals 9189 ml/hr. The line fit had an r2 = 0.98. 
Figure 5.3 Plot of gill ventilation rate (QW) vs. temperature (McMahon et al., 1978) 
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5.2.3.3 Biochemical Parameters 
Biochemical parameters in the PBTK model describe the elimination of chemical 
from the organism through metabolism and excretion. These elimination parameters are 
presented in Table 5.3. 
Table 5.3 Biochemical and Clearance Rate Constants for the PBTK model of benzo[a]pyrene in the 
dungeness crab based on a 750 g body weight. 
Parameter Abbreviation Value 
Vmax (nglhrlg hepatopancreas) 
Km (ng/ml) 
Hepatic clearance (mllhr) 
It is assumed that all elimination of benzo[a]pyrene occurs in the hepatopancreas 
compartment by metabolism and other processes represented by Michaelis Menten 
metabolic rate constants and a linear hepatic clearance rate (KL). Values for the 
Michaelis Menten rate constants, Vma, and Km for benzo[ajpyrene metabolism by 
dungeness crabs could not be found in the literature. Values for these constants were 
estimated through model optimisation by matching simulation results with observed data. 
The linear hepatic clearance, KL was estimated by subtracting Michaelis-Menten and 
renal clearances from total body clearance. Total body clearance is represented by plasma 
clearance (Cp) which was determined by pharmacokinetic methods by dividing the 
amount of an intravenously administered dose by the total area under the chemical 
concentration-time curve for the haemolymph (AUC). The intravascular dose experiment 
is described in Chapter 4 from which a Cp = 42.2 f 1.76 ml kg-' h-' was initially 
estimated from the data. A value of 5.5 ml kg-' h-' for KL, was used for model 
simulations. Values for V,, and KL were scaled using body weight by the following 
allometric Equations 5.5 and 5.6 previously defined Law et al,. (1 99 1): 
where Vmaxc and KL, are the scaling coefficients for the maximum velocity of Michaelis- 
Menten metabolism and hepatic clearance respectively. The value for Km was calculated 
as a simple function of Vmax using Equation 5.7: 
5.2.3.4 Physico-biochemical Parameters 
The tissue:haemolymph partition coefficients describe the affinity of 
benzo(a)pyrene for a tissue compartment relative to the haemolymph. The partition 
coefficients used in the model are summarised in Table 5.4. 
Table 5.4 Partition Coefficients for BaP used for the PBTK model of benzo[a]pyrene in the 
dungeness crab based on a 750 g body weight. 
Partition Coefficient Parameter Abbreviation Value 
Musc1e:haemolymph 
Hepatopancreas:haemolymph 
Gut: haemolymph 
B1adder:haemolymph 
Carcass:haemolymph 
Gil1:haemolymph 
RM 0.97 
RH 3.80 
RGT 2.20 
RB 3.30 
RC 2.82 
RGL 1.5 1 
Tissue:haemolymph partition coefficients were determined by both in vitro and in 
vivo methods as described in Chapter 4. Other biochemical parameters are presented in 
Table 5.5. 
Table 5.5 Uptake Rate Constants used for the PBTK model of benzolalpyrene in the dungeness 
crab based on a 750 g body weight. 
Parameter Abbreviation Value 
gut first order uptake rate constant (hr-') ka 0.25 
gill first order uptake rate constant (hr-I) kb 4.2 
oral bioavailability (% dose) B a 1 .O 
branchial bioavailability (% dose) B b 17.5 
First-order uptake rate constants were used to describe the uptake of 
benzo(a)pyrene from water or food; they were represented by kb and k, respectively. 
Values for these constants, kb = 4.2 hr" and ka = 0.25 hr-', were determined by calibrating 
the model with experimental data. 
The bioavailability of the oral dose (A,), was estimated to be approximately 3.3%. 
This was calculated by comparing the area under the curve (AUC) in the haemolymph of 
an intravascular dose of benzo(a)pyrene (2mgkg) and the same dose administered orally 
to the crab. The estimation of bioavailability is described in more detail in Chapter 6. A 
1.0 % A, value was used in the model simulations. An initial estimate of 70.5% for the 
branchial bioavailability of benzo[a]pyrene (Ab), was similarly obtained from the 
empirical data. However, Ah = 17.5% was used for model simulations because this value 
resulted in a better fit of predicted to observed tissue concentration values. 
5.2.4 Model Calibration and Validation 
The PBTK model was calibrated by comparing the simulated tissue 
concentrations with the experimental tissue concentrations of three separate experiments 
in which the crabs were exposed to benzo(a)pyrene either as a bolus injection (2 mgkg), 
an oral dose (2 mglkg) or via the water (20 pg/L). These experiments are described fully 
in Chapter 4. The values of some of these parameters were adjusted to obtain the best 
possible fit of the observed data with the model predictions. Model simulations were run 
to predict tissue concentrations over time for the same duration in which the exposure 
experiments were conducted. Simulations were performed using a 0.01 minute time 
increment to represent the change in time, dt. The model was calibrated using a body 
weight of 750 g; the mean body weight for crabs used in experiments was 694 + 70 g. 
Temperatures in coastal waters are often approximately 9-10•‹C. Therefore, the 
exposure and in vitro experiments were conducted at 9 f 1 OC, and this temperature was 
used to derive the model parameters. 
The calibrated model was then validated using a different oral dose or water 
exposure concentration. Model simulations were compared with data obtained from two 
additional experiments in which the crabs were exposed either to a 20 pgkg oral bolus 
dose or to a 2 pg/L water exposure. The simulation results were then compared with the 
empirical data to evaluate the validity of the model predictions. 
5.3 Uncertainty Analysis 
To evaluate model performance, model uncertainty and agreement between 
predicted and observed results were assessed using the method outlined by Gobas et al., 
(1 998). For each tissue, the ratio of predicted (Cp) vs observed (Co) concentrations i.e., 
Cp/Co for each time point were calculated. These ratios were then transformed 
logarithmically to generate a frequency distribution. The mean of this distribution was 
then expressed in arithmetic form i.e., as Cp/Co and is referred to as model bias (MB). A 
MB value of <1 indicates systematic under-prediction whereas a MB value of >l 
indicates over-prediction of the observed data. Model uncertainty was described by the 
95% probability intervals (PI) of the distribution. The PI represents the range of predicted 
concentrations that includes 95% of the observed concentrations. A large PI indicates a 
greater uncertainty in model prediction. This uncertainty estimation reflects both errors in 
measurement and variability of observed data, and errors due to parameterisation or 
assumptions of the model. 
5.4 Results 
5.4.1 Intravascular Dose 
The PBTK model was initially adapted, parameterised and calibrated by 
comparing model predictions to observations obtained from exposing crabs to a 2 mgkg 
intravascular dose. The model simulates an intravascular injection of 1.5 mg of 
benzo[a]pyrene into the pericardial chamber of a 750 g crab. Intravascular administration 
was implemented by inputting 100% of the dose to the venous haemolymph of the model 
over a 0.06 minute period. This was carried out by placing 14.3% of the dose into the 

Predicted and observed benzo[a]pyrene concentrations in the hepatopancreas, 
muscle, bladder, gill and carcass are depicted in Figure 5.5 - Figure 5.8. The predicted 
concentrations in the carcass were comparable to the mean concentrations of the heart, 
hypodermis and gonad determined empirically at each time point for all exposure routes. 
Figure 5.5 Observed and predicted concentrations of benzo[a]pyrene in hepatopancreas and muscle 
following a 2 mglkg intravascular dose (predicted - line, observed - symbol). 
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Figure 5.6 Observed and predicted concentrations of benzolalpyrene in bladder following a 2 mglkg 
intravascular dose (predicted - line, observed - symbol). 
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Figure 5.7 Observed and predicted concentrations of benzolalpyrene in gill tissue following a 
2 mglkg intravascular dose (predicted - line, observed - symbol). 
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Figure 5.8 Observed and predicted concentrations of benzolalpyrene in the carcass following a 
2 mg/kg intravascular dose (predicted - line, observed - symbol). 
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Generally, there is good agreement between predicted and observed results. 
Figure 5.4 shows that the model slightly over-predicts the concentration of 
benzo(a)pyrene in the haemolymph over time. However, all but one predicted result are 
well within one standard deviation of the mean observed tissue concentrations. The 
model predicts a slow, linear elimination of benzo[a]pyrene from all tissues as seen by 
fitting the observed data as described in Chapter 4. Visual examination and analysis of 
model bias show that the model slightly over predicts muscle concentrations (>I) while 
in some cases marginally under-predicting the other tissues (<I) (Table 5.6). 
5.4.2 Oral Dose 
5.4.2.1 Model Calibration 
The oral bolus dose was simulated such that 100% of a 2 mglkg dose of 
benzo[a]pyrene was added to the gut at time zero. The model was calibrated for oral 
exposure to benzo[a]pyrene by comparing model predictions to observed data as shown 
in Figure 5.9 - Figure 5.15. Each time point represents the mean of three crabs except at 
384 and 480 minutes which are the averages of two crabs. Error bars represent one 
standard deviation from the mean. 
Figure 5.9 Observed and predicted concentrations of benzolalpyrene in the haemolymph following 
a 2 mglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.10 Observed and predicted concentrations of benzo[a]pyrene in the hepatopancreas 
following a 2 mglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.11 Observed and predicted concentrations of benzo[a]pyrene in the muscle following a 
2 mglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.12 Observed and predicted concentrations of benzolalpyrene in the bladder following a 
2 mglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.13 Observed and predicted concentrations of benzo[a]pyrene in the gut following a 
2 mglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.14 Observed and predicted concentrations of benzo(a1pyrene in the gill following a 
2 mg/kg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.15 Observed and predicted concentrations of benzo[a]pyrene in the carcass following a 
2 mglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.9 shows that the benzo[a]pyrene concentration in the haemolyrnph is 
simulated quite well by the model, particularly during the uptake phase or during the 24 
hours after the dose was administered. A few of the time points between 72- 144 hours 
post-dosing are slightly over-predicted as indicated by model bias analysis (Table 5.6). 
This may be due to either model or experimental error. The model also slightly over- 
predicted concentrations in the hepatopancreas, bladder and gut, Figure 5.10, Figure 5.12, 
and Figure 5.13) as indicated by model bias analysis. 
Benzo(a)pyrene concentrations in the muscle, gill, and carcass, (Figure 5.1 1, 
Figure 5.14, and Figure 5.15) were under-predicted but usually within one standard 
deviation of the mean observed values. The slope of the predicted curve for the muscle 
seemed to predict a slightly faster elimination of benzo[a]pyrene from this tissue than the 
observed data although the later observed time points are less accurate than the earlier 
ones because there is one less data point in the mean, and due to error associated with the 
analytical method. 
5.4.2.2 Model Validation 
The PBTK model was validated for predicting tissue concentrations following an 
oral exposure using a dose of 20 pglkg, 100 fold lower than the dose used for the model 
calibration. A more environmentally relevant but lower dose was chosen to determine the 
importance of the rate-limiting or saturable processes in the disposition of 
benzo[a]pyrene in the crab. The results of the model predictions and observed data are 
presented in Figure 5.16 - Figure 5.22. 
Figure 5.16 Observed and predicted concentrations of benzo(a1pyrene in the haemolymph 
following a 20 pglkg oral dose (predicted - line, observed - symbol). 
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Figure 5.17 Observed and predicted concentrations of benzo[a]pyrene in the hepatopancreas 
following a 20 pglkg oral dose (predicted - line, observed - symbol). 
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Figure 5.18 Observed and predicted concentrations of benzolalpyrene in the muscle following a 
20 &kg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.19 Observed and predicted concentrations of benzo[a]pyrene in the bladder following a 
20 pglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.20 Observed and predicted concentrations of benzolalpyrene in the gut following a 
20 pgtkg oral dose (predicted - line, observed - symbol). 
Figure 5.21 
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Observed and predicted concentrations of benzolalpyrene in the gill following a 
20 pg/kg oral dose (predicted - line, observed - symbol). 
Time (hours) 
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Observed and predicted concentrations of benzolalpyrene in the carcass following a 
20 pglkg oral dose (predicted - line, observed - symbol). 
Time (hours) 
Predicted and observed concentrations are in good agreement and the predicted 
concentrations are within one standard deviation of the observed values with the 
exception of the gill. A comparison of predicted and observed concentrations in the 
haemolymph (Figure 5.16) shows that the model slightly under-predicted haemolyrnph 
concentrations especially over the first 48 hours post-exposure. Concentrations of 
benzo[a]pyrene in the hepatopancreas and muscle were somewhat over-predicted by the 
model (Figure 5.17 and Figure 5.18) while concentrations in the bladder, gut, and carcass 
(Figure 5.19, Figure 5.20, and Figure 5.22) were in agreement. Observed concentrations 
in the gill were significantly under-predicted by the model (Figure 5.21). 
5.4.3 Waterborne Exposure 
5.4.3.1 Model Calibration 
The PBTK model was adapted to predict the disposition of benzo[a]pyrene in the 
crab following exposure to waterborne chemical. Crabs were exposed to a nominal 
concentration of 20 pg benzo[a]pyrene/L for 72 hours under static conditions and then 
were removed to clean seawater for the duration of the experiment to study chemical 
elimination. The concentration of benzo[a]pyrene in the seawater was analysed over the 
duration of the exposure period. The measured concentrations were used as the input 
concentrations of the waterborne exposure experiment. The water exposure experiments 
are described fully in Chapter 4 and the observed exposure concentrations are 
summarised in Figure 4.14 and Figure 4.17. The predicted and observed results of the 
waterborne exposure study are depicted in Figure 5.23 - Figure 5.29. 
Figure 5.23 shows that the model predicted the observed concentrations of 
benzo[a]pyrene in the haemolymph extremely well over the duration of the experiment. 
Concentrations in the hepatopancreas and gut were significantly over-predicted by the 
model (Figure 5.24 and Figure 5.27). Predicted concentrations in the hepatopancreas and 
gut were generally 3.6 and 3.3 fold higher than the observed values respectively. This 
difference may be related to the problems of route-to-route extrapolation encountered 
frequently during model development. In contrast, benzo(a)pyrene concentrations in the 
bladder and carcass tissues were simulated quite well by the model (Figure 5.26 and 
Figure 5.29). The model generally under-predicted the observed concentrations of 
benzo[a]pyrene in the gill. The uncertainty analysis showed that there was a relatively 
large PI value for the gill compartment (Table 5.7). 
Figure 5.23 Observed and predicted concentrations of benzolalpyrene in the haemolymph 
following a 20 pg/L seawater exposure (predicted - line, observed - symbol). 
0 24 48 72 96 120 144 168 192 216 240 264 288 
Time (hours) 
Figure 5.24 Observed and predicted concentrations of benzo[a]pyrene in the hepatopancreas 
following a 20 pg/L seawater exposure (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.25 Observed and predicted concentrations of benzo[a]pyrene in the muscle following a 20 
pg/L seawater exposure (predicted - line, observed - symbol). 
h 
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Figure 5.26 Observed and predicted concentrations of benzo[a]pyrene in the bladder following a 20 
pg/L seawater exposure (predicted - line, observed - symbol). 
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Figure 5.27 Observed and predicted concentrations of benzolalpyrene in the gut following a 20 
pg/L seawater exposure (predicted - line, observed - symbol). 
h C 
c 
0, 
.- 
C 
Y 
0, 
1
0, 
C 
V 
al 
C 
al 
L 
>\ 
a 
n 
(TI 
Y 
0 
N 
C 
al 
13 
+ 
0 
C 
0 
. - 
C 
e 
C 
C 
8 
C 
0 
0 48 72 96 120 144 168 192 216 240 264 288 
Time (hours) 
Figure 5.28 Observed and predicted concentrations of benzolalpyrene in the gill following a 20 
pg/L seawater exposure (predicted - line, observed - symbol). 
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Figure 5.29 Observed and predicted concentrations of benzolalpyrene in the carcass following a 20 
pg/L seawater exposure (predicted - line, observed - symbol). 
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5.4.3.2 Model Validation 
The PBTK model was validated for predicting the disposition of benzo[a]pyrene 
using a seawater exposure concentration of 2 pg/L. This exposure concentration was 10 
fold lower than used for model calibration. This concentration is within the range of 
water solubility values (0.172 - 6.9 pg/L) reported for benzo[a]pyrene (Mackay et al., 
199 1). Figure 5.30 - Figure 5.36 show the predicted vs. observed tissue concentrations of 
crabs exposed to a nominal concentration of 2 pg/L waterborne benzo[a]pyrene. Each 
tissue time point represents the mean of three crabs. Haemolymph time points represent 
the means of 12 (0.5 - 72 hr), 6 (96 - 120 hr), and 3 crabs (1 44 - 168 hr). Error bars 
represent one standard deviation from the mean. The solid line represents the model 
simulation. 
Figure 5.30 Observed and predicted concentrations of benzo[a]pyrene in the haemolymph 
following a 2 pg/L seawater exposure (predicted - line, observed - symbol). 
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Observed and predicted concentrations of benzo[a]pyrene in the hepatopancreas 
following a 2 pg/L seawater exposure (predicted - line, observed - symbol). 
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Figure 5.33 
Observed and predicted concentrations of benzo[a]pyrene in the muscle following a 2 
pg/L seawater exposure (predicted - line, observed - symbol). 
Time (hours) 
Observed and predicted concentrations of benzolalpyrene in the bladder following a 2 
pg/L seawater exposure (predicted - line, observed - symbol). 
Time (hours) 
Figure 5.34 Observed and predicted concentrations of benzo[a]pyrene in the gut following a 2 F ~ / L  
seawater exposure(predicted - line, observed - symbol). 
Time (hours) 
Figure 5.35 Observed and predicted concentrations of benzo[a]pyrene in the gill following a 2 pg/L 
seawater exposure (predicted - line, observed - symbol). 
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Figure 5.36 Observed and predicted concentrations of benzo[a]pyrene in the carcass following a 2 
pg/L seawater exposure (predicted - line, observed - symbol). 
Time (hours) 
The model predicted concentrations very well in the haemolymph of crabs exposed to 
2 pg/L of benzo[a]pyrene in seawater (Figure 5.30). Observed concentrations in the 
hepatopancreas and gut were again overestimated by the model (Figure 5.3 1 and Figure 
5.34). There was good agreement between predicted and observed concentrations in the 
muscle, bladder and carcass (Figure 5.32, Figure 5.33, and Figure 5.36). However, gill 
tissue concentrations were significantly under-predicted. Again, the PI was very high, 
indicating a great deal of uncertainty in the model simulated values for this compartment 
(Table 5.7). 
5.4.4 Model Bias and Uncertainty 
A summary of the model bias analysis is for each set of model predictions and 
experimental data is presented in Table 5.6. 
Table 5.6 Model bias for fit of model predicted benzolalpyrene concentrations to empirical 
benzo[a]pyrene tissue concentrations 
Simulation hepato muscle bladder gut gill carcass haemolymph 
iv 2mgkg 0.68 1.16 0.58 - 0.82 0.69 1.20 
Oral 2mgkg 1.45 0.50 1.37 1.26 0.79 0.97 1.15 
Oral 20 pgkg 1.64 1.60 1 .07 0.78 0.29 0.91 0.71 
Water 20 pg/L 3.28 1.40 1 S O  3.56 0.07 1.19 0.89 
Water 2pg/L 4.03 1.46 1.24 2.71 0.05 1.35 0.97 
Uncertainty in the model simulated values compared with empirically determined 
concentrations of benzo[a]pyrene in each tissue compartment is surnmarised by the 95% 
probability interval values, presented in Table 5.7. 
Table 5.7 Probability Intervals calculated for estimation of uncertainty in model predicted values 
Simulation hepato muscle bladder gut gill carcass haemolymph 
iv 2mgkg 3.4 2.6 4.5 - 2.2 2.2 2.0 
Oral 2mgkg 2.1 4.6 2.4 2.6 4.1 2.8 2.0 
Oral 20 pg/kg 2.2 1.9 2.2 2.6 6.2 2.3 2.7 
Water 20 pg/L 1.6 2.3 2.7 1.4 37.1 2.7 2.3 
Water 2pg/L 1.6 3.3 4.0 2.5 130.6 2.9 2.3 
5.4.5 Application of PBTK Model to Predict PAH Concentrations in Muscle Tissue 
for Human Health Risk Assessment 
The PBTK model was used to fill data gaps in the concentrations of PAH 
determined in muscle tissues of crabs collected in Kitimat Arm. The concentrations of 
PAH were determined in the hepatopancreas of all of the 187 crabs collected in Kitimat 
Arm (Chapter 2). However, muscle tissues were only analysed in 15 of the 66 muscle 
samples from Hospital Beach that had the highest concentrations in the hepatopancreas, 
and similarly, 4 muscle samples from crabs collected at Kitamaat Village that had high 
PAH concentrations in the hepatopancreas. No muscle tissue samples were analysed from 
crabs collected at the other three sites, Wathlsto Creek, Kildala Arm, and Kitkiatka Inlet. 
The PBTK model was used to predict PAH concentrations in the muscle of crabs 
collected at all sites based on the concentration of benzo[a]pyrene in each corresponding 
hepatopancreas sample. The concentration of benzo[a]pyrene was estimated in muscle 
tissues based on regression analysis of the concentration of benzo[a]pyrene in the 
hepatopancreas and muscle tissues predicted by the model (Figure 5.37). 
Figure 5.37 Regression analysis of PBTK model predicted concentrations of benzo[a]pyrene in 
hepatopancreas and muscle tissues. 
Concentration of BaP in Hepatopancreas (nglg wet weight) 
The regression analysis was based on 130 pairs of tissue concentrations predicted 
by the model. The regression equation is presented in Equation 5.8. 
CM = 0.2587049 * CL + 0.01 7887 
The regression fit statistics are presented in Table 5.8. 
Table 5.8 Summary of Regression Analysis Statistics 
Statistic Value 
RSquare 0.999275 
RSquare Adj 
Root Mean Square Error 
Mean of Response 
Observations (or Sum Wgts) 130 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio 
Model 
Error 
C. Total 
1 887226.09 887226 176403.2 
128 643.78 5 Prob > F 
129 887869.87 <.OOO 1 
Parameter Estimates 
Term Estimate Std Error t Ratio Prob>(t( 
Intercept 
CL 
In order to predict the concentrations of other PAH in the muscle tissues of crabs 
based on the concentration of benzo[a]pyrene, the relationship of the concentration of 
each PAH to the concentration of benzo[a]pyrene in 19 muscle tissue samples was 
examined by regression analysis. The results of the regression analyses are presented in 
Table 5.9. 
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Table 5.9 Continued - Regression analysis of PAH concentrations vs. the concentration of 
benzolajpyrene determined in muscle tissues 
Bivariate Fit of Benzofluoranthenes By Benzo[a]pyrene 
Linear Fit 
Benzofluoranthenes = -0.052871 + 1.0596035 Benzo[a]pyrene 
Summary of Fit 
RSquare 0.999438 
RSquare Adj 0.999298 
Root Mean Square Error 0.063924 
Mean of Response 1.183333 
Observations (or Sum Wgts) 6 
Analysis of Variance 
Source DF SS Mean Square F Ratio 
Model 1 29.07 1988 29.0720 7 1 14.474 
Error 4 0.01 6345 0.0041 Prob > F 
C. Total 5 29.088333 <.OOO 1 
Parameter Estimates 
Term Estimate Std Error t Ratio Prob>ltl 
Intercept -0.052871 0.02993 1 -1.77 0.1521 
BaP 1,0596035 0.012562 84.35 <.0001 
The concentration of each PAH, anthracene, phenanthrene, fluoranthene, pyrene, 
chrysene, benz[a]anthracene, and benzofluoranthenes in the muscle was calculated for 
each of the 187 crabs based on the calculated concentration of benzo[a]pyrene estimated 
using the PBTK model. The concentration of BaP-TEF in the muscle for each crab was 
then calculated using the method of Nisbet and LaGoy, (1992). Figure 5.38 shows a 
comparison of the measured and predicted concentrations of BaP-TEF in the muscle 
tissues of crabs. The mean measured concentration of BaP-TEF was 0.69 nglg wet 
weight, while the mean predicted muscle tissue concentration was 0.23 nglg wet weight. 
However, a student t test of the means indicated that there was no significant difference 
between the mean values. A visual inspection of Figure 5.38 shows that the BaP-TEF 
concentrations were most often under predicted by the PBTK model. The mean 
difference between measured and predicted values was - 0.46 ng BaP-TEFIg wet weight. 
Figure 5.38 Measured and predicted concentrations of BaP-TEF in muscle samples 
El Measured 
Predicted 
The standard deviation, mean, minimum, and maximum concentration of the 
PBTK model predicted BaP-TEF are presented in Table 7.1 in Chapter 7. 
5.5 Discussion 
5.5.1 PBTK Model Parameters 
The PBTK model has been adapted for predicting the concentrations of 
benzo[a]pyrene in seven tissue compartments of the crab following exposure through a 
single intravascular bolus dose, a single oral bolus dose or waterborne chemical. 
Parameter values estimated empirically were used without adjustment except the values 
of several partition coefficients, metabolic constants (V,,, and K,) and the blood flow to 
the gut (QGT) and carcass (QC). Partition coefficients (R) were found to be the most 
sensitive model parameters and adjustment of these parameters was necessary to obtain 
one set of values which could be used to predict the tissue concentration of all three 
exposure routes. The adjusted partition coefficients did not deviate more than 1.5 times of 
the mean values determined experimentally and were within one standard deviation of the 
observed mean determined by the in vitro method. 
The metabolic constants, V,,, and K,, were modified from those determined for 
pyrene metabolism in the trout. The value of V,, for the crab is 50 fold lower than that 
used for the fish. This is in agreement with the general consensus that aquatic 
invertebrates have a capacity for PAH metabolism an order of magnitude lower than that 
of vertebrates such as fish (Dunn and Fee, 1979). Indeed comparisons to other studies in 
our laboratory showed that the rainbow trout (Kennedy, 1990; Namdari, 1994) and starry 
flounder (Namdari, 1998) metabolised PAH more rapidly than crabs. 
It was found that adjustment of QGT and QC was needed to simulate closely the 
time course of benzo(a)pyrene in the crab following oral exposure. Table 5.1 - Table 5.5 
show the two different sets of values used for model simulation. The first set are used for 
intravascular and water exposure simulation, while the second set denoted by an asterisk 
is used for oral exposure predictions. The difference in blood flow between these two sets 
of data is 5% of QT which represent the volume of blood shunted from the carcass to the 
gut compartment. This blood flow shunt is related to the physiological changes in the 
crab following food ingestion. Airriess and McMahon (1 992) have shown that 
haemolymph redistribution is subject to neurohormonal control and may be necessary to 
supply the increased metabolic requirements of digestion. 
5.5.2 Differences between PBTK Model Developed for Fish and Crab 
5.5.2.1 Physiological and Biochemical Differences 
There are many differences in the physiology and biochemistry between a 
vertebrate such as the trout, and an invertebrate such as the dungeness crab. These 
differences were considered in the design of the PBTK model. The trout has a closed 
circulatory system which is characteristic of all vertebrates, a small blood volume, (4.1 1 
% of body weight) and a cardiac output of approximately 1 184 ml kg-' hr". In contrast, 
the dungeness crab has a comparatively much larger blood volume (35.7% BW) and a 
higher cardiac output, 7638 ml kg-' hr-'. Despite the common perception of an open 
circulatory system, the crab has a complex, highly efficient, and tightly regulated 
circulatory system which rivals the closed vertebrate system in terms of tissue perfusion 
(McMahon and Burnett 1990). 
5.5.2.2 Model Conceptualisation 
Since the physiology and function of the crab differ significantly to the fish and 
other vertebrate, they require further explanation. For example, the haemolymph 
compartment of the crab is analogous to the blood compartment of vertebrates. The 
hepatopancreas is a digestive and metabolic organ which combines the functions of the 
small intestine, liver and pancreas of the vertebrates (Gibson, 1979). On the other hand, 
the urinary bladder or antenna1 gland of the crab functions very similarly to the kidney of 
fish. 
Due to these fundamental differences in physiology and biochemistry, the PBTK 
model for the crab was conceptualised differently than the fish model. The model 
developed for the fish consisted of nine compartments representing major organs such as 
the liver, kidney, muscle, gill, gut, skin, blood and carcass (Namdari, 1998). In contrast, 
the PBTK model for the crab was simplified to seven main compartments representing 
the hepatopancreas, urinary bladder, muscle, gill, gut, haemolymph, and carcass. 
Some of the tissues and organs in the PBTK model of the crab were grouped 
together differently to that of the trout model. For example, the gut compartment of the 
crab model consists of the oesophagus, cardiac stomach, midgut and hindgut whereas the 
carcass compartment consists of all other tissues such as the gill, hypodermis, carapace, 
nervous tissues, heart and gonad. 
5.5.2.3 Skin Compartment 
The skin compartment for the fish represented a barrier between the external 
environment and the internal organs. This compartment included a function for uptake of 
chemical from the water as well as from the blood compartment (Namdari, 1998). The 
crab however, has a hard chitinous exoskeleton known as the carapace which was 
assumed to be relatively impervious to chemical uptake, and not a route of chemical 
excretion. In addition, experiments involving the exposure of crabs to I4c labelled 
benzo[a]pyrene in the water demonstrated that very little chemical was associated with 
the carapace as determined by biological oxidation. Finally, the hypodermis, or skin 
below the surface of the carapace represents a small portion of the total mass of the crab, 
0.86% based on dissections of crabs used in laboratory experiments. Therefore, the skin 
compartment was not included in the crab PBTK model. 
5.5.2.4 Muscle Compartment 
A membrane-limited muscle compartment was used for the fish model since a 
flow-limited compartment resulted in the over-prediction of pyrene concentrations in the 
trout muscle (Law et al., 199 1). However, a flow-limited muscle compartment was found 
to be more appropriate for the crab since the use of a membrane-limited compartment 
under-predicted benzo[a]pyrene concentrations in the crab muscle The membrane-limited 
approach was deemed to be appropriate for the trout due to poor vascularisation of white 
muscle tissue. In contrast to the low blood supply to the fish muscle, crab locomotory 
muscle seems to be well perfused with a large centrally located artery which supplies 
haemolymph flow to each appendage (McMahon and Burnett, 1990). 
5.5.2.5 Gill Compartment 
The PBTK model for the dungeness crab uses a simple first order uptake equation 
to represent the uptake of benzo[a]pyrene from the water, through the gill and into the 
haemolyrnph compartment. 
dCGL/dt =((Qt (CB V - CGL/RGL) + (Cw(@) (Ab) UR))/VGL 
where the first order uptake function is described by: 
This differs from the fish model from which it was adapted (Namdari, 1998). The 
fish model uses a more complicated flow and diffusion limited equation to describe the 
flux of chemical across the gills as follows; 
Where: I(G = chemical uptake 
QW = water flow across gills 
KB = blood flow 
KD = diffusion rate 
This model for the exchange of organic chemicals at fish gills is described in 
detail by Erickson and McKim (1 99Ob). Although this more complicated equation, 
(5.1 I), describes the uptake of chemical using physiological parameters in the fish, the 
simple, first order uptake equation, (5.9) was found to be more effective for predicting 
uptake of benzo[a]pyrene through the gills from the water for the crab. As Figure 5.23 
and Figure 5.30 show, the first order uptake equation was able to adequately simulate the 
uptake of benzo[a]pyrene from the water, through the gill compartment and into the 
haemolymph. Equation 5.1 1, used for the fish model, describes a much more rapid uptake 
of chemical from the water. Repeated attempts to parameterise the model with this 
equation were fruitless. 
The fish model was calibrated for use with a wide range of polar and non-polar 
molecules (Erickson, 1 WOb; Namdari, 1998; Law, 1999). The fish model developed by 
Namdari, (1 998) was calibrated for waterborne exposure to pyrene. While pyrene is a 
neutral PAH similar to benzo[a]pyrene, the log Kow for pyrene ranges from 4.38 - 5.32 
(Mackay, 1991). The log Kow for benzo[a]pyrene is estimated to be an order of 
magnitude greater. Benzo[a]pyrene log Kow measurements range from 4.05 - 6.5 7 
(Mackay, 1991). As stated by Hayton and Barron, (1 990), chemicals with different 
properties may have different rate limiting barriers that control uptake through the gill. 
The uptake of more polar compounds like pyrene may be governed more by flow and 
diffusion limitations and less by a first order process such as passive diffusion. Erickson 
and McKim (1 990a) have found that for high log Kow compounds, the uptake rate is 
approximately constant and approaches Qw, the rate at which water can transport 
chemical to and from the gill. Therefore, the simple first order equation may be adequate 
to describe the uptake of high log Kow compounds such as benzo[a]pyrene. When 
modelling, it is often the best practice to use the simplest expression that can be used 
adequately perform simulations. However, it is probable that the uptake equations 
developed by Erickson and McKim (1 990a, 1990b) may be more effective with the crab 
PBTK model for describing the uptake of less water soluble compounds than 
benzo[a]pyrene through the gills. 
While the uptake equations used to simulate uptake of benzo[a]pyrene into the 
haemolymph from the gill seemed to work fairly well to simulate concentrations of 
benzo[a]pyrene in the haemolymph and some other tissues, such as the muscle, bladder, 
and carcass, the fit was often not as good for the hepatopancreas, gut, gill tissues. This 
lead to the adjustment of some partition coefficients in an attempt to improve model fit 
for these compartments. These problems may in fact be due to the equations used to 
model benzo[a]pyrene uptake and excretion by the gill compartment. In the future, it 
would be wise to revisit this part of the PBTK model to improve the ability of the model 
to accurately predict the concentration of benzo[a]pyrene in all tissues following 
waterborne or oral exposure. It would be best to re-examine the applicability of either the 
simple, flow limited gill model developed by Erickson and McKim (1 990a) or the more 
complicated flow and diffusion limited gill model developed by Erickson and McKim 
(1 990b) used by Namdari (1 988) and Law (1 999) for PBTK modelling in fish. 
5.5.3 Adaptability of PBTK Model to Environmental Conditions 
The PBTK model for predicting the disposition of benzo[a]pyrene in the 
dungeness crab was designed to be adaptable to the external environment. Environmental 
factors such as temperature and salinity are known to cause changes in the physiology of 
aquatic organisms. Cardiac output, Qt is affected by external ambient temperature as 
described by Equation 5.3 based on water temperature effects on cardiac output of 
observed by B. McMahon et al., (1978). Observed effects on the ventilation rate of the 
gills, Qw, is also controlled by temperature as shown in Equation 5.4 (McMahon et al., 
1978). 
Salinity has also been shown to affect cardiac output and haemolymph flow 
patterns (McGaw and McMahon, 1996,2003). Salinity is an important factor because 
crabs often venture into estuaries where salinities below 11 ppt are present (Cleaver, 
1957; Stevens et al., 1984; Pauley et al., 1986; McGaw and McMahon, 2003). Studies 
have shown that crabs exposed to reductions in salinity from 100% seawater to 35% 
seawater (1 2 ppt) increased heart rates immediately after salinity was reduced (McGaw 
and McMahon, 2003). Crabs also will burrow into sediments and become quiescent in 
response to low salinity (McGaw et al., 1999). This behaviour is associated with a drop in 
cardiac output and haemolymph flow through the gills (McGaw and McMahon, 2003). 
Because cardiac output and haemolymph flow rates are important physiological factors 
for controlling the disposition of chemicals in the PBTK model, the model could be made 
to be more responsive to external conditions by incorporating equations that vary cardiac 
output and haemolyrnph flow patterns based on water salinity. Other external factors such 
as hypoxia, and dissolved oxygen content in the water have also been shown to affect 
cardiac output, haemolymph flow, and gill ventilation rates (Airriess and McMahon, 
1994; McGaw and McMahon, 2003). 
5.5.4 Applications of PBTK Model 
The PBTK model is a useful tool to study the toxicokinetics of chemicals in the 
crab. The model can point to areas that require more study to understand properly, such 
as uptake and excretion of chemicals by the gill. The model can be used as a framework 
to study the parameters that are most important for describing the disposition of chemical 
in the various compartments or tissues. 
The model can also be used as a tool to predict the concentration of chemical in 
one compartment, based on known amounts of chemical in another. For example, the 
PBTK model for the dungeness crab has been used to predict concentrations of 
benzo[a]pyrene in the muscle of crabs based on hepatopancreas concentrations. This data 
was then used to estimate the concentration of BaP-TEF for the stochastic risk 
assessment (Chapter 7). This is a very useful application of the model for risk assessment 
purposes to fill data gaps. 
5.5.5 Further Studies 
Future studies of the PBTK model should be focused on improving the chemical 
uptake equations for the gill compartment. This would help to resolve any problems in 
simulating uptake of benzo[a]pyrene from the water, and disposition into the tissue 
compartments. 
An exciting extension of the model would be to incorporate MontC Carlo 
simulation techniques. The model is currently parameterised using mean values for most 
input parameters. Many input parameters such as blood flow to various compartments 
could be described by frequency distributions, rather than by a single mean value. In this 
way, the model could incorporate more variability in the measurement of input 
parameters, and this variability and the effect on model output could be studied further. 
For example, there is frequency distribution data available describing the heart rate and 
flow rates of haemolymph through the arteries of the dungeness crab (McGaw et al., 
1994). Most of the haemolymph flow rates are described as lognormal distributions, 
while heart rate appears to be normally distributed crab (McGaw et al., 1994). It would 
be very interesting to incorporate these frequency distributions into the parameters 
describing haemolymph flow to the various compartments. This would allow for a better 
estimation of the flow parameters, and would make the PBTK model more powerful in 
predicting the disposition of benzo[a]pyrene in the crab. 
Another extension of the of the PBTK model for the dungeness crab would be to 
calibrate the model for predicting the disposition of other PAH on the EPA priority list of 
16 PAH. This could be done by adjusting important parameters such as partition 
coefficients for the different PAH. Table 5.9 shows that there is a stronger relationship 
between the concentrations of some PAH in the muscle tissue compared with 
benzo[a]pyrene than others. Generally, there was a strong linear relationship between the 
concentrations of larger molecular weight PAH such as chrysene, benzanthracene, 
fluoranthene and benzofluoranthenes and the concentration of benzo[a]pyrene. The 
model might only require some small adjustments in partition coefficients to simulate the 
disposition of these compounds in the crab. Other lower molecular weight PAH such as 
anthracene, phenanthrene and pyrene did not fit a linear relationship with benzo[a]pyrene 
concentrations as well. A greater adjustment in partition coefficients and perhaps 
metabolic parameters might be necessary to predict the disposition of these PAH with the 
PBTK model. However, this illustrates the power and flexibility of the PBTK model in 
that it could be used with minor adjustments to predict the disposition of other PAH in 
the crab. 
Finally, this PBTK model which describes the internal toxicokinetics of 
benzo[a]pyrene could be linked to the food web model of Hams and Gobas, (Hams, 
1999) as an extension of their model for predicting concentrations of benzo[a]pyrene and 
other PAH in the tissues of crabs. Currently, the model employs a non-equilibrium 
steady-state model developed by Morrison et al. (1 996), and parameterised by Hams 
(1999) to calculate steady-state biota sediment accumulation factors (BSAF) in adult 
crabs. This comparatively simplified approach has been found to work reasonably well to 
predict the tissue concentration of non-metabolisable environmental contaminants such as 
dioxins, however, it lacks the ability to deal with metabolisable compounds such as PAH. 
Therefore, this type of model usually over predicts the BSAF of PAH such as 
benzo[a]pyrene in the tissues of crabs (Harris 1999). The PBTK model therefore, can be 
used to enhance the power of the food web model to more accurately predict BSAF 
values for crabs. 
5.6 Conclusion 
A PBTK model has been adapted to describe the disposition of benzo[a]pyrene in 
the tissues of the dungeness crab. This represents the first time that a PBTK model has 
been applied to describe toxicokinetics in crabs. The model has been calibrated and 
validated with empirical data to predict concentrations of benzo[a]pyrene in seven tissue 
compartments following intravascular injection, oral dose, and water-borne exposure. 
CHAPTER 6 
DETERMINISTIC ESTIMATION OF HUMAN HEALTH 
RISK DUE TO CONSUMPTION OF PAH- 
CONTAMINATED DUNGENESS CRABS CAUGHT IN 
KITIMAT ARM, B.C 
6.1 Introduction: 
An aluminium smelter has emitted polycyclic aromatic hydrocarbons (PAH) into 
the receiving waters since 1954. The determination of PAH levels in the sediments and 
biota of Kitimat Arm has been the subject of previous studies (Cretney et al., 1983; EVS, 
1995 1998; Paine et al., 1996; Simpson, 1996; Simpson, 1997). In general, these studies 
have demonstrated elevated levels of PAH in the sediments. However, inconsistent 
results have been reported on the extent of PAH contamination in the biota. 
Significant levels of high molecular weight PAH were determined in the tissues of 
dungeness crabs collected at sites close to the aluminium smelter as described in 
Chapter 2 (Eickhoff, 1999; Eickhoff, 2000, Eickhoff 2003a). Moreover, PAH 
concentrations in the crab tissues were found to decrease significantly with increasing 
distance from the alleged source of pollution. HPAH such as benzo[a]pyrene and 
benz[a]anthracene are of particular concern because of their carcinogenic potentials. 
Therefore, these results suggest that Kitimat Arm has been contaminated by PAH and 
that ingestion of crabs may be a significant pathway of human exposure to these 
carcinogens. 
The dungeness crab (Cancer magister) is a significant food source and 
recreational fishery for the local residents. Concerns of health safety due to consumption 
of crabs and shellfish exposed to dioxins and furans have led to closure of commercial 
fishing activity in 1989 (DFO, 1989). Health and Welfare Canada also has established a 
consumption advisory for the hepatopancreas of crabs at 30 glweek for the aboriginal and 
recreational harvesters. Although the consumption advisory for the hepatopancreas of 
crabs was lifted in 1996, the area is still closed to the commercial fishing of crabs (DFO, 
1 996). 
The objective of this study was to determine if PAH contaminated crabs are a 
significant health risk to local consumers of crabs. For this purpose, a deterministic 
human health risk assessment (HHRA) was conducted. The risk assessment was based on 
the concentrations of PAH determined in the crabs, and information from a dietary survey 
conducted by the Kitamaat Village Council of the Haisla Nation who live in Kitarnaat 
Village on the east shore of Kitimat Arm (Figure 1.2). 
6.2 Risk Assessment 
6.2.1 Hazard Identification and Dose-response Assessment 
The hazard identification and dose-response assessment paradigm promulgated by 
the U.S. Environmental Protection Agency (USEPA, 1989) and the Ontario Ministry of 
Environment (OME, 1997) were used for the risk assessment. PAH such as BaP and BA 
are classified as B2 or probable human carcinogens (USEPA-IRIS, 1998). The toxic 
endpoints are the probability of developing stomach cancer (USEPA, year) or stomach 
and lung cancer (OME, 1997) in humans due to consumption of the PAH-contaminated 
crabs. The mechanism of cancer development is assumed to be a non-threshold process. 
6.2.2 Exposure Assessment 
6.2.2.1 Field Data Collection and Analysis 
PAH concentrations in crab tissues were taken from the field study on dungeness 
crabs (Chapter 2). Concentrations below the estimated sample specific detection limit 
(EDL) were represented as '/2 of the EDL according to the U.S. EPA Risk Assessment 
Guidance Manual (US EPA, 1991). The arithmetic mean values and standard deviation 
for concentrations of PAH determined in the crabs used in the risk assessment are 
presented in Table 6.1. 
Table 6.1 Mean concentrations of PAH in crab tissues (nglg wet weight). 
Tissue Hepatopancreas Muscle 
Site Hospital Kitamaat Wathlsto Kildala Hospital Kitamaat 
Beach Village Creek Arm Beach Village 
Analyte Mean + SD Mean * SD Mean * SD Mean * SD Mean * SD Mean + SD 
PHN 
ANT 
FLR 
PYR 
B A 
CRY 
BF 
BaP 
6.2.2.2 PAH Toxic Equivalents 
Benzo[a]pyrene toxic equivalents (BaP-TEQ) were calculated from the PAH 
concentrations in crab tissues according to the methods recommended by the EPA (1 989) 
and OME (1997). The IPM TEQ calculation is based on the assumption that the risk from 
individual PAH in a mixture are additive. By comparison, the OME WMM approach is 
based on the assumption that the potency of a PAH mixture is proportional to the BaP 
content. These TEQ approaches are summarised as follows: 
(a) The BaP-TEF of Nisbet and LaGoy (1 992) were used to calculate the TEQ for 
the U.S. EPA model. 
(b) The OME IPM model uses a formula to determine BaP-TEF, based on relative 
potency of each individual PAH to benzo[a]pyrene (OME, 1997). 
(c) The OME WMM model includes a statistical comparison of the concentrations 
of carcinogenic PAH relative to benzo[a]pyrene with a Mixture of Standard Composition, 
(MSC) (OME, 1997). 
Toxic equivalents were calculated for hepatopancreas, muscle, and 
hepatopancreas and muscle tissues combined as in a typical meal of crab. The amount of 
hepatopancreas for a typical crab was estimated at 13% of the edible portion while the 
muscle constituted the remaining 87%. This estimate was based upon dissections of crabs 
to determine the proportion of each tissue to the total mass. The hepatopancreas 
constitutes 3.46% of total body weight, while the muscle makes up 23.2% (Chapter 6). It 
was assumed that the hepatopancreas and muscle tissues together represented the total 
edible mass of the dungeness crab. 
6.2.2.3 Calculation of Lifetime Average Daily Dose 
Lifetime average daily dose (LADD) values were calculated for the following 
consumption scenarios: hepatopancreas alone (worst case), muscle alone (best case), and 
a combination of muscle and hepatopancreas (most likely). It should be noted that while 
many North Americans do not consume the hepatopancreas of crabs, it is a delicacy for 
the aboriginal and Asian consumers. We assume that aboriginal consumers eat all edible 
portions of the crab in a typical meal based on personal conversations with members of 
the Haisla Nation of Kitamaat Village. 
LADD values based on the consumption of PAH-contaminated crab tissues over a 
period of 75 years were calculated for the EPA and OME exposure assessment models 
using the following equations: 
EPA model: LADD = CcICv x IR x EF x ED I BW x AT 
OME model: LADD = CcICv x IR x EF x ED I AT 
where: 
LADD = lifetime average daily dose (ngkg-day) 
Cc = concentration of BaP-TEF in edible portion of crab (nglg wet weight) 
IR = crab intake rate (glmeal) 
EF = exposure frequency (mealslyear) 
ED = exposure duration; 75 years 
Cv = volume reduction of crab meat due to cooking; 0.57 
B W = body weight 
AT = averaging time or lifetime in days; 27375 days 
The concentration of PAH-TEF in the edible portion of the crab, Cc can be further 
characterised as follows: 
Where: 
Ch = concentration of BaP-TEF in the hepatopancreas (nglg wet weight) 
Cm = concentration of BaP-TEF in the muscle (nglg wet weight) 
Hp = proportion of hepatopancreas to total crab mass; 3.46% 
Hm = proportion of muscle to total crab mass; 23.2% 
The major difference between the EPA and OME LADD calculations is the 
absence of body weight in the OME exposure model. Mean exposure estimates for intake 
rate (IR) and exposure frequency (EF) were obtained from the Haisla Diet Survey (1 994); 
and are summarised in Table 6.2. The number of respondents who participated in the 
survey upon which the mean IR and EF estimates are based upon is also reported. The IR 
varied significantly with the season, gender and age of respondents. Crab consumption is 
generally the highest in adult males during the summer months (Table 6.2). 
Table 6.2 Mean intake rate of crab of aboriginal population by gender, age group, and season* 
Age 1-1 1 12-17 18-49 50+ 
Season winter summer winter summer winter summer winter summer 
- - 
Gender F M F M F M F M F M F M F M F M  
# Resp. 9 7 7 6 4 5 5 5 2 4 3 4 1 6 2 9 1 3 1 2 1 1  9 
IR, 118 237 118 237 118 237 118 237 327 473 237 473 237 473 327 710 
(glmeal) 
EF 6 12 12 12 6 6 12 9 12 12 18 12 6 6 12 18 
(mealslyr) 
*Data from Haisla Diet Survey, Kitimat Village Council 1994. 
The exposure frequency, or the number of meals per year also varied with the 
gender, age and season. For the risk assessment, each year was equally divided into two 
six month seasons, winter and summer based on the northern location of Kitimat Arm 
and the available consumption behaviour data for the population. The calculated 
exposures were summed for both seasons over each year as follows: 
Where, s = summer, w = winter, a = age, g = gender. 
PAH concentration as TEQ in the crab tissues (Cc) was divided by Cv to correct 
for the reduction in tissue volume due to cooking (Winquist, 1998). The net effect is an 
increase in TEQ concentrations in the cooked meat of crabs. 
Mean body weights (BW) of the Haisla were used to estimate the LADD in the 
EPA model; they were obtained from the same dietary survey (Table 6.3). Mean weights 
of typical North American populations were included for comparison. It is believed that 
aboriginal populations generally have a greater average weight than that of North 
American communities (Winquist, 1998). 
Table 6.3 Body weight data used for risk assessment 
Age 
Group 
North American Aboriginal 
body weightt (kg) body weight* (kg) 
1-1 1 18 30 
12-17 49 5 6 
18-49 70 84 
50+ 70 8 7 
' ~ a w  and Gudaitis (1994); *Kitamat Village Council (1994) 
6.2.3 Risk Characterisation 
Human health risks associated with the exposure to PAH through the 
consumption of contaminated crabs were estimated by 3 different approaches: the 
standard EPA approach and the approaches using the Whole Mixture Model (WMM) and 
Individual PAH Model (IPM) of the OME. The risks are estimated using the following 
equations: 
EPA model: Risk = LADD x CPF x CF 
where: 
LADD = Lifetime average daily dose (ngkg-day) 
CPF* = Cancer potency factor for stomach cancer (risk mg-' kg-' day-') 
CF = Conversion factor (1 o - ~  mglng) 
OME model: Risk = LADD x (CPFstm + CPF,,,) 
where: 
LADD = Lifetime average daily dose (nglday) 
CPF,~,+ = Cancer potency factor for stomach cancer (risk ng-' day-') 
CPFI,; = Cancer potency factor for lung cancer (risk ng-' day-') 
*EPA CPF 7.3 (risk mg-' kg-' day-') (Oral in diet) (IRIS, 1998) 
'OME IPM CPFstm 2.6 E-9 (risk ng-' day-') (Oral in diet) (OME, 1997) 
'OME IPM CPF,,,, 2.1 E-10 (risk ng-' day") (Oral in diet) (OME, 1997) 
'OME WMM CPF,,, 4.2 E-8 (risk ng-' day-') (Oral in diet) (OME, 1997) 
'OME WMM CPFln, 3.4 E-9 (risk ng-I day-') (Oral in diet) (OME, 1997) 
The cancer slope factors (risk per nglkg d-', EPA; risk per ngld, OME) are derived 
fiom a low-dose extrapolation model. The conversion factor, CF is used in the EPA 
model to convert units fiom ng to mg. 
6.3 Results 
The arithmetic mean of tissue PAH concentration in crabs as BaP TEQ used for 
the US EPA risk assessment model are presented in Table 6.4. Unless specifically noted, 
the concentration refers to that determined in the hepatopancreas of crabs. 
Table 6.4 Summary Statistics for BaP-TEQs used for EPA Model. 
Statistic Hospital btamaat Wathlsto Kildala HB Village- 
Beach Village Creek Arm Muscle Muscle 
Mean 1.36 0.34 0.20 0.24 0.83 0.16 
Minimum 0.08 0.07 0.06 0.05 0.13 0.0 1 
Maximum 9.91 0.78 0.48 2.78 6.28 0.23 
The mean concentrations of BaP-TEQ calculated as a measure of relative potency for the 
OME IPM model are presented in Table 6.5. 
Table 6.5 Summary Statistics for BaP Relative Potency used for IPM. 
Statistic Hospital Kitamaat Wathlsto Kildala HB Village 
Beach Village Creek Arm Muscle Muscle 
Mean 1.18 0.29 0.18 0.22 0.84 0.13 
Minimum 0.05 0.05 0.03 0.03 0.12 0.00 
Maximum 9.73 0.55 0.46 2.69 6.55 0.2 1 
SD 1.74 0.14 0.13 0.48 1.61 0.1 1 
The mean concentrations of BaP surrogates (BaPS) calculated using the OME WMM 
approach are presented in Table 6.6. 
Table 6.6 Summary Statistics for Concentration of BaP in Crab Tissues used for WMM. 
Statistic Hospital Kitamaat Wathlsto Kildala HB Village 
Beach Village Creek Arm Muscle Muscle 
Mean 0.81 0.23 0.14 0.18 0.78 0.19 
Minimum 0.00 0.00 0.00 0.00 0.1 1 0.02 
Maximum 6.30 0.47 0.41 2.58 5.83 0.16 
SD 1.3 1 0.14 0.13 0.47 1.43 0.2 1 
The WMM expresses PAH mixtures that are statistically similar to the MSC as 
benzo[a]pyrene surrogates, BaPS. Of the two OME methods, IPM and WMM, the WMM 
method was found to be most applicable to the data set because the total risk estimated 
for the crab tissue PAH concentrations (CC) was similar to that of the MSC. The criteria 
of applying the OME WMM for a given PAH mixture is that the ratio of "total risks" of 
the two PAH mixtures CC and MSC must be between 0.1 and 10 (OME, 1997). A 
summary of the values calculated to determine the application of the OME IPM or WMM 
method is displayed in Table 6.7. 
Table 6.7 Stomach tumour risk attributable to PAH mixtures due to oral exposure for comparison 
of MSC and Kitimat PAH crab hepatopancreas concentrations, (HC) relative to 
benzolajpyrene. 
Mixture PHEN BA CRY BF TOTAL MSCIH Use 
RiskPAH RiskpAH RiskPAH RiskpAH RiskpAH C Ratio IPM Or 
(Ing Bap/rn3) (Ing Bap/rn3) (Ing Bap/rn3) (Ing Bap/rn3) (Ing Bap/m3) WMM 
Hospital 9.4 E-12 5.8 E-1 1 4.4 E-10 9.3 E-10 1.4 E-09 0.47 WMM 
Beach 
Kitamaat 8.3 E-12 4.3 E-11 2.7 E-10 6.0 E-10 9.2 E-10 0.73 WMM 
Village 
Wathlsto 6.2 E-13 1.3 E-10 6.7 E-10 1.8 E-09 2.6 E-09 0.26 WMM 
Creek 
Kildala 7.8 E-11 1.9 E-10 9.1 E-10 3.6 E-09 4.7 E-09 0.14 WMM 
Arm 
Kitimat 1 .  - 1  1 6.9 E-1 1 3.7 E-10 9.4 E-10 1.4 E-09 0.48 WMM 
Arm Ave. 
MSC 7.3E-12 4.4E-11 1.4E-10 4.9E-10 6.8E-10 1.00 WMM 
Figure 6.1 shows the mean concentrations of PAH in crab tissues collected from 
the four sites expressed as benzo[a]pyrene toxic equivalents, BaP-TEQ (EPA, year; OME 
IPM, year) or benzo[a]pyrene surrogates (BaPS), (OME WMM, year). The data are 
grouped under the following consumption scenarios: hepatopancreas alone, muscle alone 
and a combination of hepatopancreas and muscle (H&M). The hepatopancreas and 
muscle tissues together are assumed to represent the total edible mass of the dungeness 
crabs. Also, the hepatopancreas and muscle represent about 13% and 87%, respectively 
of the edible tissue in crabs (unpublished observations). Therefore, the H&M 
concentrations were calculated as a ratio of the concentrations determined in the 
hepatopancreas and muscle tissues. 
Figure 6.1 Calculated PAH toxic equivalent or surrogate concentrations in crab tissues from 
different sites in Kitimat Arm. 
HE! Village Wathlsto Kildala HB - Village - HB - Village - 
Muscle Muscle H&M H&M 
TEQ levels were the highest in crabs collected in at Hospital Beach close to the 
aluminium smelter and decreased with distance from the smelter. Moreover, TEQ 
concentrations in crabs were slightly higher in Kitamaat Village than those collected 
downstream at Wathlsto Creek and Kildala Arm. In general, TEQ and BaPS levels were 
higher in the hepatopancreas than the muscle. The TEQ and BaPS of combined H&M are 
only slightly higher than the muscle, due to the fact that a large proportion of the edible 
tissue is comprised of the muscle tissue and that muscleihepatopancreas weight ratio is 
approximately 6.7 in crabs. 
Figure 6.2 shows the LADD in the different age groups of both genders due to 
consumption of the hepatopancreas only as the entire amount of crab tissues consumed. 
Figure 6.2 Chronic daily intake (LADD) of BaP-TEQs based on consumption of PAH contaminated 
crab hepatopancreas estimated by following models; a) EPA, b) OME-IPM, c) OME- 
WMM. 
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The LADD predicted by the EPA model range from 0.03 - 1.23 ng BP 
equivalentslkg-d (Figure 6.2a). Male children (1-1 1) and senior males (50+) are exposed 
to more PAH than the other age groups. Females are exposed to lower TEQ than males in 
all age groups due to smaller meal sizes and less frequency of crab consumption (Table 
6.3). By comparison, both OME models predict a very different age-related exposure 
scenario; both adult groups are exposed to greater LADD than children or youth (Figure 
6.2 b and c). 
The OME models predict that children and youth are exposed to roughly half of 
the LADD in the adult groups, and senior adults are exposed to even higher levels than 
adults (1 8-49). The LADD calculated using the IPM BaP-TEF range from 1.33 - 88.6 ng 
BP equivalents Id (Figure 6.2b) while the WMM BaPS range is slightly lower at 1.44 - 
60.52 ng BP Id (Figure 6 .2~) .  The LADD calculated by the OME methods are much 
higher than those obtained from the EPA approach due to absence of body weight in the 
OME exposure assessment equation. 
Figure 6.3 shows the LADD in the different age groups of both genders due to 
consumption of muscle only or a combination of muscle and hepatopancreas. PAH 
exposure is much greater after consuming muscle or whole crab (combined H&M) caught 
at Hospital Beach. PAH exposure due to the consumption of muscle or combined H&M 
is lower than the worst case scenario of eating hepatopancreas alone. The LADD due to 
consumption of muscle alone is only slightly lower than that of H&M because the muscle 
makes up 87% of the edible crab tissue. The PAH exposure patterns in different age and 
gender groups due to consumption of crabs caught near atamaat Village are not found to 
be very different to one another. 
Figure 6.3 Life-time average daily dose due to consumption of the muscle tissue or hepatopancreas 
and muscle (H&M) calculated by; a) EPA, b) IPM, c) WMM, model. 
Figure 6.4 shows the number of excess cancer incidences predicted from eating 
only the hepatopancreas of crabs as the entire meal using the EPA and OME approaches. 
The risk estimates generally reflect the corresponding LADD values in Figure 6.2. The 
EPA model predicts the greatest risk of cancer in the 1-1 1 age group whereas the OME 
models predict the greatest risk to adults and mature adults. Consumption of the 
hepatopancreas from crabs caught at Hospital Beach near the source of PAH 
contamination poses the greatest cancer risk, which exceeds the virtual safe risk level (1 
E-6) in all age groups. The maximum risk for male children is 9.0 E-6 and the risk to 
senior adult males is 8.5 E-6 (Figure 6.4a). 
Figure 6.4 Probability of developing stomach cancer (EPA) or stomach and lung cancer (OME) due 
to the consumption of the hepatopancreas of crabs; a) EPA, b) IPM, c) WMM. 
The risk estimates determined according to the OME-IPM model are an order of 
magnitude lower than the EPA estimates; the maximum risk for senior males is 2.3 E-7 
(Figure 6.4b). The WMM model predicts a risk estimate, which is closer to, but lower 
than the EPA estimate; the maximum risk of stomach tumours for senior males 
consuming crabs from Hospital Beach is 2.5 E-6 (Figure 6.4c), while the risk for stomach 
and lung tumours is 2.7 E-6. As expected from the LADD values (Figure 6.2), the risk to 
females of all age groups is much lower than that for males. However, the risk estimates 
of the EPA and WMM models also exceed for adult females (ages 18-49) eating crab 
caught near the smelter. The risk of consuming crabs from the other sites in Kitimat Arm 
is below the risk criterion of 1 E-6. 
Figure 6.5 shows the probability of developing cancer from eating muscle alone 
or the whole crab (H&M) collected fiom the Hospital Beach and the village sites. 
Figure 6.5 Probability of developing stomach cancer (EPA) or stomach and lung cancer incidence 
(OME) due to the consumption of muscle or hepatopancreas and muscle; a) EPA, b) 
IPM, c) WMM. 
The cancer risk of consuming the whole crab (H&M) is just slightly higher than 
that of eating muscle alone. The EPA approach-predicted cancer risk exceeds the virtual 
safety criterion of 1 E-6 in both genders for all age groups. The highest risk is for male 
children consuming the whole crab (6.0 E-6) while the lowest risk is for female youths 
(1.2 E-6) (Figure 6.5a). The IPM approach predicts that the risk of consuming the whole 
crab or muscle alone from either Hospital Beach or the village site is below 1 E-6 for all 
gender and age groups. These risk estimates are several orders of magnitude lower than 
the EPA estimates and range from a minimum of 3.5 E-9 for female youth and children 
eating crab muscle to a maximum of 1.7 E-7 for senior males consuming the whole crab 
(H&M). The WMM risk estimates are lower than those predicted by the EPA model but 
are an order of magnitude greater than the IPM estimates. The WMM shows that adults 
of both genders and senior males consuming the muscle or the whole crab have a risk of 
stomach tumours or stomach and lung tumours higher than the 1 E-6 criterion. 
A summary of the minimum and the maximum cancer risks for the Haisla is 
displayed in Figure 6.6. The risk estimates calculated by the three approaches decrease in 
the order of EPA > WMM > IPM. 
Figure 6.6 A summary of the mean, minimum and maximum risk estimates obtained using the EPA 
and OME models. 
EPA OME WMM OME IPM 
The crab consumption rates reported in the aboriginal dietary survey (Kitamaat 
Village Council, 1994) are similar to those reported in a diet survey conducted among 
different Asian groups living in Greater Vancouver, BC (Marion, 1996). The 
hepatopancreas consumption rate of the Haisla was estimated by multiplying the 
consumption rate of the whole crab by the proportion of hepatopancreas in the edible 
tissues (1 3%) and is found to lie between the mean and the maximum hepatopancreas 
consumption rates of the Asian population in Vancouver, BC, Canada. (Table 6.8). 
Table 6.8 Aboriginal and Asian hepatopancreas consumption (glyear) 
Age Aboriginal* ~ s i a n l  
Group Female Male Max Mean 
12-17 2 76 46 1 2137 185 
1 8-49 1063 1473 4274 397 
50+ 694 2027 4274 293 
*Kitamaat Village Council (1994); f ~ a r i o n  (1996) 
Figure 6.7a shows a comparison of risk estimates calculated for the Aboriginal 
and Asian communities consuming crab hepatopancreas alone using the U.S. EPA model. 
This contrasts with the previous risk estimates where the worst case scenario was 
assumed that the entire meal or LADD consisted of hepatopancreas tissue. Generally, the 
aboriginal consumers are at a greater risk from consuming crab hepatopancreas than the 
Asian consumers based on mean consumption rates. The risk for both consumer groups 
for consuming a relatively small portion of hepatopancreas alone per meal was less than 
the acceptable risk criteria of 1 E-6. As shown in Table 6.8, there was a large difference, 
>10 fold, between maximum and mean consumers of hepatopancreas among the Asian 
community. Figure 6.7b shows a comparison of risks calculated for the maximum and 
mean consumers of hepatopancreas among the Asian survey respondents. The estimated 
risk for the heaviest consumers in the Asian community ranged from 2.1 E-6 to 5.6 E-6, 
which is greater than the acceptable risk criteria of 1 E-6. 
Figure 6.7 Comparison of Risk values calculated a) for Aboriginal (Native) and Asian consumers of 
hepatopancreas alone; b) for maximum and mean consumers of crab hepatopancreas 
among the Asian community using the USEPA model. 
6.4 Discussion 
6.4.1 Use of Arithmetic means for Input Data 
The arithmetic means of PAH concentrations in the hepatopancreas and muscle 
(Table 6.1) are used in the exposure assessment because the arithmetic means introduce 
less bias than the geometric means in a data set (Crurnp, 1998). 
6.4.2 Comparison of Calculated BaP-TEQ with Water Quality Criteria 
As shown in Figure 6.1, the mean TEQ of hepatopancreas and muscle are about 
1.0 ng BaP equivalentslg and 0.8 ng BaP equivalentslg wet weight, respectively in crabs 
collected near the smelter. These are very close to the maximum BaP concentration 
allowed in fish and shellfish (1 nglg wet weight) for a heavy seafood consumer (about 
200 glweek) (BCMELP, 1995). Therefore, consumption of crab tissues at a rate of 200 
glweek may pose a serious health risk to the human consumers. It should be pointed out 
that the mean BaP concentration is calculated from 16 muscle samples whereas the 
hepatopancreas data is composed of 147 samples (Table 6.1). Therefore, the mean BaP 
concentration in the hepatopancreas is much more reliable than that of the muscle. 
6.4.3 Comparison of Dietary Survey Results with Consumption Criteria 
The Haisla7s dietary survey (Kitamaat Village Council, 1994) shows that the 
consumption rate of crabs varies significantly among the different age groups and 
genders. According to the BCMELP consumption criteria (BCMELP, 1995), the Haisla 
may be categorised into the following consumption groups: (a) less than low consumer 
group (2,600 glyr). This group includes female children (1,416 glyr) and juveniles (2,124 
glyr); (b) low to moderate consumer group. (2,600-5,200 glyr). This includes male 
juveniles (3,555 glyr), (c) moderate consumer group (5,200glyr). This includes male 
children (5,688 glyr) and senior females (5,346g), and (d) heavy consumer group 
(10,400glyr). This includes male adults (1 1,352 glyr) and seniors (15,618 glyr). 
6.4.4 Comparison of Haisla and Canadian-Asian Dietary Survey Data 
The comparison of the aboriginal (Kitamaat Village Council, 1994) and Asian 
dietary survey (Marion, 1996) (Table 6.5) corroborates the intake rates and exposure 
frequencies obtained from the aboriginal dietary survey. 
6.4.5 Difference in LADD Among Age Groups 
The LADD of the youth is the lowest among the four age groups (Table 6.3) for 
the U.S. EPA model. Perhaps, this is a result of the different body weights of the age 
groups and the low IR of this age category. In general, juveniles consume a less varied 
and healthy diet than adults and children. Therefore, the IR for juvenile males (1 2-1 7) is 
lower than that of male children (1-1 1) (Table 6.2). This is similar to the results of the 
Asian diet survey where the consumption rate for juveniles is reported to be the same as 
that of the children (Table 6.8). 
6.4.6 Effect of Cooking Crab Tissues on PAH Bioavailability 
It is assumed that the PAH in crab tissues are completely bioavailable and 
absorbed by the human consumer. Moreover, the PAH in the crab tissues are not 
destroyed by cooking; although some lower molecular weight PAH may volatilise 
through heating but the less volatile high molecular weight, and carcinogenic PAH are 
probably unaffected. Indeed, cooking of crab tissue may result in an increase rather than a 
decrease in PAH concentration because the volume of tissue is reduced while the amount 
of PAH remains unchanged. 
6.4.7 Differences in EPA and OME Risk Assessment Models 
There are a number of differences in risk assessment approaches taken by the 
EPA and the OME. These differences have resulted in markedly different cancer risk 
predictions. The differences in approach are listed as follows: 
(a) The OME characterises the health risks of PAH exposure by cancer development in 
the stomach (as the primary organ) and the lung (as the secondary organ) (OME, 1997) 
while the EPA characterises risk from stomach cancer development only. 
(b) The methods of determining the TEF of PAH differ in the two agencies. Although a 
number of TEF estimation methods has been proposed (Thomas Petry et al., 1996), the 
method of Nisbet and LaGoy (1992), which reflects the relative potency of individual 
PAH, is commonly used to estimate cancer risk in the EPA approach. In contrast, the 
OME has devised it's own methods of TEF calculation (OME, 1997); the OME IPM and 
the OME WMM methods. The OME IPM method estimates the risks of a PAH mixture 
by summing the risks attributable to individual PAH present in the mixture. It is very 
similar to the Nisbet and LaGoy approach (1 992) but differs in the manner by which the 
relative potency of individual PAH is ascribed to BaP. In contrast the OME WMM 
method assesses the risk of a PAH mixture as a whole and assumes that the potency is 
proportional only to the BaP content of the mixture. This model assumes that both the 
profile and the potency of a PAH mixture are similar to those of a mixture of standard 
composition (MSC). The assumption is based on the fact that the differences between the 
PAH profiles are too small to have a significant effect on the potency of the mixtures 
(OME, 1997). The different TEF calculation methods do not seem to affect the results 
significantly since all three methods produce similar TEQ in the crab tissues (Figure 6.1). 
(c) Results of the present study show that the EPA model generally predicts the greatest 
cancer risk in children whereas the OME model predicts the greatest risk in adults. The 
difference in results may be explainable by the absence of body weight in the OME 
exposure assessment equation. In the EPA model, a child's body weight is less than that 
of an adult. Therefore, the LADD of children is divided by a smaller number, which 
results in a higher risk estimate. In the OME approach, the weight bias on risk calculation 
is removed from the equation so that the LADD estimate is influenced mainly by intake 
rate and exposure frequency. 
6.4.8 Comparison of Risk Estimates Produced from EPA and OME Models 
In general, the EPA approach yields a more conservative risk estimate than the 
OME models (Figure 6.4-Figure 6.6). The EPA model predicts a risk of >I E-6 in all age 
groups and genders when consuming crabs caught near the smelter. The WMM model 
also predicts a risk of >1 E-6 for adults and mature adults consuming crabs collected near 
the smelter. But children, youth and adults do not exceed the 1 E-6 risk level when 
consuming the muscle or a combination of muscle and hepatopancreas in crabs from the 
other sites (Figure 6.5). The IPM model produces the lowest risk estimates (Figure 6.4- 
Figure 6.6); this model does not predict a <1 E-6 risk for any age group consuming crabs 
from any of the four study sites in Kitimat Arm. 
According to the OME (1997), the "actual risk" of cancer due to PAH exposure 
lies somewhere between the WMM and IPM estimates although it is likely to be closer to 
the WMM estimate. The WMM model generally predicts a higher risk estimate than the 
IPM model although the IPM model predicts slightly higher exposure levels (Figure 6.2- 
Figure 6.3). The WMM employs a slope factor in the risk calculation, which is more than 
an order of magnitude greater than that used by the IPM model for risk characterisation. 
The WMM is recommended by the OME as the primary model in most circumstances. 
The IPM is indicated only when the PAH mixture deviates from the mixture of standard 
composition (MSC). Table 6.2 shows that the PAH mixture in the crab tissue samples 
conformed to the MSC and so the WMM model is the most appropriate approach to 
conduct the risk assessment. 
6.4.9 Features of the OME-WMM Approach 
The WMM method can be used to reduce analysis time and costs once a 
preliminary study has been performed to determine if the PAH mixture in the sample is 
conformed to the MSC since the WMM method requires only the analysis of BaP in 
environmental samples. This also serves to reduce the uncertainty inherent in assessing 
the potency of individual PAH relative to BaP and in determining the concentrations of 
all the individual PAH in the environmental samples. It may also be useful in comparing 
the cancer risks of different PAH mixtures as long as these mixtures contain BaP. 
6.4.10 Comparison of Risk Estimates Based on Haisla and Asian Diet Surveys 
The risks estimated for the aboriginal community consuming hepatopancreas 
tissues as a portion of a larger meal of crab was compared to that for a Canadian-Asian 
community based on published hepatopancreas consumption rates (Marion, 1996). While 
the risk estimates for the mean consumers of crab hepatopancreas among the Asian 
community were lower than those for the aboriginal community and the acceptable risk 
limit, the risk estimates for the maximum Asian consumers was much greater than the 
aboriginal consumers and exceeded 1 E-6 (Figure 6.7). 
6.4.11 Future Directions for Assessment of Risk to PAH Exposure in Kitimat Arm 
This study has focused on quantifying the risk of cancer due to PAH exposure 
through one route, the consumption of PAH contaminated dungeness crabs. A natural 
extension of this work would be to expand this risk assessment to estimate the risk of 
cancer through consumption of a variety of other traditional foods which may be 
contaminated with PAH including a variety of fish species, seaweed, seals, game species, 
and other shellfish such as clams and mussels as well as traditionally processed foods 
such as eulachon grease and smoked fish. 
6.5 Summary 
This quantitative human health risk assessment has shown that heavy consumers 
of crab caught near the aluminium smelter are at risk (>1 E-6) based on an exposure 
assessment and risk characterisation using the EPA and OME models. The most 
conservative risk estimates were obtained using the EPA model, while the OME IPM 
model yielded the lowest risk estimates. In addition, the EPA model predicts the greatest 
risk for children, while the OME models predict greater risk for adult consumers of PAH 
contaminated crabs. Further studies are required to examine the cancer risk of consuming 
crabs in combination with other traditional foods. 
CHAPTER 7 
HUMAN HEALTH RISK ASSESSMENT FOR THE 
CONSUMPTION OF PAH-CONTAMINATED CRABS 
USING A MONTE CARL0 MICRO-EXPOSURE EVENT 
APPROACH. 
7.1 Introduction 
The deterministic risk assessment described in Chapter 6 examined the risk of 
cancer due to the consumption of PAH contaminated crabs. This risk assessment was 
based on the hazard identification and dose response assessments promulgated by the 
U.S. Environmental Protection Agency, (EPA 1989) and the Ontario Ministry of 
Environment, (OME 1997). It was determined that heavy consumers of crabs from an 
area contaminated with PAH, particularly adult males, were at an unacceptable risk for 
developing cancer. This risk assessment also determined that the risk estimates obtained 
using the EPA exposure assessment and risk characterisation were more conservative 
than those obtained using the OME approach. 
The deterministic risk assessment involved an exposure assessment based on 
mean values for PAH concentrations in crab tissues, and mean intake rates, exposure 
frequencies, and body weight, data obtained from a dietary survey study performed for a 
local aboriginal population (Kitamaat Village Council, 1996). This risk assessment used a 
simple algebraic equation to estimate mean exposure and risk estimates (Equation 5.1). 
This approach is often used to make conservative estimates of the LADD and cancer risk. 
In order to examine inter-individual variability and uncertainty in the parameters 
used for the deterministic risk assessment, a probability based, stochastic risk assessment 
was performed using probability distributions for the input data used in the exposure 
assessment. The stochastic risk assessment model was implemented with the micro- 
exposure event approach (Price et al. 1996) using the Microsoft ~ x c e l @  spreadsheet, 
Visual ~ a s i c @  language, and Montk Carlo analysis. The exposure assessment and risk 
characterisation was based on the method promulgated by the U.S. EPA. 
MontC Carlo analysis can be used to characterise the uncertainty and inter- 
individual variability inherent in each parameter involved in the exposure estimate 
equation. Variability represents the true heterogeneity in a population, whereas 
uncertainty represents a lack of perfect knowledge of each input parameter. In order to 
introduce individual and exposure concentration variability, probability distributions can 
be used instead of a single mean value. In addition, a micro-exposure event approach can 
be used to incorporate different dose or exposure rates over the lifetime of many 
individuals. This is important because a number of the parameters that are used to 
calculate the LADD, such as intake rate, exposure frequency, and body weight vary over 
the lifetime of each individual. There is also a great deal in variability in these parameters 
within a given population. Gender is also an important determinant of these parameters, 
and seasonal changes in food consumption patterns can also influence the estimation of 
exposure. 
The Montk Carlo micro-exposure event approach is used to incorporate 
uncertainties and variability in input parameters that the deterministic approach cannot 
easily accommodate. Therefore, it is expected that the stochastic approach will produce a 
more "realistic" estimate of exposure to PAH over the lifetime of a population, and will 
provide a more detailed estimate of the risk of cancer from consuming PAH 
contaminated crabs over the duration of a lifetime. 
We are fortunate to have very detailed and specific dietary information in the 
Haisla diet survey (Kitamaat Village Council, 1996) that can be used to estimate 
exposure. Therefore, this data was used to incorporate the individual and gender specific 
variability into the risk assessment examine the effects of inter-individual, and gender 
differences on exposure and cancer risk in this population. 
The objective of this study was to further investigate the lifetime cancer risk due 
to consumption of PAH contaminated crabs in Kitimat Arm, and to incorporate the 
individual variability inherent in the Haisla diet survey to examine dietary PAH exposure 
for aboriginal individuals who consume crabs from specific sites in Kitimat arm for 
which we have crab tissue concentration data (Chapter 2). 
7.2 Approach Description 
The Monte Carlo micro-exposure event model was adapted from the micro 
exposure event model described by Price et al., 1996. The model was designed to 
characterise variability in the following input parameters: gender, body weight, intake 
rate, exposure frequency, crab mass, and concentration of benzo[a]pyrene toxic 
equivalents (BaP-TEF) in the hepatopancreas and muscle of the crabs consumed from 
different locations in Kitimat Arm. The model simulates the consumption of crab caught 
at specific sites by individuals of a local aboriginal population over a lifetime in order to 
obtain distribution estimates for the LADD and lifetime cancer risk. 
7.3 Model Description 
A flowchart for the MontC Carlo, micro-exposure event model is presented in 
Figure 7.1. 
Figure 7.1 Flow diagram of micro-exposure event MontC Carlo model 
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Before running the model, the site from which crabs are consumed is selected. 
The model starts by selecting the gender of an individual. The gender is randomly 
selected based on a probability of 0.55 1 that the individual is female. 
The body weight of the individual was randomly selected from lognormal 
distributions specific to the age and gender of the individual and based on body weight 
statistics obtained from the Haisla Dietary Survey (Kitamaat Village Council 1996). The 
model evaluates each meal of crab as a separate exposure event. The size of the meal 
portion was randomly selected from the distribution appropriate for the age and gender of 
the individual and the season. 
The mass of the crabs ingested during the meal was randomly selected from the 
input distribution of crab weights. A nested loop is included to ensure that the mass of the 
crab equals the meal portion size (intake) for each meal. 
The number of exposure events (meals of crab) in a given month of an 
individual's life was determined from the exposure frequencies for the winter and 
summer seasons. It was assumed that each year in this northern community was equally 
divided into 6 winter and 6 summer months, and each year is divided into 12 months or 
exposure periods. Annual exposure is the sum of the exposures simulated over the winter 
and summer months. 
At the end of each year, the model determined if the individual had reached the 
maximal age of 75 years, thus, the model assumes that exposures occurred over the 
duration of a lifetime. The LADD and lifetime cancer risk for the individual were 
calculated by summing the annual doses and dividing by the average human life span of 
75 years. The model continues to calculate individual LADD and risk estimates until it 
has completed estimates for 10,000 individuals. 
The LADD for each individual was calculated based on the model shown in 
Figure 5.1 which is summarised by Equation 7.1 : 
1 ,f 1 crabconsumed j 
LADD=- - (Chi/ * Hp + Cmi, * Mp) * Crab mass  / CV 
75 yrs. ,=, BW, i=, (7.1) 
where crab consumedj is the amount of crab consumed in the jth year of the individual's 
exposure; BW, is the body weight in the jth year; Chij is the concentration of BaP-TEF in 
the hepatopancreas; Hp is the proportion of hepatopancreas tissue of the crab mas^^; Cmij 
is the concentration of BaP-TEF in the muscle, Mp is the proportion of muscle tissue of 
the Crab masso; Crab massij is the mass of each crab consumed as a meal portion for the 
ith meal in the jth year. 
The risk for each individual was calculated based on the U.S. EPA risk 
characterisation presented in Equation 7.2: 
Risk = LADD x CPF x CF 
where: 
LADD = Lifetime average daily dose (ngkg-day) 
CPF* = Cancer potency factor for stomach cancer (risk mg-' kg-' day-') 
CF = Conversion factor (1 o4 mglng). 
7.4 Model Input Parameters 
The model input parameters and distributions describing the tissue concentration 
distributions, tissue masses and volumes, and carcinogenic potential of BaP-TEF are 
presented in Table 7.1. 
Table 7.1 Model input parameters and distributions 
Parameter Mean SD Max Min Distribution Type 
Measured Tissue Concentrations (ng BaP-TEFIg wet weight) 
C ~ H B  1.356 1.794 9.907 0.081 Lognormal 
Chvillage 0.337 0.158 0.779 0.068 Lognormal 
Chwathlsto 
Chkildala 
C ~ H B  
0.197 0.130 0.479 0.056 Lognormal 
0.242 0.514 2.782 0.050 Lognormal 
0.833 1.534 6.278 0.134 Lognormal 
Cmvillage 0.157 0.098 0.226 0.012 Lognormal 
Predicted Tissue Concentrations (ng BaP-TEFlg wet weight) 
C ~ H B -  P 0.264 0.395 1.926 0.026 Lognormal 
CmHB - M&P 0.380 0.780 5.834 0.026 Lognormal 
Cmvillage - P 0.089 0.039 0.159 0.026 Lognormal 
Cmvillage - M&P 0.093 0.046 0.206 0.026 Lognormal 
Chwathlsto - P 0.064 0.037 0.141 0.026 Lognormal 
Chkildala - P 0.076 0.141 0.800 0.026 Lognormal 
Crab mass (g) 740 131 1120 378 lognormal 
HP (%I 3.1 - 
MP (%I 23.2 - 
FP (%I 55.1 - 
CV* 0.57 1 - 
CPF' (risk mg-' kg-' day1) 7.3 
CF ' (mglng) 1 .OE-6 - 
' ( ~ i n ~ u i s t ,  1998), t ( ~ ~ ~  CPF 7.3 risk mg-' kg-' day-', Oral in diet, IRIS, 1998) 
Table 7.2 shows the input parameters used to generate lognormal distributions for 
individual bodyweights. 
Table 7.2 Descriptive statistics for individual body weights* (kg) 
Age 1-1 1 12-17 18-49 50+ All 
Gender F M F M F M F M F M 
Mean 32 29 5 1 6 1 7 5 90 8 2 93 68 80 
Min 2 1 18 39 43 55 64 64 76 2 1 18 
Max 5 2 45 60 118 100 126 102 108 102 126 
*Kitamaat Village Council (1 996) 
The probabilities used to generate exposure frequency distributions for crab 
consumption during summer, (a) and winter, (b) months are shown in Figure 7.2. 
Figure 7.2 Exposure frequency, number of meals per month in a) summer. b) winter. 
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Figure 7.3 displays the probability distribution for the amount of crab consumed 
per meal during summer, (a) and winter, (b) months. 
Figure 7.3 Amount of crab consumed per meal in: a) summer, b) winter. 
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The data used to develop the probability distributions was obtained from the 
dietary survey study performed for a local aboriginal population (Kitamaat Village 
Council, 1996). These custom frequency distributions were used directly to characterise 
exposure and were not fitted to standard distribution patterns. 
The input data used to characterise the variability in the concentration of 
benzo[a]pyrene toxic equivalent factors (BaP-TEF) in crab tissues were obtained from 
the concentrations of PAH determined in dungeness crab tissues as described in Chapter 
2. 
Muscle tissue concentrations were predicted for samples that were not analysed 
using the PBTK model and measured muscle tissue concentration data. The muscle tissue 
concentrations were estimated based on the concentration of BaP in the hepatopancreas 
of each crab. These calculations are presented and described in Chapter 5. 
BaP-TEF were calculated from parent PAH concentrations following the method 
of Nisbet and LaGoy (1 992). The parent PAH concentrations below the estimated sample 
specific detection limit, ESSDL were represented as % ESSDL. The mean and standard 
deviation for whole crab and tissue wet weights were determined by weighing crabs and 
tissues that were collected for analysis of PAH. 
7.5 Model Specifications 
The model was written in Microsoft Visual Basic@ using the Microsoft Excel@ 97 
SR-2 spreadsheet for storing input variables used to generate distributions. Random 
numbers were generated for normal and lognormal parameter distributions using 
functions coded in Visual Basic' and Excel'. The model also allows for the use of a 
random number generator (RNG) based on a normal distribution function derived from 
source code written by Dr. Michael P. McLaughlin from his Urandom library 
(McLaughlin 1998). This code was translated into Visual Basic by Thomas Achenbach 
based on a Macintosh implementation of the Ultra pseudo-random number generator, 
Urandom, developed by: Dr. George Marsaglia et al. (1 99 1). These functions are 
presented in Appendix D. The model was run various computers including a Pentium I1 
based PC with 400 MHz clock speed, Pentium 4 PCs with 1 GHz clock speed, and an 
AMD Athalon XP based PC with 1700 MHz clock speed. 
Each MontC Carlo model run simulated the consumption of crab for 10,000 
individuals. Several model runs were conducted which demonstrated that 10,000 
individuals provided stable estimates for the minimum, 5'h percentile, mean, median, 95'h 
percentile and maximum of the LADD and risk output values (Table 7.3 - Table 7.5). 
The Pentium I1 computer took approximately 5 hours of computing time to 
estimate the LADD and risk for 10,000 individuals. The Pentium 4 and AMD Athalon 
XP based PCs were much faster and required approximately 15 - 19 minutes per run. 
The model output generated for each individual was stored in an ~xce l@ 
spreadsheet which held the values for LADD, risk, amount of crab consumed per year, 
and concentrations of BaP-TEF in crab hepatopancreas and muscle tissues. Statistical 
analysis of model output was performed using Microsoft Excel. Crystal Ball 4.0, 
Decisioneering Inc. 1996, was used to evaluate the output of the ExcelB RNG, the 
Urandom RNG, and the visual basic lognormal distribution function. 
7.6 Results 
7.6.1 Random Number Generator Validity 
Monte Carlo simulation requires a pseudo-random number generator with good 
statistical properties (Barry, 1996). The random number generator (RNG), in Microsoft 
Excel was used in the MontC Carlo simulations to obtain numbers for the input parameter 
distributions. A number of authors have questioned the numerical accuracy of some 
statistical functions in Microsoft ExcelB 5.0, (Barry 1996) and the ExcelB version in 
Microsoft Office 97 for windowsB (Kniisel, 1998; McCullough and Wilson, 1999). The 
output of the RNG of was assessed by McCullough and Wilson (1999) using statistical 
tests for randomness. McCollough and Wilson (1999) concluded that the random number 
generator was inadequate for statistical calculations. Therefore, the performance of the 
excel random number generator, RAND, was evaluated to ensure that the Monte Carlo 
simulations were performed using a random number generator with good statistical 
properties. Figure 7.4 displays the output obtained running the RAND with a simple 
lognormal function coded in Visual ~ a s i c "  to generate 50,000 lognormally distributed 
random numbers. 
Figure 7.4 Random numbers generated using RAND and simple lognormal function 
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An improved lognormal distribution function, Lognormalcalc, was introduced 
into the Visual ~ a s i c @  risk assessment model and was used to produce lognormally 
distributed random numbers from RAND. The output is presented in Figure 7.5. 
Figure 7.5 Random numbers generated using RAND and Lognormalcalc function 
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The random numbers produced by RAND and the simple lognormal function 
produced a very irregular distribution of random numbers (Figure 7.4). There were a 
number of values in the tail of the distribution with an often recurring frequency of 27 
and 0. The random numbers produced with RAND and Lognormalcalc produced a much 
smoother frequency distribution of random numbers. Also, the numbers in the tail were 
distributed much more evenly (Figure 7.5). This is very important because the numbers in 
the upper tail of the BaP-TEQ tissue concentration distributions represent the maximum 
concentrations and contribute most significantly to the maximum LADD and risk. 
The ~ x c e l @  RAND with the simple lognormal function, and improved 
Lognormalcalc were evaluated by comparison with random numbers generated by 
Crystal Ball 4.0@, and the ultra pseudo random number generator, Urandom coupled with 
Lognormalcalc. The four random number generation methods were each implemented 
three times to produce lognormal distributions of BaP-TEQ based on 10,000 iterations. 
Each run was implemented with the following input values: mean = 1.1 91, SD = 1.773, 
minimum = 0, maximum = 9.91. The standard deviation, minimum, 5th percentile, 
median, mean, 95th percentile, and maximum values were determined for each of the 
three runs using ~ x c e l @  functions. The mean results of this statistical analysis are 
presented in Figure 7.6. 
Figure 7.6 Comparison of output distributions from four random number generators, Crystal Ball 
4.0, RAND-Lognormalcalc, Urandom-Lognormalcalc, and RAND with a simple 
lognormal function. 
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Figure 7.6 shows that the distributions generated by Crystal Ball 4.0@, RAND- 
Lognormalcalc, and Urandom-Lognormalcalc were statistically very similar. However, 
the ~ x c e l @  RAND coupled with the simple lognormal function produced an unacceptable 
frequency distribution of randomly generated BaP-TEF tissue concentrations. The 
minimum, 5th percentile, median, mean, and 95th percentile values were much greater 
than those obtained from the other three random number generators. 
7.6.2 Simulation Results 
The micro-exposure event model was implemented using the statistically 
acceptable RAND-lognormalcalc random number generator for generating lognormal 
input distributions. The minimum BaP-TEF tissue concentrations in the hepatopancreas 
and muscle were set to 0 to avoid left censoring the input distributions (Porter et al., 
1988; Newman et al., 1989). 
The mean, 5th percentile, median, and 95th percentile, and maximum (if one 
exists) values are shown in graphs and tables according to principles of good practice for 
the use of Monte Carlo techniques in human health risk assessment (Burmaster and 
Anderson, 1993). 
Table 7.3 and Table 7.4 display summary statistics of the LADD and risk 
estimates calculated by two model runs of 10,000 individuals, male and female, who 
consumed crabs collected from Hospital Beach in Kitimat Arm. 
Table 7.3 Output value stability of Lifetime Cancer Risk from two separate model runs of 10,000 
individuals consuming crabs caught at Hospital Beach near Smelter 
Statistic Run 1 Run 2 Mean Relative 
Precision 
SD 6.35E-7 6.36E-7 6.36E-7 0.04% 
Minimum 8.03E-7 7.85E-7 7.94E-7 1.14% 
5th Percentile 1.20E-6 1.20E-6 1.20E-6 0.18% 
Median 1.72E-6 1.72E-6 1.72E-6 0.05% 
Mean 1.98E-6 1.97E-6 1.97E-6 0.10% 
95th Percentile 3.03E-6 3.04E-6 3.04E-6 0.10% 
Maximum 3.97E-6 4.16E-6 4.06E-6 2.35% 
Table 7.4 Output value stability of Lifetime Cancer Risk from two separate model runs of 10,000 
and 20,000 individuals consuming crabs caught at Hospital Beach near Smelter 
Statistic Run 1 Run 2 Mean Relative 
10,000 20,000 Precision 
SD 6.36E-7 6.44E-7 6.40E-7 0.65% 
Minimum 7.85E-7 7.44E-7 7.65E-7 2.63% 
5th Percentile 1.20E-6 1.16E-6 1.18E-6 1.79% 
Median 1.72E-6 1.73E-6 1.73E-6 0.42% 
Mean 1.97E-6 1.96E-6 1.97E-6 0.20% 
95th Percentile 3.04E-6 3.05E-6 3.04E-6 0.21% 
Maximum 4.16E-6 4.05E-6 4.1 1 E-6 1.28% 
If the MontC Carlo risk assessment is run with minimum concentration values for 
BaP-TEF in the hepatopancreas and muscle tissues, the LADD and resultant risk 
estimates are slightly greater. Table 7.5 shows the results of two simulations where 
minimum concentration values were set at 0.08 1 and 0.134 ng BaP-TEFIg wet weight for 
the hepatopancreas and muscle respectively. 
Table 7.5 Output value stability of Lifetime Cancer Risk from two simulations of 10,000 
individuals consuming crabs caught at Hospital Beach near Smelter using minimum 
concentration values 
Statistic Run 1 Run 2 Mean Relative 
Precision 
SD 7.50E-7 7.50E-7 7.50E-7 0.01% 
Minimum 7.83E-7 8.17E-7 8.00E-7 2.1 1% 
5 th Percentile 1.38E-6 1.37E-6 1 .3 8E-6 0.07% 
Median 1.99E-6 2.02E-6 2.00E-6 0.67% 
Mean 2.29E-6 2.30E-6 2.29E-6 0.24% 
95th Percentile 3.55E-6 3.54E-6 3.54E-6 0.08% 
Maximum 4.68E-6 4.58E-6 4.63E-6 1.07% 
The maximum risk increased from 4.16E-6 to 4.68E-6, approximately a 12.5% 
increase when the model was run with the minimal values for tissue BaP-TEF 
concentrations. The mean relative precision of the statistical parameters shows that there 
is little difference in variability in the risk estimates when minimum tissue concentration 
values are used in the model simulation. However, it is more realistic to assume that 
crabs with tissue concentrations lower than those measured in my limited sample number 
may be encountered. Also, the minimum concentration is influenced by the analytical 
detection limits. Therefore, the risk assessment was performed using no fixed minimum 
BaP-TEF tissue concentrations. 
Figure 7.7 and Figure 7.8 display frequency distributions of PAH-TEF residues in 
the hepatopancreas and muscle tissues of crabs collected from Hospital Beach produced 
by a model exposure simulation. 
Figure 7.7 Frequency distribution for the concentration of BaP-TEF in hepatopancreas tissues of 
crabs consumed from Inner Harbour. 
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Figure 7.8 Frequency distribution for the concentration of BaP-TEF in muscle tissues of crabs 
consumed from Inner Harbour 
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Figure 7.7 and Figure 7.8 show that the PAH-TEF tissue concentrations generated 
by the model were lognormally distributed similar to the measured tissue concentrations. 
Table 7.6 shows a statistical comparison of lognormal distributions predicted by the 
stochastic model for BaP-TEF in the hepatopancreas of crabs and concentrations of BaP- 
TEF determined in the hepatopancreas of crabs obtained from Hospital Beach. 
Table 7.6 Comparison of BaP-TEF determined in crab hepatopancreas tissues from Hospital 
Beach, and PBTK and Stochastic Risk Assessment model predicted values. 
Measured BaP-TEF Model BaP-TEF (min) Model BaP-TEF (no min) 
I 
-9. 
u 
; o ' 2 3 4 5 6 7 8 9  
# 
Quantiles Quantiles Quantiles 
100.0% maximum 9.9070 100.0% maximum 9.9000 100.0% maximum 9.8800 
99.5% 9.9070 99.5% 8.1899 99.5% 7.9400 
97.5% 7.5317 97.5% 5.3895 97.5% 5.3398 
90.0% 3.6438 90.0% 2.9700 90.0% 2.9000 
75.0% quartile 1 S933 75.0% quartile 1.6200 75.0% quartile 1.6100 
50.0% median 0.7365 50.0% median 0.8300 50.0% median 0.8 100 
25.0% quartile 0.3273 25.0% quartile 0.4300 25.0% quartile 0.4 100 
10.0% 0.1516 10.0% 0.2400 10.0% 0.2200 
2.5% 0.1 121 2.5% 0.1 300 2.5% 0.1 100 
0.0% minimum 0.0810 0.0% minimum 0.0800 0.0% minimum 0.0100 
Moments Moments Moments 
Mean 1.356258 Mean 1.307036 Mean 1.275 167 
Std Dev 1.794509 Std Dev 1.390984 Std Dev 1.364467 
Std Err Mean 0.220889 Std Err Mean 0.013910 Std Err Mean 0.01 3645 
upper 95% Mean 1.797403 upper 95% Mean 1.334303 upper 95% Mean 1.301914 
lower 95% Mean 0.9 15 1 12 lower 95% Mean 1.279769 lower 95% Mean 1.248420 
N 66. N 10000 N 10000 
Table 7.7 shows a statistical comparison of lognormal distributions predicted by 
the stochastic model for BaP-TEF in the muscle of crabs with measured and PBTK model 
predicted concentrations of BaP-TEF in the muscle of crabs from Hospital Beach. 
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The amount of crab consumed per person is shown in Figure 7.9. It is readily 
apparent that males typically consumed significantly larger amounts of crab per meal 
than females in the model simulations. 
Figure 7.9 Frequency distribution of the amount of crab consumed from Hospital Beach. 
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The predicted LADD from the model simulation is shown for all persons, (Figure 
7.10a) and for each gender (Figure 7.1 Ob). The probability distributions for the lifetime 
cancer risk associated with the consumption of crabs from Hospital Beach are shown in 
Figure 7.1 1. The predicted lifetime cancer risk from consumption of contaminated crabs 
is shown for all persons, (Figure 7.1 la) and for each gender (Figure 7.1 lb). The mean 
lifetime cancer risks estimated in Chapter 6 using the deterministic US EPA risk model 
for each age group are shown on Figure 7.1 la  for comparison. 
Figure 7.10 Relative Frequency distributions of lifetime average daily dose estimated for the 
consumption of crabs from the Inner Harbour: a) all persons, b) genders identified. 
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Figure 7.11 Probability distributions for lifetime cancer risk from the consumption of crabs collected 
from Hospital Beach: a) both genders, b) genders separated. 
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The mean lifetime cancer risks estimated for different age groups in the 
deterministic risk assessment (Chapter 6) are indicated on Figure 7.1 l a  for comparison. 
The mean lifetime cancer risk estimated by the stochastic model, 1.97E-6, is between the 
mean estimated risk of 1.6E-6 for 12-1 7 year olds and 3.7E-6 estimated for adults aged 
18-49 obtained from the deterministic risk model. The maximum risk estimated by the 
Mont6 Carlo approach, 4.OE-6, was between the mean risks estimated for adults over 50 
years old, 3.8E-6, and the most conservative risk level for children aged 1 - 1 1,4.1 E-6. 
Figure 7.1 lb  shows that the estimated lifetime cancer risk distribution for males is 
significantly greater than that for females. This reflects the difference in consumption of 
crab tissue (Figure 7.9) and lifetime average daily dose Figure 7. lob between males and 
females. 
Table 7.8 and Table 7.9 present the model output estimates for exposure and risk 
associated with consuming dungeness crabs from Hospital Beach and Kitamaat Village 
respectively. These risk estimates were performed using parameters based on the 
measured concentrations of PAH in the hepatopancreas and muscle tissues. The LADD 
and risk estimates are generally an order of magnitude greater for consuming crabs from 
Hospital Beach. The lifetime cancer risk associated with consuming crabs from Hospital 
Beach near the smelter lagoon discharge exceeds the acceptable cancer risk of The 
mean risk is 1.98 E-6, while the maximum risk is 3.97 E-6. Generally, it is safer to 
consume crabs further away from the source of PAH contamination, the maximum risk of 
excess cancer from consuming crabs collected near the village, 7.57 E-7, is lower than 
the acceptable cancer risk of 
Table 7.8 Descriptive statistics of model output for consumption of crabs caught at Hospital Beach 
near smelter 
SD 1.36 0.89 2128 0.09 6.35 E-7 
Minimum 0.01 0.004 2214 0.1 1 8.03 E-7 
5th percentile 0.15 0.05 3077 0.16 1.20 E-6 
Median 0.81 0.38 3947 0.24 1.72 E-6 
Mean 1.28 0.71 5396 0.27 1.98 E-6 
95th percentile 4.09 2.52 8327 0.42 3.03 E-6 
Maximum 9.88 6.18 9400 0.54 3.97 E-6 
Table 7.9 Descriptive statistics of model output for consumption of crabs caught near Kitamaat 
Village 
SD 0.14 0.05 2155 0.0 16 1.20 E-7 
Minimum 0.05 0.02 2066 0.019 1.40 E-7 
5th percentile 0.15 0.05 2975 0.030 2.1 8 E-7 
Median 0.30 0.12 3971 0.044 3.21 E-7 
Mean 0.33 0.12 5378 0.050 3.66 E-7 
95th percentile 0.60 0.21 8376 0.078 5.67 E-7 
Maximum 0.78 0.23 9541 0.104 7.57 E-7 
The MontC Carlo, micro-exposure event model was run in two different modes: 1) 
with an exposure frequency defined by the minimum exposure level of 0 meals per month 
(Figure 7.2) obtained from the Haisla dietary survey (Kitamaat Village Council, 1996), 
and 2) with a minimum exposure of 1 meal per month. The differences in LADD and risk 
estimates from these two simulation modes are shown in Figure 7.12. The LADD and 
risk estimates from the deterministic risk assessment (Chapter 6 )  are indicated for 
comparison. 
Figure 7.12 Comparison of model estimates calculated with min EF = 0, and min EF = 1 meal per 
month a) Lifetime Average Daily Dose, and b) Lifetime Cancer Risk 
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Table 7.10 shows the descriptive statistics for the LADD and risk when the model 
is run with a minimum EF of 0 meals per month, and a minimum EF of 1 meal per month 
for consumption of crabs obtained from Hospital Beach. 
Table 7.10 Descriptive statistics of model output for consumption of crabs from Hospital Beach with 
a minimum EF = 0 and a minimum EF = 1 meal per month. 
Min EF = 0 I Min EF = 1 
Minimum 22 14 0.1 1 8.03E-7 1 5616 0.25 1.85E-6 
Statistic Ac/yr LADD Risk 
(g> ( n g k  d-'1 
SD 2 128 0.09 6.35E-7 
5th Percentile 3077 0.16 1.20E-6 1 6727 0.34 2.5 1 E-6 
Ac/yr LADD Risk 
(g> ( n g k  d-'1 
2539 0.10 7.19E-7 
Median 3947 0.24 1.72E-6 1 7562 0.45 3.27E-6 
Mean 5396 0.27 1.98E-6 1 9396 0.47 3.45E-6 
95th Percentile 8327 0.42 3.03E-6 1 12744 0.65 4.72E-6 
Maximum 9400 0.54 3.97E-6 1 13977 0.80 5.83E-6 
The maximum risk estimated when a minimum exposure fiequency of 1 meal per 
month, (5.83E-6) was significantly greater than that obtained with a minimum exposure 
frequency of 0 meals per month (3.97E-6). However, it is expected that the minimum EF 
= 0 is a more realistic scenario for most consumers of crab. Figure 7.12 shows that the 
mean lifetime cancer risk when the minimum EF=l is similar to the mean lifetime cancer 
risk estimates obtained from the deterministic risk assessment. 
The stochastic risk assessment was also performed using parameters based on 
measured hepatopancreas concentrations for all four sites, and predicted, or combined 
measured and predicted concentrations of PAH in the muscle tissues of crabs collected at 
four sites, Hospital Beach, Kitamaat Village, Wathlsto Creek, and Kildala Arm. Table 
7.1 1 - Table 7.14 summarise the output estimates from simulations run for consumption 
of crabs from each site. The risk assessment model was run using either predicted, or 
combined measured and predicted muscle BaP-TEF concentrations for the Hospital 
Beach (HB) and Kitamaat Village (KV) sites. The combined predicted and measured 
(M&P) muscle BaP-TEF tissue concentrations were obtained by filling the existing data 
set of measured concentrations with those predicted by the PBTK model. Measured 
concentrations of PAH in muscle were not available for the Wathlsto Creek and Kildala 
Arm sites, therefore, PBTK model predicted values were used. Table 7.11 displays the 
descriptive statistics for the concentration of BaP-TEF in the muscle generated by the 
model simulations for each site. 
Table 7.11 Descriptive statistics for the concentrations of BaP-TEF in muscle tissue generated by 
model simulation based on either predicted, or combined measured and predicted 
(M&P) muscle tissue concentrations, (nglg wet weight). 
Statistic Wathlsto Kildala KV KV HB HB 
Predicted Predicted Predicted M&P Predicted M&P 
SD 0.03 0.10 0.03 0.04 0.28 0.58 
Minimum 0.0063 0.0003 0.01 70 0.01 29 0.001 7 0.001 2 
5th Percentile 0.022 0.005 0.039 0.038 0.025 0.020 
Median 0.05 0.03 0.08 0.08 0.15 0.17 
Mean 0.06 0.07 0.08 0.09 0.24 0.36 
95th Percentile 0.1 1 0.26 0.14 0.16 0.8 1 1.37 
Maximum 0.14 0.80 0.16 0.2 1 1.90 5.83 
The descriptive statistics for the concentrations of BaP-TEF in the hepatopancreas of 
consumed crabs simulated for each site are presented in Table 7.12. 
Table 7.12 Descriptive statistics for the concentrations of BaP-TEF in hepatopancreas tissue 
generated by model simulation with either predicted, or combined measured and 
predicted (M&P) muscle tissue concentrations, (nglg wet weight) . 
Statistic Wathlsto Kildala KV KV HB HB 
Predicted Predicted Predicted M&P Predicted M&P 
SD 0.02 0.083 0.14 0.14 1.40 1.35 
Minimum 0.004 0.0002 0.05 0.07 0.02 0.02 
5th Percentile 0.02 0.003 0.15 0.15 0.15 0.16 
Median 0.04 0.026 0.30 0.3 1 0.8 1 0.79 
Mean 0.05 0.056 0.33 0.33 1.29 1 .25 
95th Percentile 0.10 0.212 0.60 0.60 4.12 3.98 
Maximum 0.12 0.712 0.78 0.78 9.90 9.83 
There were no significant differences in the amount of crab consumed at each site in the 
model simulations. The lifetime average daily dose distributions estimated for the 
consumption of crabs from each site based on measured and/or predicted tissue 
concentrations are presented in Table 7.13. 
Table 7.13 Descriptive statistics for the estimated LADD (nglkg d-') based on either predicted, or 
combined measured and predicted (M&P) muscle tissue concentrations. 
Statistic Wathlsto Kildala KV KV HB HB 
Predicted Predicted Predicted M&P Predicted M&P 
SD 0.01 0.0 1 0.01 0.01 0.04 0.05 
Minimum 0.01 0.01 0.01 0.02 0.05 0.07 
5 th Percentile 0.012 0.014 0.024 0.025 0.076 0.097 
Median 0.02 0.02 0.03 0.03 0.1 1 0.14 
Mean 0.02 0.02 0.04 0.04 0.13 0.16 
95th Percentile 0.03 0.04 0.06 0.06 0.19 0.25 
Maximum 0.04 0.05 0.08 0.08 0.26 0.32 
The estimated lifetime cancer risk distributions based on combined measured and 
predicted muscle tissue concentrations are described in Table 7.14. 
Table 7.14 Descriptive statistics for the estimated lifetime cancer risk based on either predicted, or 
combined measured and predicted (M&P) muscle tissue concentrations. 
Statistic Wathlsto Kildala KV KV HB HB 
Predicted Predicted Predicted M&P Predicted M&P 
SD 4.67E-8 5.45E-8 9.10E-8 9.45E-8 2.95E-7 3.77E-7 
Minimum 6.23E-8 6.40E-8 9.46E-8 1.3 1E-7 3.58E-7 4.77E-7 
5th Percentile 8.86E-8 1.03E-7 1.72E-7 1.80E-7 5.55E-7 7.08E-7 
Median 1.24E-7 1.48E-7 2.44E-7 2.52E-7 8.00E-7 1 .O1 E-6 
Mean 1.44E-7 1.70E-7 2.81E-7 2.93E-7 9.14E-7 1.17E-6 
95th Percentile 2.23E-7 2.60E-7 4.32E-7 4.53E-7 1.41E-6 1.79E-6 
Maximum 2.91E-7 3.38E-7 5.62E-7 6.1 1 E-7 1.93E-6 2.36E-6 
The lifetime cancer risk estimates for all four sites based on both measured and predicted 
tissue concentrations are presented for comparison in Figure 7.1. Mean values and the 
acceptable lifetime cancer risk are indicated. 
Figure 7.13 Lifetime cancer risk estimates based on measured hepatopancreas and measured and 
predicted muscle BaP-TEF concentrations for consumption of crabs from each site. 
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Figure 7.14 shows a plot of lifetime cancer risk model output obtained for 
sensitivity analysis of input parameters. 
Figure 7.14 Plot of lifetime cancer risk descriptive statistics for sensitivity analysis 
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Parameter values for Ch, Cm, EF, IR, Hp, Mp, CF, and CSF were individually 
multiplied by a factor of 2 prior to model runs to examine the effect on model output. 
Body weight (BW), which is in the denominator of Equation 7.1, was also divided by a 
factor of 2 for comparison. 
7.7 Discussion 
7.7.1 Adaptations of the Price Micro-Exposure Event Model 
There are a number of adaptations or changes that were made in the micro-event 
exposure (MEE) model developed by Price et al. (1 996) for this risk assessment. First, 
the Price MEE model is designed to simulate the exposure of fishermen to toxic 
compounds in fish, thus has provision for fishermen moving away and it is also designed 
to look at exposure over a relatively short period of time in a lifetime, 7 years (Price, 
1996). The current risk assessment is designed to examine the potential health effects for 
an aboriginal population that does not move or change location over the course of an 
individual's lifetime. Therefore, no provision for individuals moving has been 
incorporated into the MEE, and exposure is simulated over the duration of a lifetime. 
The Price MEE used an annual consumption rate to simulate exposure over the 
course of each year (Price, 1996). The current MEE incorporates monthly changes in 
exposure frequency and intake rates over the course of each year. This adaptation has 
been made to accommodate seasonal differences in EF and IR that were observed in the 
Haisla Diet Survey (Kitamaat Village Council, 1996). This adaptation allows for greater 
temporal variability in crab consumption rates for each simulation. 
The current MEE model is designed to incorporate concentrations of potentially 
toxic compounds such as BaP-TEF in both the hepatopancreas and muscle tissue of crabs. 
This adaptation was made because the Price model was designed to use a concentration 
of toxic compound in only the muscle tissue. It is expected that most consumers of fish 
eat only the meat portion of the fish. However, consumers of crab may eat both the 
muscle and hepatopancreas, and the concentrations of BaP-TEF in each tissue are quite 
different (Table 7.1, Figure 7.7 and Figure 7.8). 
7.7.2 Advantages of the Stochastic, Micro-Exposure Model Approach 
The stochastic risk assessment approach is more powerful than the deterministic 
approach because the ability to incorporate variability in input parameters provides a 
more realistic assessment of risk for a population. For example, the exposure frequency 
that describes the number of meals per month allows for a number of possible scenarios 
over time, including 0 meals per month. This is important because the frequency 
distributions that describe exposure frequency (Figure 7.2) in the population show that 
respondents in the dietary survey indicated that the ate 0 meals of crab per month more 
often than they ate one or more meals. The standard equation for the deterministic 
exposure model is not able to accommodate monthly changes in exposure or an exposure 
frequency of 0 meals per month. As a result, the LADD and risk estimates can be 
considered to be much more "realistic" than those estimated using the deterministic 
approach. 
Another advantage of the micro-exposure event model approach is the ability to 
accommodate temporal changes in the input variables, such as seasonal changes in 
consumption rates, and age related changes in body weight, exposure frequency and 
intake rates. This allows for a better assessment of the range of exposure and lifetime 
cancer risk that might be for a given population. 
The stochastic, micro-exposure event stochastic risk assessment approach has 
enabled the incorporation of detailed information on the consumption behaviour and 
physical characteristics of the aboriginal population situated along the shore of htimat 
Arm. Thus, the greatest advantage of stochastic model is the ability to represent 
variability in the input parameters that describe exposure, such as intake rate, exposure 
frequency, tissue concentration data, and human body weight over the lifetime of a 
population of individuals for a given population The result of this incorporation of human 
variability can be seen in Figure 7.1 1. Variability in consumption rates related to gender 
can be observed in the probability distributions estimated by the stochastic model for 
lifetime cancer risk. Figure 7.1 lb shows that probability curve for female risk is steeper 
than that for males. This reflects the gender related differences in the consumption of 
crabs observed in Figure 7.9, and the LADD (Figure 7.10). Therefore, the ability to 
estimate risk for a "population of individuals" rather than for a mean characteristics of a 
population allows the risk assessor to examine variability within a population and pick 
out trends related to differences in gender or other influences on human behaviour. 
7.7.3 Model Parameterisation 
The model input distributions were based on statistical analysis of the population 
and tissue concentration data. Lognormal distributions were chosen for human body 
weight because this parameter is known to be lognormally distributed (Burmaster, 1997). 
Body weight statistics were obtained from the Haisla Diet Survey (Kitamaat Village 
Council, 1996). Concentrations of PAH in hepatopancreas and muscle tissues of 
dungeness crabs collected in Kitimat Arm were also found to be lognormally distributed 
(Chapter 2), as shown in Figure 7.7 and Figure 7.8. The probability distributions for 
exposure frequency, the number of meals consumed per month in winter or summer, 
appear to be lognormal (Figure 7.2). However, the probability distributions for the 
amount of crab consumed per meal appear to be normally distributed (Figure 7.3). 
7.7.4 Input Parameter Uncertainty 
There are a number of sources of uncertainty in the current risk assessment which 
should be recognised. This uncertainty is inherent in the input parameters used for 
simulating exposure to PAH through the consumption of PAH contaminated crabs. These 
input parameters include those that describe human factors affecting dietary uptake, and 
the characteristics of the food that is consumed. 
7.7.4.1 Parameters Describing Dietary Exposure 
The parameters that describe exposure based on human factors are intake rate, exposure 
frequency, and body weight. The population statistics used to characterise these 
parameters are based on a subset of an aboriginal population that responded to 
questionnaires used to obtain information about age, gender, body weight, and 
consumption rates and frequencies. It is assumed that this information adequately reflects 
the overall population. There is also error and uncertainty in the recollections of 
individual estimates of exposure frequency and meal portion sizes. Respondents were 
asked to remember how often they consumed various fish and shell fish species over both 
winter and summer months. Respondents used different sized mounds or bowls to 
indicate meal portion size (Kitamaat Village Council, 1996). There is additional error 
inherent in the body weights; most individuals self reported these without use of a scale 
at the time this information was recorded. Finally, probability distributions for gender, 
body weight, exposure frequency, and meal portion sizes were developed from the 
available data. These probability distributions were not fit to generic probability 
distributions. As such, there may be gaps in the distributions which may have been filled 
if a larger number of respondents were involved in the dietary survey. 
7.7.4.2 Crab Tissue Concentration Data 
There is a relatively large sample size of BaP-TEF concentrations determined in 
crab hepatopancreas tissues for each of the four sites (Chapter 2). However, very few 
muscle tissue samples were tested for analysis. The model generated muscle tissue 
concentrations for Hospital Beach are based on only 15 samples, and only 4 for the 
village sites in contrast to 66 and 53 BaP-TEF hepatopancreas tissue concentrations for 
the Hospital Beach and Kitamaat Village sites respectively. Therefore, there is much less 
certainty in the muscle tissue concentrations used for the risk assessment. In order to fill 
this data gap, the PBTK model was used to predict BaP-TEF concentrations in the muscle 
tissues, based on the concentration of benzo[a]pyrene in the hepatopancreas, and the 
relationships between other individual PAH in the muscle with benzo[a]pyrene. This 
approach is described in detail in Chapter 5. 
The same concentration distribution of BaP-TEF in crab tissues was used over the 
lifetime of the individual. In actual circumstances, the concentrations of PAH in crabs 
collected from Kitimat Arm may decline or increase depending on the rate of input from 
industry over time. 
7.7.5 Random Number Generator 
In this study, the ~ x c e l @  random number generator, RAND, coupled with a simple 
lognormal distribution function in Visual BasicB, was also found to be inadequate for 
generating lognormal distributions (Figure 7.4). RAND was found to produce a very 
rough frequency distribution, and repeatedly picked similar values in the tail of the 
lognormal distribution. This problem was also reported by Barry (1 996). Therefore, 
alternative methods were sought to generate lognormal distributions. An improved 
lognormal number generator function was coded into Visual BasicR. This function, 
Lognormalcalc, presented in Appendix D, uses two random numbers generated from 
RAND for each lognormal number generated. Lognormalcalc calls a function, 
Randshuffle, that stores 100 random numbers and then randomly picks a new number and 
replaces that random number from the stored numbers. This prevents the newly generated 
number from having dependencies on the previously generated number. In this manner, 
Lognormalcalc solves the problem of dependency on previously generated random 
numbers that is known to occur in RAND. In this manner, the random number generator 
was significantly improved as shown in Figure 7.5 
Lognormal distributions obtained using the RAND-Lognormalcalc combination 
were compared to those obtained from RAND and the simple lognormal function, from 
Crystal Ball 4.0, an accepted program used commonly as a Microsoft Excel add-in for 
MontC Carlo risk assessments, and Urandom, an ultra random number generator 
developed by Marsaglia and Zaman (1 99 1). It should be noted that Crystal Ball does not 
use RAND (Decisioneering 1996). Lognormal distributions (1 0,000 iterations) for the 
concentration of PAH TEF in the hepatopancreas of crabs were obtained using each 
program. These lognormal distributions were compared statistically. There appeared to be 
no differences between the lognormal distributions obtained from RAND-lognormalcalc, 
Urandom-lognormalcalc and Crystal Ball 4.0 (Figure 7.6). Therefore, the RAND- 
lognormalcalc random number generator was considered to be acceptable for generating 
lognormal input distributions for the MontC Carlo simulations. However, the output from 
RAND with a simple function for deriving lognormal output was quite different, and was 
therefore no longer used in the model. 
7.7.6 Model Stability and Convergence 
The results from three independent simulations with 10,000 iterations were 
compared to test the convergence and stability of the model (Table 7.3 - Table 7.5). 
Thompson (1 992) stated that for two independent runs of 10,000 each, the estimated 
means, standard deviations, variances, and the 9oth and 95th percentiles should agree 
within 1 %. Also, for two independent runs of 10,000 and 20,000 iterations, all of the 
summary statistics except the sensitive 95th percentile and maximum should agree within 
1 % (Thompson 1992). For two runs where no minimum tissue concentration was used, 
the estimated, standard deviation, 5th percentile, median, mean, and 95th values all agreed 
within 1 %. Only the mean relative precision of the minimum, 1.14%, and maximum, 
2.35%, values varied slightly over 1% (Table 7.3). The same trend was found when the 
descriptive statistics were compared between a run of 10,000 and a separate run of 20,000 
iterations (Table 7.4). 
The variability in the minimum, and maximum values, was very similar when 
minimum tissue concentrations were used in the model simulation (Table 7.5). The mean 
relative precision was 2.1 1 %, and 1.07% for minimum and maximum values 
respectively. From these results, it was concluded that 10,000 iterations were sufficient to 
ensure convergence and stability of the output distributions according to the criteria of 
Thompson et al. (1 992). 
7.7.7 Sensitivity Analysis 
A sensitivity analysis was performed to examine the sensitivity of the stochastic 
model to important input parameters. The deterministic, one at a time analysis of each 
factor was performed, holding all others constant at nominal values according to the 
method of Morgan and Henrion (1 990). Each parameter was multiplied by a factor of 2 to 
examine the resulting effect on lifetime cancer risk output estimates. 
The results showed that the model was equally sensitive to changes in intake rate, 
IR, exposure frequency, EF, cancer potency factor, CPF, and conversion factor, CSF 
(Figure 7.14). Changes in these parameters resulted in a similar increase in the resultant 
lifetime cancer risk. The concentration of BaP-TEF in muscle, Cm, was also very 
sensitive, and a two fold increase in both Ch and Cm, resulted in a two fold increase in 
risk. The concentration of BaP-TEF in the hepatopancreas, Ch, was less sensitive than 
Cm. This shows that it is important to have adequate data describing the concentration of 
PAH in muscle tissues, and underlines the usefulness of the PBTK for predicting 
concentrations when sufficient data is unavailable. The model was less sensitive to 
changes in body weight, BW, than most of the other model parameters. Body weight is in 
the denominator of Equation 7.1, therefore it was also divided by a factor of 2 The least 
sensitive parameters of the model were those for the percent composition of muscle, Mp 
and hepatopancreas, Hp in the crab. 
7.7.8 Discussion of MontC Carlo Simulation Results 
7.7.8.1 Comparison of Simulated and Measured Tissue Concentrations 
The model simulated BaP-TEF tissue concentration distributions are presented in 
Figure 7.7and Figure 7.8. The model predicted concentrations of BaP-TEF in the 
hepatopancreas were very similar to those determined in the tissues of crabs collected 
from Hospital Beach. A statistical comparison of simulated and measured BaP-TEF in 
the hepatopancreas of crabs caught at Hospital Beach is shown in Table 7.6. The 
simulated hepatopancreas tissue concentrations had lognormal distributions similar to 
that observed for the measured concentrations determined in the tissues by GCIMS. Table 
7.7 compares the model simulated BaP-TEF concentrations in the muscle with measured, 
and those predicted by the PBTK model. The MontC Carlo simulated BaP-TEF 
concentrations in the muscle were statistically very similar to the limited number of 
measured, or combined measured and predicted tissue concentrations, although the PBTK 
model predicts concentrations that are somewhat lower than measured concentrations 
(Chapter 5). 
The simulated values generated when a minimum value was specified for 
characterising the lognormal distribution had minimum and maximum values that were 
closer to the combined measured and predicted tissue concentration values than the 
simulations where no min was specified. However, as stated previously, it is more 
realistic to assume that crabs with lower tissue concentrations than those measured may 
be encountered, and the minimum concentration is influenced by the analytical detection 
limits. 
For both simulated hepatopancreas and muscle tissues, the Monte Carlo 
simulations generated lognormal distributions of numbers that were statistically quite 
similar to the combined measured and predicted BaP-TEF tissue concentration 
distributions in the hepatopancreas and muscle. This shows that the model was effective 
for predicting BaP-TEF tissue concentrations in the Monte Carlo simulations. 
7.7.8.2 Annual Consumption of Crab 
The Monte Carlo simulation produced a bimodal frequency distribution that 
describes the amount of crab consumed per person (Figure 7.9). The frequency 
distribution shows that males are predicted to consume greater amounts of crab per year 
than females. Each mode of the frequency distribution is normally distributed and 
represents a fusion of the custom distributions for exposure frequency and intake rate. 
The variability in consumption by males is a little greater than that for females. The mode 
describing the amount consumed by males is shorter and wider, while the distribution 
representing female consumption is narrower and higher around the mean. 
The maximum amount of crab consumed by females, 49 18 glyr, is less than the 
minimum amount of crab consumed by males, 5627 glyr. The mean amount of crab 
consumed by males, 77 1 1 glyr, is 2.2 fold greater than the mean amount consumed by 
females, 3521 glyr over a year. The maximum amount of crabs consumed by males, 9400 
glyr is almost twice (1.9) the maximum amount consumed by females. 
7.7.8.3 Lifetime Average Daily Dose Associated with Hospital Beach Crab Consumption 
The frequency distribution that describes the LADD is bimodal as may be 
expected based on the frequency distribution for the amount of crab consumed per year 
(Figure 7.1 Oa). Again, the greater LADD values in the distribution represent predicted 
values for males, and the lower values represent the daily dose expected for females 
(Figure 7.1 Ob). However the frequency distributions, for each gender, overlap. The 
minimum LADD for males, 0.24 ngkg d-I, is lower than the maximum for females, 0.33 
ngkg 6'. This is due to the fact that the LADD frequency distribution represents a 
synthesis of the distributions for BaP-TEF concentrations in the muscle and 
hepatopancreas, and the frequency distributions representing intake rate, exposure 
frequency, and body weight. 
The mean LADD for males, 0.36 ngkg d-' was 1.8 fold greater than the mean 
LADD for females, 0.20 ngkg d-I. However, the maximum male LADD, 0.54 ngkg d-I, 
was only 1.6 fold greater than the maximum LADD for females due to the difference in 
shape for each mode of the frequency distribution. 
7.7.8.4 Lifetime Cancer Risk Associated with Consumption of Crabs from Hospital Beach 
The lifetime cancer risk for consuming crabs from the most PAH contaminated 
area of Kitimat Arm is summarised in Figure 7.1 la. The minimum cancer risk is 8.OE-7, 
while the maximum risk is 4.OE-6. This maximum risk is 4 times the acceptable cancer 
risk level (1 .OE-6). The mean cancer risk is 2.OE-6 for the entire population, double the 
acceptable level. The shape of the probability plot suggests that it is bimodal in nature. 
This might be expected from the bimodal nature of the frequency distributions for the 
amount of crab consumed and LADD. 
7.7.8.5 Gender Differences in Lifetime Cancer Risk 
Gender differences in the annual consumption of crab meals and LADD result in 
similar differences in the lifetime cancer risk estimated for both males and females. The 
differences in risk estimates are shown in Figure 7.1 1 b. It is readily apparent that females 
have a significantly lower lifetime cancer risk than males, mainly due to lower 
consumption rates. The mean cancer risk for females associated with the consumption of 
crabs from Hospital Beach, 1.5 E-6, is 1.8 fold lower than the mean risk for males, 2.6 E- 
6. While the mean risk for females is lower than that for males, it exceeds the acceptable 
cancer risk level. In fact, the 1 percentile risk value for females is 1.04 E-6. This means 
that 99% of women consuming crabs from Hospital Beach will have an excess lifetime 
cancer risk. All risk estimates for males were in excess of the acceptable cancer risk 
level. The model predicts that 95% of males will have a cancer risk greater than twice the 
acceptable cancer level, and 5% of males will have a risk greater than 3 times the 
acceptable cancer level. 
7.7.8.6 Comparison of Cancer Risk Calculated by Deterministic and Stochastic Risk 
Assessment Models 
The mean risk predicted by the stochastic model for crabs consumed from 
Hospital Beach is between the mean risk estimated for youth (1 2-1 7 yrs) and adults (1 9- 
49 yrs) using the deterministic model. The maximum risk is between the mean risk 
calculated for mature adults (50+ yrs) and children (1-1 0 yrs), (Figure 7.1 la). 
These risk estimates were obtained by running the stochastic model with an 
exposure frequency of 0 meals per month. Figure 7.2 shows that the highest probability 
for the number of meals consumed per month for both males and females in summer and 
winter months is 0. This is very significant because the deterministic risk model has no 
provision for including probabilities of different exposure levels, only the mean exposure 
values. As a result, the LADD and risk levels estimated by the deterministic method are 
expected to be more conservative than those obtained using the stochastic model. In order 
to examine this further, the Monte Carlo simulations were performed after removing the 
probabilities for 0 meals per month, so that consumers always consumed crab between 1 
to 8 times per month (Figure 7.2). 
Figure 7.12a shows that the LADD and risk estimates are shifted to the right when 
the minimum exposure frequency of 0 meals per month is removed. The mean LADD, is 
increased from 0.27 ngikg d-I to 0.47 ngkg d-', a 1.7 fold increase. Without the minimal 
exposure level, the LADD now exceeds the BC Ministry of Land Air Water and Parks 
acceptable limit of 0.41 ngikg d-' for benzo[a]pyrene equivalents. In addition, the mean 
LADD is much closer to the most conservative deterministic LADD estimates for mature 
adults and children (Figure 7.12a). 
The risk estimates are similarly increased from a mean of 2 E-6 to 3.5 E-6 (Figure 
7.12b) when the minimal exposure level of 0 meals of crab per month was removed. The 
mean risk was now much closer to the estimates obtained using the deterministic risk 
model. The maximum risk level was increased to 5.8 E-6, almost 6 times the acceptable 
risk level. Therefore, presence or absence of the minimum EF of 0 meals per month 
illustrates the main difference between the LADD and risk estimates obtained by the two 
risk assessment approaches. 
7.7.8.7 Lifetime Cancer Risk Associated with Consumption of Crabs from Four Sites in 
Kitimat Arm 
The concentrations of PAH determined in crab tissues were highest in crabs 
obtained from Hospital Beach. The other sites that were examined had much lower PAH 
concentrations in the hepatopancreas. The risk estimates obtained from the stochastic 
model for all four sites are summarised in Figure 7.13. The risk estimates based on either 
measured or PBTK model predicted BaP-TEF muscle tissue concentrations show that 
consumers are only at an excess cancer risk when consuming crab tissues from Hospital 
Beach. 
Crabs consumed from Kitamaat Village posed a greater health risk than those 
obtained from either Kildala Arm or Wathlsto Creek. The mean cancer risk estimates for 
the consumption of crabs collected near Kitamaat Village 2.8 - 2.9E-7, are approximately 
3.5 fold lower than the acceptable cancer limit while the mean risks estimated for 
consuming Kildala Arm or Wathlsto Creek crabs are 6 and 7 fold lower respectively 
(Figure 7.1 3). 
7.7.8.8 Uncertainty in Lifetime Cancer Risk Estimates 
There is some uncertainty in the lifetime cancer risk estimates that is linked to the 
uncertainty in the concentration of PAH in the muscle tissues. This uncertainty is 
represented in Figure 7.13. The greatest amount of uncertainty is related to the risk 
estimates for crabs consumed from Hospital Beach. The risk estimates are strongly 
related to the use of measured and PBTK model predicted BaP-TEF for the input 
distribution. If measured concentrations are used for the risk assessment, the mean 
estimated risk, 2.0 E-6, is 1.7 fold greater than the mean for combined measured and 
predicted values, 1.17E-6, and 2.2 fold greater than the mean for PBTK model predicted 
concentrations, 9.14E-7. As shown in Figure 7.13, the mean estimated risk is either above 
the acceptable cancer risk level, when measured, or combined measured and predicted 
concentrations are used, or below the acceptable risk, when only predicted concentrations 
are used. Analysis of the PBTK model predicted muscle concentrations indicated that 
they were under predicted in most cases (Chapter 5). Therefore, the "true" risk is 
probably closest to the risk estimated using measured BaP-TEF concentrations in the 
muscle tissue. 
Figure 7.13 indicates that there is less uncertainty in the risk estimates for 
Kitamaat Village based on the combined measured and predicted muscle tissue 
concentrations. This is mainly because there were fewer, namely 4, measured muscle 
tissue concentrations that might influence the predicted muscle concentrations in the 
input distributions. Also, there was a smaller difference between the combined measured 
and predicted BaP-TEF concentrations compared to those observed for Hospital Beach. 
Because the concentration of BaP-TEF in muscle tissues been shown to be a very 
sensitive parameter, it is important that a sufficient number of muscle tissue 
concentrations are available for the risk assessment to reduce uncertainty in the risk 
estimates. 
7.7.8.9 Implications of Stochastic Risk Assessment for the Local Aboriginal Population 
The results of the stochastic risk assessment have shown that consumption of 
crabs from sites in Kitimat Arm other than areas with high PAH concentrations such as 
Hospital Beach is reasonably safe. The maximum lifetime cancer risk estimates 
associated with males who consume crabs most regularly from the Kitamaat Village site 
were between 5.6 E-7 and 6.1 E-7, which is below the acceptable risk level. Similarly, the 
risk of cancer for the heaviest consumers of crabs from either Kildala Arm or Wathlsto 
Creek is below acceptable levels. Therefore, the consumption of crabs from areas that are 
not close to the source of PAH near the head of Kitimat Arm on the west side near the 
aluminium refinery can be considered to be safe in terms of PAH exposure. All 
consumers should avoid the regular consumption of crabs collected at Hospital Beach or 
other sites near the industrial area that are contaminated with PAH. The stochastic risk 
assessment has shown that the regular consumption of crabs collected from the Hospital 
Beach area poses an unacceptable lifetime cancer risk. 
7.7.9 Further Studies 
This risk assessment has focused on estimating the risk associated with the 
consumption of crab tissues by an aboriginal population, collected from an area known to 
be contaminated with PAH. Aboriginal populations in Canada are known to subsist to a 
great extent on wildlife obtained from their local environments. Therefore, a logical 
extension of this risk assessment would be to examine the risks associated with the 
consumption of other food organism collected from this region such as fish, shellfish, 
seals, deer, and other wildlife that are common dietary items. The Haisla Dietary Survey 
(Kitamaat Village Council, 1996) has information related to the consumption of other 
types of foods other than crabs. If data could be obtained for the concentrations of PAH 
or other potentially toxic compounds in other species, the scope of the risk assessment 
could be expanded to encompass the consumption of all fish and wildlife species. 
The uncertainty and sensitivity analyses have shown that it is important to have as 
much certainty in the input parameters as possible. Therefore, this risk assessment could 
be improved if more information was available for the most important input parameters 
such as exposure frequency, intake rate, and the concentrations of BaP-TEF in the muscle 
tissues of crabs collected from sites that are commonly used for crab fishing. The Haisla 
Dietary Survey has provided fairly detailed information on consumption of crab tissues 
that has been used in the model. However, more information on the concentration of PAH 
in the muscle of crabs could be obtained to reduce uncertainty in the risk assessment. 
The concentrations of PAH in crab tissues may change over time depending on in 
the flux of PAH into or out of the aquatic environment. PAH levels may increase over 
time through increased industrial activities, or they may decrease due to reductions in 
sediment concentrations caused by biological metabolism or sediment burial. The risk 
assessment is based on concentrations determined or estimated in crab tissues collected 
from Kitimat Arm over a finite period of four years. Therefore, this risk assessment could 
be updated periodically with new information regarding concentrations of PAH in crab 
tissues and local population statistics that influence exposure. 
The stochastic MEE model was implemented in Microsofi ~ x c e l @  and Visual 
~ a s i c @  because this framework allowed us to program loops in the model and the 
generation of randomly generated input distributions for each parameter. Crystal Ball is a 
software platform that is commonly used for stochastic risk assessment. However, at the 
time that the model was originally developed, Crystal Ball could not easily accommodate 
program loops. Since this time, Crystal Ball has been improved to incorporate this 
feature. Crystal Ball also has more tools that makes sensitivity and uncertainty analysis 
easier to perform. Therefore, if the current model was to be adapted for future risk 
assessments, it could be rewritten into the newest version of Crystal Ball. This would be 
beneficial if the model was expanded to incorporate all possible dietary sources of PAH. 
7.8 Conclusions 
A stochastic, micro-exposure event risk assessment model was implemented to 
examine the potential adverse health effects associated with the consumption of PAH 
contaminated crabs collected in Kitimat Arm. The stochastic model was used 
successfully to examine uncertainties in the deterministic risk assessment, and to 
incorporate inter-individual variability associated with a local aboriginal population 
situated in Kitamaat Village. The stochastic risk assessment showed that the deterministic 
risk approach (Chapter 6) yielded lifetime cancer risks that were a little more 
conservative than might be expected if inter-individual variation was incorporated into 
the risk assessment process. The stochastic risk assessment also corroborated the general 
level of risk (within an order of magnitude) that might be expected from the consumption 
of contaminated crab tissues collected from Kitimat Arm. 
This stochastic risk assessment has indicated that members of the local aboriginal 
population or other local residents in the Kitimat region should avoid consuming crabs 
from areas near the source of the PAH contamination such as Hospital Beach. The 
consumption of crabs from other sites in IQtimat Arm further away from the source of 
PAH contamination that are relatively "clean" such as Kddala Arm and Wathlsto Creek 
can be considered to be safe in terms of the lifetime risk of cancer due to the consumption 
of crab tissues. 
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APPENDICES 
Appendix A 
Concentrations of PAH in Tissues of Crabs Collected in Kitimat Arm 
Tables A-1 to A-6 present the concentrations of PAH determined in crab tissue 
samples. Non-detected concentrations are represented by the ESSDL, na = samples that 
were not analysed. Concentrations are nglg wet weight. 
Table A- 1. Concentrations of PAH in hepatopancreas of crabs collected from Hospital 
Beach 
-- 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
Table A-2. Concentrations of PAH in hepatopancreas of crabs collected from Kitamaat 
Village site 
- 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
KVC-01 
KVC-02 
KVC-03 
KVC-04 
KVC-06 
KVC-07 
KVC-08 
KVC-08 
KVC-09 
KVC- 10 
KVC-11 
KVC-12 
KVC- 1 3 
KVC- 14 
KVC- 15 
KVC- 1 6 
KVC- 17 
KVC- 1 8 
KVC- 19 
KVC-20 
KIT3-0 1 
KIT3-02 
KIT3-03 
KIT3-04 
KIT3-06 
KIT3-08 
KIT3-10 
KIT3-11 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
Table A-3. Concentrations of PAH in hepatopancreas of crabs collected from Wathlsto 
Creek site 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
Table A-4. Concentrations of PAH in hepatopancreas of crabs collected from Kildala 
Arm site 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
KIL-0 1 
KIL-02 
KIL-03 
KIL-04 
KIL-05 
KIL-06 
KIL-07 
KIL-08 
KIL-09 
KIL-10 
KIL-11 
KIL- 12 
KIL- 13 
KIL-14 
KIL- 15 
KIL-16 
KIL-17 
KIL-18 
KIL- 19 
KIL-20 
KIL-2 1 
KIL-22 
KIL-23 
KIL-24 
KIL-25 
KIL-26 
KIL-27 
KIL-28 
KIL-29 
KIL-30 
Table A-5. Concentrations of PAH in hepatopancreas of crabs collected from Kitkiatka 
Inlet site 
Sample ACN PHEN ANTH FLR PYR BA CRY BF BAP 
KIT-0 1 
KIT-02 
KIT-03 
KIT-04 
KIT-05 
KIT-06 
KIT-07 
KIT-09 
KIT- 10 
KIT- 1 1 
KIT- 12 
KIT-13 
KIT-14 
KIT-15 
Table A-6. Concentrations of PAH in muscle of crabs collected from Hospital Beach and 
Kitamaat Village sites 
Sample PHEN ANTH FLR PYR BA CRY BF BAP 
KIT2-08M 
KIT2-09M 
KIT2-1 IM 
KIT2- 1 5M 
KIT2- 1 7M 
KIT2-18M 
KIT2-34M 
KIT2-39M 
KIT2-42M 
KIT2-46M 
KIT2-50M 
KIT2-56M 
KIT2-57M 
KIT2-62M 
KIT2-64M 
KIT3-16M 
KIT3-30M 
KVC-07M 
KVC- 1 1 M 
Appendix B 
Concentrations of Hydroxypyrene equivalents Determined by SFS 
Table B- 1 presents concentrations of 1 -OH pyrene equivalents (1 -0HP) 
determined in the haemolymph of crabs collected from sites in Kitimat Arm. 
Concentrations are expressed in ng pyrene equivalents/ml haemolyrnph. 
Table B- 1 .  Concentrations of 1 -hydroxypyrene equivalents in haemolymph of crabs 
collected from Hospital Beach. 
Sample I-OHP Sample 1-OHP Sample I-OHP Sample 1-OHP 
Table B-2. Concentrations of 1 -hydroxypyrene equivalents in haemolymph of crabs 
collected from Kitamaat Village. 
Sample 1-OHP Sample 1-OHP Sample 1-OHP Sample 1-OHP 
KVC-0 1 
KVC-02 
KVC-03 
KVC-04 
KVC-07 
KVC-08 
KVC-08 
KVC-09 
KVC- 1 0 
KVC-11 
KVC- 1 2 
KVC-13 
KVC-14 
KVC- 1 5 
KVC- 16 
KVC- 17 
KVC- 1 8 
KVC- 1 9 
KIT3-01 
KlT3-02 
KIT3-03 
KIT3-04 
KIT3-06 
KIT3-08 
KIT3-10 
KIT3- 1 1 
Table B-3. Concentrations of 1 -hydroxypyrene equivalents in haemolymph of crabs 
collected from Wathlsto Creek. 
Sample 1-OHP Sample 1-OHP Sample 1-OHP Sample 1-OHP 
Table B-4. Concentrations of 1 -hydroxypyrene equivalents in haemolymph of crabs 
collected from Kildala Arm. 
Sample 1-OHP Sample 1-OHP Sample 1-OHP Sample 1-OHP 
KIL-0 1 0.27 KIL-09 0.29 KIL-17 0.33 KIL-25 0.14 
KIL-02 0.03 KIL- 10 0.37 KIL-18 0.34 KIL-26 0.23 
KIL-03 0.06 KIL-11 0.24 KIL- 19 0.12 KIL-27 0.27 
KIL-04 0.29 KIL-12 0.33 KIL-20 0.36 KIL-28 0.25 
KIL-05 0.17 KIL-13 0.36 KIL-21 0.16 KIL-29 0.38 
KIL-06 0.37 KIL- 14 0.27 KIL-22 0.10 KIL-30 0.23 
KIL-07 0.38 KIL- 1 5 0.40 KIL-23 0.27 
IUL-08 0.5 1 KIL- 16 0.32 KIL-24 0.1 5 
Table B-5. Concentrations of 1 -hydroxypyrene equivalents in haemolymph of crabs 
collected from Kitkiatka Inlet. 
- - -- 
Sample 1-OHP Sample 1-OHP Sample 1-OHP Sample 1-OHP 
KIT-03 0.19 KIT-06 0.18 KIT-10 0.42 KIT-1 3 0.43 
KIT-04 0.35 KIT-07 0.98 KIT-1 1 0.25 KIT- 14 0.22 
KIT-05 0.14 KIT-09 0.15 KIT- 12 0.25 KIT- 15 0.30 
Appendix C 
PBTK Model Equations 
The following mass balance differential and algebraic equations are used in the 
PBTK model to simulate the disposition of benzo[a]pyrene in the dungeness crab. 
E.l Equations which describe the uptake of benzo[a]pyrene into the gut 
compartment from the oral dose 
First order uptake in the gut is described by the following functions: 
RSTOM = URo(Ao)D (E2) 
where U& and k, are the first order uptake rate and rate constant respectively, RSTOM is 
the amount remaining in the stomach, A, is the bioavailability constant and D is the dose. 
The concentration, partition coefficient and volume parameters for the gut are represented 
by CGT, RGT and VGT. 
E.2 Equations which describe the uptake of benzo[a]pyrene into the gill 
compartment from the water 
The flux of chemical in the gill is described by the following equations: 
where the first order uptake function is described by: 
The uptake of benzo[a]pyrene in the gill is regulated by the water concentration, 
Cw, venous haemolyrnph concentration, CBV, gill ventilation rate, Qw, cardiac output, 
Qt, partition coefficient, RGL first order uptake rate constant, kb, and branchial 
bioavailability constant, Ab. 
E 3 Equations which describe the concentration of benzo[a]pyrene in the remaining 
tissue compartments: 
Arterial Haemolymph: 
where: CBA is the arterial haemolymph concentration, Qt is cardiac output, CGL 
is the gill compartment concentration, RGL is the gill partition coefficient, and VB is the 
volume of haemolymph compartment. 
Hepatopancreas: 
where: CL is the concentration of the hepatopancreas compartment, QL is the 
flow to the hepatopancreas, QGT is the flow to the gut, CGT is the concentration of the 
gut compartment, RGT is the gut partition coefficient, RL is the hepatopancreas partition 
coefficient, and the volume of the compartment is VL. Hepatic clearance is denoted by 
KL and the Michaelis-Menten rate constants are V,, and Km. 
Muscle: 
where: CM is concentration in the muscle, QM is the flow to the muscle, RM is 
the muscle partition coefficient, and VM is the volume of the muscle. 
Carcass: 
where: CC is the concentration of the carcass compartment, QC is the flow to the 
carcass, RC is the carcass partition coefficient, and VC is the volume of the carcass. 
Bladder: 
where: CK is the concentration in the bladder, QK is the flow to the bladder, KK 
is the bladder elimination constant, RK is the bladder partition coefficient, and VK is the 
volume of the compartment. 
Venous Haemolymph: 
where: CBV is the concentration in the venous haemolymph. 
Appendix D 
Visual Basic Code for Micro-exposure Event Stochastic Risk 
Assessment Model 
The Visual ~ a s i c @  macro that is built into the ~ x c e l @  spreadsheet for calculating 
stochastic micro-exposure event risk estimates is presented below. 
Model Code 
Monte Carlo Modelling of time-Dependent Exposures Using a Micro-exposure event 
approach for ingestion of crab. 
This model is the result of a labour of love of computer modelling by Thomas 
Achenbach and Curtis Eickhoff, and the lab and field work of Curtis Eickhoff 
'This model is copyright 0 1  998-2004 and may be used and distributed for educational 
purposes only. 
'This Model contains code fiom other sources. 
'The normal distribution function is fiom code by Dr. Michael P. McLaughlin fiom his 
Urandom library which is a Macintosh implementation of Ultra pseudo-random number 
generator by Dr. George Marsaglia and co - workers in the Dept. of Statistics, Florida 
State University 
'information on Urandom can be found at 
http://www.mactech.com/articles/mactech/Vol. 141 14.1 O/URandomLib/index.html 
Option Explicit 
Dim Bodywtaverage As Single 
Dim a As Single, dose As Single, bodyweight As Single, 
bodywtsum As Single, maxpeople As Integer, gender As Boolean 
Dim age As Integer, femalepercent As Single, gmaleagemean As 
Integer, gmaleagesd As Integer 
Dim gfemaleagemean As Integer, gfemaleagesd As Integer 
Const male = 1 
Const female = 0 
Dim gcrabmassmean As Single, gcrabmassSD As Single, 
ghcrabconcmean As Single, ghcrabconcSD As Single, 
gmcrabconcmean As Single, gmcrabconcSD As Single 
Dim gSchldIR As Single, musclepercent As Single, 
hepatopercent As Single 
Dim gSjuvIR As Single, gSadltIR As Single, gSmturIR As 
Single, gwchldIR As Single, gwjuvIR As Single, gwadltIR As 
Single, gwrnturIR As Single 
Dim gmchldmean As Single, gmchldsd As Single, gmjuvmean As 
Single, gmjuvsd As Single, gmadltmean As Single, gmadltsd As 
Single 
Dim gmmturmean As Single, gmmtursd As Single,, gfchldmean As 
Single, gfchldsd As Single, gfjuvmean As Single, gfjuvsd As 
Single, gfadltmean As Single, gfadltsd As Single, gfmturmean 
As Single, gfmtursd As Single 
Dim ghconcmax As Single, ghconcmin As Single, gmconcmax As 
Single, gmconcmin As Single, gcrabmassmin As Single, 
gcrabmassmax As Single 
Dim CV As Single 
Dim ageoption As Integer 
Dim siteindex As Integer 
Dim risk As Single, csf As Single, cf As Single 
Dim averageintake As Single 
Dim RanOY As Double 
Dim RanOV(97) As Double 
Dim aa, m, q, r As Integer 
Dim invm As Double 
Dim rndindex As Integer 
Private Sub initialize ( ) 
'Initial parameters 
rndindex = Range("rndindexw) 
maxpeople = Range("maxpeop1e") 
musclepercent = Range("musclepercentM) 
hepatopercent = Range ( "hepatopercent ) 
femalepercent = Range("femalepercentM) 
' Range ( llagelt) .Value = f emalepercent 
CV = Range ( "CV" ) . Value 
csf = Range ( "csf ) .Value 
cf = Range(Itcfn) .Value 
'this defines a named range of cells used for storing the 
output 
Names .Add ttLADDdatall, "=output !R2C2 :RIt & 
maxpeople + 1 & "C" & 6 & " "  
siteindex = Range("siteindexW) 
gcrabmassmean = Range ( ltcrabmassmeantt ) 
gcrabmassSD = Range ( "~rabmassSD~~) 
gcrabmassmin = Range("crabma~smin~~) 
gcrabmassmax = Range("crabmassmax") 
ghcrabconcmean = Range(~crabconcdata").Cells(l, 
siteindex) .Value 
ghcrabconcSD = Range ( llcrabconcdatall ) .Cells (4, 
siteindex) .Value 
gmcrabconcmean = Range("crabconcdata") .Cells(l, siteindex + 
4) .Value 
gmcrabconcSD = Range ( llcrabconcdatall ) . Cells (4, siteindex + 
4) .Value 
ghconcmax = Range("crabconcdata").Cells(3, siteindex) .Value 
ghconcmin = Range("crabconcdata").Cells(2, siteindex) .Value 
gmconcmax = Range("crabconcdata").Cells(3, siteindex + 
4) .Value 
gmconcmin = Range("crabconcdata11).Cells(2, siteindex + 
4 .Value 
gmaleagemean = Range("maleagemeanN) 
gmaleagesd = Range("maleagesdu) 
gfemaleagemean = Range("femaleagemeanfl) 
gfemaleagesd = Range("fema1eagesd") 
gmchldmean = Range("mch1dmean") 
gmchldsd = Range ( llmchldsdu 
gmj uvmean = Range ( "mj uvmean" ) 
gmjuvsd = Range ( "mjuvsd" )
gmadltmean = Range("madltmeanN) 
gmadltsd = Range("mad1tsd") 
gmmturmean = Range("mmturmean") 
gmmtursd = Range("mmtursd") 
gfchldmean = Range("fchldmeanM) 
gfchldsd = Range("fchldsdU) 
gf j uvmean = Range ( " f j uvmean" ) 
gfjuvsd = Range(llfjuvsd") 
gfadltmean = Range("fadltmeanM) 
gfadltsd = Range (Iffadltsd " )  
gfmturmean = Range ( " fmturmean" ) 
gfmtursd = Range("fmtursdn) 
gSchldIR = Range ( "SchldIRu ) 
gSjuvIR = Range (llSjuvIR1l) 
gSadltIR = Range("SadltIRn) 
gSmturIR = Range ( "SmturIRI1) 
gwchldIR = Range ( I1wchldIR" ) 
gwjuvIR = Range ( llwjuvIR1l ) 
gwadltIR = Range("wadltIRn) 
gwmturIR = Range ( "wmturIRI1 ) 
ageoption = Range("ageoptionn) 
End Sub 
Private Sub MainCalc(1R As Single) 
Dim crab As Single, muscle As Single, hepato As Single, 
tcrabmass As Single 
Dim Cmcrab As Single, Chcrab As Single, Muscleconc As 
Single, Hepatoconc As Single 
tcrabmass = 0 
Do 
crab = crabmass 
Cmcrab = crabmconc 
Chcrab = crabhconc 
muscle = crab * musclepercent 
hepato = crab * hepatopercent 
'if concentration is different in muscle and hepato then 
change this 
Muscleconc = Cmcrab ' *  muscle 
Hepatoconc = Chcrab ' *  hepato 
dose = dose + muscle * Muscleconc + hepato * Hepatoconc 
tcrabmass = tcrabmass + (muscle + hepato) * CV 
Loop Until tcrabmass >= IR 
End Sub 
Private Function crabmass0 
'make function get crab mass 
crabmass = lograndom(gcrabmassmean, gcrabmassSD, 
gcrabmassmin, gcrabmassmax) 'put proper values here 
End Function 
Private Function crabhconco 
'make function get crab Concentration 
crabhconc = lograndom(ghcrabconcmean, ghcrabconcSD, 
ghconcmin, ghconcmax) 
If crabhconc < 0 Then crabhconc = 0 
End Function 
Private Function crabmconc() 
'make function get crab Concentration 
crabmconc = lograndom(gmcrabconcmean, gmcrabconcSD, 
gmconcmin, gmconcmax) 
If crabmconc < 0 Then crabmconc = 0 
End Function 
Private Function getgender() 
Dim a As Single 
getgender = female 
Randomize 
a = Rnd 
If a > femalepercent Then getgender = male 
'Make function get gender 
End Function 
Private Function getage (gender) 
'make function get age 
'add stuff here if this is not a normal distribution 
Select Case gender 
Case male 
'get age using male data 
getage = Int (random (gmaleagemean, gmaleagesd, 0, 
7 5 )  
Case female 
'get age using female data 
getage = Int(random(gfemaleagemean, gfemaleagesd, 0, 
75)) 
End Select 
End Function 
Private Function getbodywt(gender, age) 
Select Case gender 
'get bodywt using male age 
Case male 
Select Case age 
Case 1 To 11 
getbodywt = lograndom(gmchldmean, 
gmchldsd, 18, 45) 
Case 12 To 17 
getbodywt = lograndom (gm j uvmean, 
gmjuvsd, 43, 118) 
Case 18 To 49 
getbodywt = lograndom(gmadltmean, 
gmadltsd, 64, 126) 
Case Is > 49 
getbodywt = lograndom(gmmturmean, 
gmmtursd, 76, 108) 
End Select 
'get bodywt using female age 
Case female 
Select Case age 
Case 1 To 11 
getbodywt = lograndom(gfchldmean, 
gfchldsd, 21, 52) 
Case 12 To 17 
getbodywt = lograndom(gfjuvmean, 
gfjuvsd, 39, 60) 
Case 18 To 49 
getbodywt = lograndom(gfadltmean, 
gfadltsd, 55, 100) 
Case Is > 49 
getbodywt = lograndom(gfmturmean, 
gfmtursd, 64, 102) 
End Select 
End Select 
End Function 
Private Sub getnewperson(gender, age, bodyweight) 
gender = getgender 
Do 
age = getage(gender) 
Loop Until age > 0 
Do 
bodyweight = getbodywt (gender, age) 
Loop Until bodyweight > 0 
End Sub 
Private Function NewsummerIR(gender) 
Dim probability As Single 
Randomi ze 
probability = Int((100 - 0 + 1) * Rnd) 
Select Case gender 
Case female 
Select Case probability 
Case 0 To 7 
NewsummerIR = 59 
Case 8 To 20 
NewsummerIR = 104 
Case 21 To 27 
NewsummerIR = 118 
Case 28 To 73 
NewsummerIR = 237 
Case 74 To 80 
NewsummerIR = 327 
Case 81 To 100 
NewsummerIR = 710 
End Select 
Case male 
Select Case probability 
Case 0 To 3 
NewsummerIR = 59 
Case 4 To 14 
NewsummerIR = 118 
Case 15 To 28 
NewsummerIR = 237 
Case 29 To 36 
NewsummerIR = 327 
Case 37 To 56 
NewsummerIR = 473 
Case 57 To 92 
NewsummerIR = 710 
Case 93 To 94 
NewsummerIR = 946 
Case 95 To 1 0 0  
NewsummerIR = 1 4 2 0  
End Selec t  
End Selec t  
End Function 
Pr ivate  Function summerexposurefr(gender) 
D i m  p robab i l i ty  A s  Single 
Randomize 
p robab i l i ty  = I n t ( ( 1 0 0  - 0 + 1) * Rnd) 
Selec t  Case gender 
Case female 
Selec t  Case p robab i l i ty  
Case 0 To 54 
surnmerexposurefr = 0 
Case 55 To 62 
surnmerexposurefr = 1 
Case 63 To 85 
summerexposurefr = 2 
Case 86 To 98 
surnmerexposurefr = 4 
Case 9 9  To 1 0 0  
surnmerexposurefr = 8 
End Selec t  
Case male 
Selec t  Case p robab i l i ty  
Case 0 To 31 
surnmerexposurefr = 0 
Case 32 To 51 
surnmerexposurefr = 1 
Case 52 To 75 
surnmerexposurefr = 2 
Case 76 To 87 
surnmerexposurefr = 3 
Case 88 To 9 7  
surnmerexposurefr = 4 
Case 98 To 1 0 0  
surnmerexposurefr = 8 
End Selec t  
End Selec t  
End Function 
Pr ivate  Function NewWinterIR(gender) 
D i m  p robab i l i ty  A s  Single 
Randomize 
p robab i l i ty  = I n t ( ( 1 0 0  - 0 + 1) * Rnd) 
Selec t  Case gender 
Case female 
Select Case probability 
Case 0 To 4 
NewWinterIR = 15 
Case 5 To 18 
NewWinterIR = 59 
Case 19 To 39 
NewWinterIR = 118 
Case 40 To 68 
NewWinterIR = 237 
Case 69 To 71 
NewWinterIR = 327 
Case 72 To 93 
NewWinterIR = 473 
Case 94 To 96 
NewWinterIR = 654 
Case 97 To 100 
NewWinterIR = 710 
End Select 
Case male 
Select Case probability 
Case 0 To 7 
NewWinterIR = 59 
Case 8 To 14 
NewWinterIR = 104 
Case 15 To 24 
NewWinterIR = 118 
Case 25 To 48 
NewWinterIR = 237 
Case 49 To 62 
NewWinterIR = 327 
Case 63 To 83 
NewWinterIR = 473 
Case 84 To 86 
NewWinterIR = 654 
Case 87 To 97 
NewWinterIR = 946 
Case 98 To 100 
NewWinterIR = 1420 
End Select 
End Select 
End Function 
Private Function Winterexposurefr(gender) 
Dim probability As Single 
Randomize 
probability = Int((100 - 0 + 1) * Rnd) 
Select Case gender 
Case female 
Select Case probability 
Case 0 To 42 
Winterexposurefr = 0 
Case 43 To 76 
Winterexposurefr = 1 
Case 77 To 94 
Winterexposurefr = 2 
Case 94 To 100 
Winterexposurefr = 3 
End Select 
Case male 
Select Case probability 
Case 0 To 48 
Winterexposurefr = 0 
Case 49 To 69 
Winterexposurefr = 1 
Case 70 To 86 
Winterexposurefr = 2 
Case 87 To 95 
Winterexposurefr = 3 
Case 96 To 98 
Winterexposurefr = 4 
Case 99 To 100 
Winterexposurefr = 8 
End Select 
End Select 
End Function 
Private Function summerIR(age As Integer) 
'function to determine summerIR 
Select Case age 
Case 1 To 11 
summerIR = gSchldIR 
Case 12 To 17 
summerIR = gSjuvIR 
Case 18 To 49 
summerIR = gSadltIR 
Case Is > 49 
summerIR = gSmturIR 
End Select 
End Function 
Private Function WinterIR(age As Integer) 
'function to determine winterIR 
Select Case age 
Case 1 To 11 
WinterIR = gwchldIR 
Case 12 To 17 
WinterIR = gwjuvIR 
Case 18 To 49 
WinterIR = gwadltIR 
Case Is > 49 
WinterIR = gwmturIR 
End Select 
End Function 
Sub Main ( )  
Cells (2, 1) .Value = Now 
Dim IR As Single, people As Integer, startage As Integer, 
count As Integer 
'initialize all the variables 
initialize 
'set people to zero hence we are starting the model 
people = 0 
'This DO loop does the life cycles of the number of 
persons defined on the spreadsheet 
Do 
people = people + 1 
getnewperson gender, age, bodyweight 
'checks to see if we want to start our population as 
babies 
If ageoption = True Then age = 1 
startage = age 
dose = 0 
bodywtsum = 0 
averageintake = 0 
'This DO loop does the life cycle of a person till 
they are 76 
Do 
'If the age is 12, 18 or 4 9  we need to find a new 
body weight 
Select Case age 
Case 12, 18, 4 9  
bodyweight = getbodywt(gender, age) 
End Select 
'add bodyweight for calculation of risk 
bodywtsum = bodywtsum + bodyweight 
'Determine summer intake rate 
IR = 0 
For count = 1 To 6 
IR = IR + NewsummerIR(gender) * 
summerexposurefr(gender) 
Next count 
MainCalc (IR) 
averageintake = averageintake + IR 
'Determine winter intake rate 
IR = 0 
For count = 1 To 6 
IR = IR + NewWinterIR(gender) * 
Winterexposurefr(gender) 
Next count 
MainCalc (IR) 
averageintake = averageintake + IR 
age = age + 1 
'age is 76 since we want to include the 75 th year 
Loop Until age >= 76 
If age <> startage Then 
Bodywtaverage = bodywtsum / (age - startage) 
averageintake = averageintake / (age - startage) 
Else '<-this else is here to catch people who 
started off at age 75 
Bodywtaverage = bodywtsum 
averageintake = averageintake 
End If 
DetermineLADD people 
Loop Until people = maxpeople 
Cells (3, 1) .Value = Now 
End Sub 
Private Sub DetermineLADD(peop1e As Integer) 
Dim ladd As Single 
'is this bodywtaverage or bodywtsum 
ladd = 1 / (75 * 365) * 1 / Bodywtaverage * dose 
add a storage routine for storing LADD (array or on 
spreadsheet 
Select Case gender 
Case False 
Range ("LADD") .Cells (people, 1) .Value = 
I1f emale" 
Case Else 
Range ("LADD") .Cells (people, 1) .Value = 
"male I' 
End Select 
Range (llLADD1l) .Cells (people, 2) .Value = ladd 
risk = ladd * csf * cf 
Range ("LADD") .Cells (people, 3) .Value = risk 
Range ("LADD") .Cells (people, 4) .Value = averageintake 
Range ( "laddU ) . Cells (people, 5) .Value = crabmconc 
Range("laddU) .Cells(people, 6) .Value = crabhconc 
End Sub 
Function random (mean, sd, min, max) 
Dim sigma, zeta As Double 
Select Case rndindex 
Case 3 
Case Else 
random = normal (mean, sd, min, max) 
End Select 
End Function 
Private Function normal (mean, sd, min, max) 
Dim u, v, r, sigma, zeta As Single, z As Double 
Do 
Do 
Select Case rndindex 
Case 1 
u = -1 + 2 * Rnd 
v = -1 + 2 * Rnd 
Case 2 
u = -1 + 2 * RandShuffle(1) 
v = -1 + 2 * RandShuffle(1) 
End Select 
'{see if it is in the unit circle } 
r = u * u + v * v  
Loop Until (r < 1 And r <> 0 )  
z = u * Sqr(-2# * Log(r) / r) 
normal = Exp(sd * z + mean) 
Loop Until (normal < max) And (normal > min) 
End Function 
Function lograndom (mean, sd, min, max) 
Select Case rndindex 
Case 3 
Range(llcrystalballrndoutput").Activate 
'cb.DefineAssumND cbDfaLognorma1, mean, sd, mini max 
'lograndom = Range(ncrystalballrnd~utput~l) .Value 
Case Else 
lograndom = lognormalcalc(mean, sd, min, max) 
End Select 
End Function 
Function lognormalcalc(mean, sd, min, max) 
'This function returns a random number from a lognormal 
distribution. 
'One thing to note is that the incoming mean and SD are 
arithmic and we convert to normal distribution return log 
Dim u, v, r, normal, sigma, zeta As Single, z As Double 
'this code here converts from arithmic to normal 
sigma = Sqr(Log(1 + sd A 2 / mean A 2)) 
zeta = Log(mean) - 0.5 * sigma A 2 
Do 
Do 
Select Case rndindex 
Case 1 
u = -1 + 2 * Rnd 
v = -1 + 2 * Rnd 
Case 2 
u = -1 + 2 * RandShuffle(1) 
v = -1 + 2 * RandShuffle(1) 
End Select 
'{see if it is in the unit circle } 
r = u * u + v * v  
Loop Until (r < 1 And r < >  0) 
normal = u * Sqr(-2# * Log(r) / r) 
lognormalcalc = Exp(sigma * normal + zeta) 
Loop Until (lognormalcalc < max) And (lognormalcalc > min) 
End Function 
Sub testtest ( )  
Dim i As Integer, j As Integer, probability As Integer, 
crabmass As Single 
Randomize 
rndindex = Range ( "rndindex" )
Randshuffle (-3) 
For j = 1 To 1 
For i = 1 To 1 
'crabmass = newlog(l.191, 1.773, 0.03, 9.907) 
Range (llcrystalballrndoutput ' I )  .Activate 
lcb.DefineAssumND cbDfaLognorma1, 1.191, 1.773, , 0.03, 
9.9, I1Fredl1 
'crabmass = lograndom(l.l91, 1.773, 0.03, 9.907) 
'crabmass = newlog(0.288, 0.188, 0.013, 0.843) 
Cells(i, j) .Value = crabmass 
Next i 
Next j 
End Sub 
'this function generates a random number from a normal 
distribution with a Mean and SD 
'This is the old method of use 
Private Function oldrandom(mean, sd, min, max) 
Dim n As Single, j As Integer 
Do 
Randomize 
n = O  
For j = 1 To 12 
n = n + Rnd 
Next j 
random = (n - 6) * sd + mean 
Loop Until (random c max) And (random > min) 
End Function 
Private Function oldlograndom (mean, sd, mint max) 
Dim n As Double, j As Integer, lsd As Double, lmean As 
Double, lrandom As Double 
'remember in visual basic log = In 
A lsd = Sqr(Log(1 + sd 2 / mean A 2)) 
lmean = Log (mean) - 0.5 * lsd A 2 
Randomize 
Do 
n = O  
For j = 1 To 12 
n = n + Rnd 
Next j 
lrandom = (n - 6) * lsd + lmean 
lograndom = Exp(1random) 
Loop Until (lograndom c max) And (lograndom > min) 
End Function 
'this function stores 100 random numbers and then picks and 
replaces that random number, this prevents any artefacts of 
the newly 
'generated number having dependencies on the previous number 
which is known to occur in Excel's Random number generator 
Function RandShuffle(idum As Integer) 
Dim dum As Double 
Dim j As Integer 
If idum c 0 Then 
Randomize (-idurn) 
For j = 1 To 97 
dum = Rnd ( ) 
Next 
For j = 1 To 97 
RanOV(j) = Rnd() 
Next 
RanOY = RndO 
End If 
RanOY = RndO 
j = 1 + Int(97 * RanOY) 
If ( j  > 9 7 )  Or ( j  < 1) Then 
MsgBox "Error" 
End If 
RanOY = RanOV( j ) 
Randshuffle = RanOY 
RanOV(j) = RndO 
End Function 
